Voya Financial (VOYA) 10-Q 4 Aug 22 2022 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - $ / shares	6 Months Ended
	Jun. 30, 2022	Jul. 29, 2022	Dec. 31, 2021	May 01, 2020
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2022
Document Transition Report	false
Entity File Number	001-35897
Entity Registrant Name	Voya Financial, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	52-1222820
Entity Address, Address Line One	230 Park Avenue
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10169
City Area Code	212
Local Phone Number	309-8200
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		97,918,656
Common stock, par value	$ 0.01		$ 0.01	$ 0.01
Entity Central Index Key	0001535929
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q2
Amendment Flag	false
Common Stock, $.01 par value
Entity Information [Line Items]
Title of 12(b) Security	Common Stock, $.01 par value
Trading Symbol	VOYA
Security Exchange Name	NYSE
Depositary Shares, each representing a 1/40th
Entity Information [Line Items]
Title of 12(b) Security	Depositary Shares, each representing a 1/40th
Trading Symbol	VOYAPrB
Security Exchange Name	NYSE

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Investments:
Short-term investments under securities loan agreements, including collateral delivered	$ 1,123,000,000	$ 1,108,000,000
Accrued investment income	413,000,000	428,000,000
Premium receivable and reinsurance recoverable	13,117,000,000	13,663,000,000
Less: Allowance for credit losses on reinsurance recoverable	38,000,000	28,000,000
Premium receivable and reinsurance recoverable, net	13,079,000,000	13,635,000,000
Deferred policy acquisition costs and Value of business acquired	2,480,000,000	1,378,000,000
Deferred income taxes	1,795,000,000	986,000,000
Assets related to consolidated investment entities:
Assets held in separate accounts	80,017,000,000	100,433,000,000
Total assets	147,520,000,000	171,262,000,000
Liabilities and Shareholders' Equity:
Future policy benefits	9,970,000,000	9,952,000,000
Contract owner account balances	43,181,000,000	42,806,000,000
Payables under securities loan and repurchase agreements, including collateral held	1,220,000,000	1,183,000,000
Short-term debt	1,000,000	1,000,000
Long-term debt	2,385,000,000	2,595,000,000
Derivatives	307,000,000	231,000,000
Pension and other postretirement provisions	205,000,000	226,000,000
Current income taxes	19,000,000	23,000,000
Liabilities related to consolidated investment entities:
Liabilities related to separate accounts	80,017,000,000	100,433,000,000
Total liabilities	141,307,000,000	161,441,000,000
Commitments and Contingencies (Note 14)
Shareholders' equity:
Preferred stock ($0.01 par value per share; $625 aggregate liquidation preference as of 2022 and 2021 respectively)	0	0
Common stock ($0.01 par value per share; 900,000,000 shares authorized; 110,634,763 and 108,987,650 shares issued as of 2022 and 2021, respectively; 97,912,907 and 107,758,376 shares outstanding as of 2022 and 2021, respectively)	1,000,000	1,000,000
Treasury stock (at cost; 12,721,856 and 1,229,274 shares as of 2022 and 2021, respectively)	(821,000,000)	(80,000,000)
Additional paid-in capital	7,500,000,000	7,542,000,000
Accumulated other comprehensive income (loss)	(963,000,000)	2,100,000,000
Retained earnings (deficit):
Unappropriated	(1,201,000,000)	(1,310,000,000)
Total Voya Financial, Inc. shareholders' equity	4,516,000,000	8,253,000,000
Noncontrolling interest	1,697,000,000	1,568,000,000
Total shareholders' equity	6,213,000,000	9,821,000,000
Total liabilities and shareholders' equity	147,520,000,000	171,262,000,000
Allowance for credit Losses	4,000,000	0
Excluding consolidated VIEs
Investments:
Fixed maturities, available-for-sale, at fair value (amortized cost of $31,205 as of 2022 and $30,656 as of 2021; allowance for credit losses of $47 as of 2022 and $58 as of 2021)	29,324,000,000	33,699,000,000
Fixed maturities, at fair value using the fair value option	2,159,000,000	2,354,000,000
Equity securities, at fair value (cost of $234 as of 2022 and $240 as of 2021)	234,000,000	240,000,000
Short-term investments	36,000,000	97,000,000
Mortgage loans on real estate	5,415,000,000	5,627,000,000
Less: Allowance for credit losses	12,000,000	15,000,000
Mortgage loans on real estate, net	5,403,000,000	5,612,000,000
Policy loans	373,000,000	392,000,000
Limited partnerships/corporations	1,848,000,000	1,739,000,000
Derivatives	277,000,000	171,000,000
Other investments	76,000,000	79,000,000
Securities pledged (amortized cost of $1,265 as of 2022 and $1,091 as of 2021)	1,183,000,000	1,198,000,000
Total investments	40,913,000,000	45,581,000,000
Cash and cash equivalents	954,000,000	1,402,000,000
Other assets (net of allowance for credit losses of $4 as of 2022 and $0 as of 2021)	2,581,000,000	2,532,000,000
Liabilities and Shareholders' Equity:
Other liabilities	1,848,000,000	2,098,000,000
VIEs
Investments:
Limited partnerships/corporations	2,943,000,000	2,469,000,000
Cash and cash equivalents	85,000,000	171,000,000
Other assets (net of allowance for credit losses of $4 as of 2022 and $0 as of 2021)	15,000,000	28,000,000
Assets related to consolidated investment entities:
Corporate loans, at fair value using the fair value option	1,122,000,000	1,111,000,000
Total assets	4,165,000,000	3,779,000,000
Liabilities and Shareholders' Equity:
Other liabilities	1,135,000,000	1,013,000,000
Liabilities related to consolidated investment entities:
Collateralized loan obligations notes, at fair value using the fair value option	$ 1,019,000,000	$ 880,000,000

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Fixed maturities, amortized cost	$ 31,205,000,000	$ 30,656,000,000
Fixed maturities, allowance for credit losses	47,000,000	58,000,000
Equity Securities, cost	234,000,000	240,000,000
Securities pledged, amortized costs	1,265,000,000	1,091,000,000
Allowance for credit Losses	$ 4,000,000	$ 0
Preferred stock, par value (usd per share)	$ 0.01	$ 0.01
Preferred stock, aggregate liquidation preference	$ 625,000,000	$ 625,000,000
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	900,000,000	900,000,000
Common stock, shares issued	110,634,763	108,987,650
Common stock, shares outstanding	97,912,907	107,758,376
Treasury stock, shares	12,721,856	1,229,274

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Revenues:
Net investment income	$ 581	$ 656	$ 1,211	$ 1,370
Fee income	411	436	844	894
Premiums	595	516	1,208	(4,471)
Net gains (losses):
Total impairments	(2)	0	(9)	0
Other net gains (losses)	(225)	(37)	(503)	1,705
Total net gains (losses)	(227)	(37)	(512)	1,705
Other revenue	44	374	84	484
Income (loss) related to consolidated investment entities:
Net investment income	115	558	198	564
Total revenues	1,519	2,503	3,033	546
Benefits and expenses:
Policyholder benefits	406	457	837	(3,977)
Interest credited to contract owner account balances	237	229	471	473
Operating expenses	605	706	1,237	1,308
Net amortization of Deferred policy acquisition costs and Value of business acquired	67	26	147	565
Interest expense	33	39	73	88
Operating expenses related to consolidated investment entities:
Interest expense	13	12	19	17
Other expense	5	6	5	6
Total benefits and expenses	1,366	1,475	2,789	(1,520)
Income (loss) from continuing operations before income taxes	153	1,028	244	2,066
Income tax expense (benefit)	10	112	17	64
Income (loss) from continuing operations	143	916	227	2,002
Income (loss) from discontinued operations, net of tax	0	(6)	0	8
Net income (loss)	143	910	227	2,010
Less: Net income (loss) attributable to noncontrolling interest	75	447	118	447
Net income (loss) available to Voya Financial, Inc.	68	463	109	1,563
Less: Preferred stock dividends	4	4	18	18
Net income (loss) available to Voya Financial, Inc.'s common shareholders	$ 64	$ 459	$ 91	$ 1,545
Net income (loss) per common share:
Income (loss) from continuing operations available to Voya Financial, Inc.'s common shareholders	$ 0.62	$ 3.86	$ 0.88	$ 12.64
Income (loss) available to Voya Financial, Inc.'s common shareholders	0.62	3.81	0.88	12.71
Income (loss) from continuing operations available to Voya Financial, Inc.'s common shareholders	0.57	3.58	0.80	11.78
Income (loss) available to Voya Financial, Inc.'s common shareholders	$ 0.57	$ 3.53	$ 0.80	$ 11.84

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 143	$ 910	$ 227	$ 2,010
Other comprehensive income (loss), before tax:
Unrealized gains (losses) on securities	(1,886)	661	(3,877)	(2,829)
Pension and other postretirement benefits liability	0	(1)	0	(1)
Other comprehensive income (loss), before tax	(1,886)	660	(3,877)	(2,830)
Income tax expense (benefit) related to items of other comprehensive income (loss)	(396)	139	(814)	(363)
Other comprehensive income (loss), after tax	(1,490)	521	(3,063)	(2,467)
Comprehensive income (loss)	(1,347)	1,431	(2,836)	(457)
Less: Comprehensive income (loss) attributable to noncontrolling interest	75	447	118	447
Comprehensive income (loss) attributable to Voya Financial, Inc.	$ (1,422)	$ 984	$ (2,954)	$ (904)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($) $ in Millions	Total	Total Voya Financial, Inc. Shareholders' Equity	Preferred Stock	Common Stock	Treasury Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Retained Earnings (Deficit), Unappropriated	Noncontrolling Interest
Beginning balance at Dec. 31, 2020	$ 11,178	$ 10,110	$ 0	$ 2	$ (1,016)	$ 11,183	$ 4,898	$ (4,957)	$ 1,068
Comprehensive income (loss):
Net income (loss)	2,010	1,563	0	0	0	0	0	1,563	447
Reversal of Other Comprehensive Income (Loss) due to Individual Life Transaction	913	913					913
Other comprehensive income (loss), after tax	(1,554)	(1,554)	0	0	0	0	(1,554)		0
Other comprehensive income (loss), after tax	(2,467)							0
Less: Comprehensive income (loss) attributable to noncontrolling interest	447								447
Comprehensive income (loss)	(457)	(904)
Net consolidations (deconsolidations) of consolidated investment entities	8	0		0		0	0	0	8
Common stock issuance	2	2				2	0	0
Common stock acquired - Share repurchase	(803)	(803)	0	0	(753)	(50)	0	0
Dividends on preferred stock	(18)	(18)	0	0	0	(18)	0	0
Dividends on common stock	(40)	(40)	0	0	0	(40)	0	0
Share-based compensation	15	15	0	0	(51)	66	0
Contributions from (Distributions to) noncontrolling interest, net	(110)		0	0	0	0	0		(110)
Ending Balance at Jun. 30, 2021	9,775	8,362	0	2	(1,820)	11,143	2,431	(3,394)	1,413
Beginning balance at Mar. 31, 2021	8,999	7,931	0	2	(1,301)	11,177	1,910	(3,857)	1,068
Comprehensive income (loss):
Net income (loss)	910	463	0	0	0	0	0	463	447
Other comprehensive income (loss), after tax	521	521					521
Other comprehensive income (loss), after tax	521		0	0	0	0		0	0
Less: Comprehensive income (loss) attributable to noncontrolling interest	447								447
Comprehensive income (loss)	1,431	984
Net consolidations (deconsolidations) of consolidated investment entities	8		0						8
Common stock issuance			0	0	0				0
Common stock acquired - Share repurchase	(548)	(548)	0	0	(518)	(30)	0	0	0
Dividends on preferred stock	(4)	(4)	0	0	0	4	0	0	0
Dividends on common stock	(20)	(20)	0	0	0	(20)	0	0	0
Share-based compensation	19	19	0	0	(1)	20	0	0	0
Contributions from (Distributions to) noncontrolling interest, net	(110)	0	0	0	0	0	0	0	(110)
Ending Balance at Jun. 30, 2021	9,775	8,362	0	2	(1,820)	11,143	2,431	(3,394)	1,413
Beginning balance at Dec. 31, 2021	9,821	8,253	0	1	(80)	7,542	2,100	(1,310)	1,568
Comprehensive income (loss):
Net income (loss)	227	109	0	0	0		0	109	118
Other comprehensive income (loss), after tax	(3,063)	(3,063)	0	0	0	0	(3,063)	0	0
Other comprehensive income (loss), after tax	(3,063)
Less: Comprehensive income (loss) attributable to noncontrolling interest	118								118
Comprehensive income (loss)	(2,836)	(2,954)
Common stock issuance	2	2	0	0	0	2	0	0	0
Common stock acquired - Share repurchase	(750)	(750)	0	0	(700)	(50)	0	0	0
Dividends on preferred stock	(18)	(18)	0	0	0	(18)	0	0	0
Dividends on common stock	(41)	(41)	0	0	0	(41)	0	0	0
Share-based compensation	24	24	0	0	(41)	65	0	0	0
Contributions from (Distributions to) noncontrolling interest, net	11	0	0	0	0	0	0	0	11
Ending Balance at Jun. 30, 2022	6,213	4,516	0	1	(821)	7,500	(963)	(1,201)	1,697
Beginning balance at Mar. 31, 2022	7,704	6,198	0	1	(565)	7,504	527	(1,269)	1,506
Comprehensive income (loss):
Net income (loss)	143	68	0	0	0	0	0	68	75
Other comprehensive income (loss), after tax	(1,490)	(1,490)		0	0	0	(1,490)	0	0
Less: Comprehensive income (loss) attributable to noncontrolling interest	75								75
Comprehensive income (loss)	(1,347)	(1,422)
Common stock acquired - Share repurchase	(250)	(250)	0	0	(255)	5	0	0	0
Dividends on preferred stock	(4)	(4)	0	0	0	(4)	0	0	0
Dividends on common stock	(20)	(20)	0	0	0	(20)	0	0	0
Share-based compensation	14	14	0	0	(1)	15	0	0	0
Contributions from (Distributions to) noncontrolling interest, net	116	0	0	0	0		0	0	116
Ending Balance at Jun. 30, 2022	$ 6,213	$ 4,516	$ 0	$ 1	$ (821)	$ 7,500	$ (963)	$ (1,201)	$ 1,697

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Cash Flows from Operating Activities:
Net cash provided by (used in) operating activities - continuing operations	$ 715	$ (75)
Net cash (used in) operating activities - discontinued operations	0	(250)
Net cash provided by (used in) operating activities	715	(325)
Proceeds from the sale, maturity, disposal or redemption of:
Fixed maturities	3,454	2,996
Equity securities	0	193
Mortgage loans on real estate	545	356
Limited partnerships/corporations	127	549
Acquisition of:
Fixed maturities	(4,613)	(3,589)
Fixed maturities, trading	0	(45)
Equity securities	0	(271)
Mortgage loans on real estate	(330)	(334)
Limited partnerships/corporations	(177)	(231)
Short-term investments, net	61	82
Derivatives, net	116	12
Sales from consolidated investment entities	578	508
Purchases within consolidated investment entities	(1,426)	(771)
Proceeds from sale of business	0	250
Collateral (delivered) received, net	23	16
Receipts on deposit asset contracts	60	28
Other investments, net	8	508
Net cash used in investing activities - discontinued operations	0	376
Net cash (used in) provided by investing activities	(1,574)	633
Cash Flows from Financing Activities:
Deposits received for investment contracts	3,548	3,132
Maturities and withdrawals from investment contracts	(3,112)	(3,300)
Settlements on deposit liability contracts	(3)	(4)
Repayment of debt with maturities of more than three months	(215)	(85)
Borrowings of consolidated investment entities	959	398
Repayments of borrowings of consolidated investment entities	(309)	(97)
Contributions from (distributions to) participants in consolidated investment entities, net	322	(143)
Proceeds from issuance of common stock, net	2	2
Share-based compensation	(40)	(41)
Common stock acquired - Share repurchase	(750)	(392)
Dividends paid on common stock	(18)	(18)
Dividends paid on preferred stock	(41)	(40)
Principal payments for financing leases	(13)	(13)
Other	(5)	0
Net cash provided by (used in) financing activities	325	(601)
Net decrease in cash and cash equivalents, including cash in CIEs	(534)	(293)
Cash and cash equivalents, including cash in CIEs, beginning of period	1,573	2,143
Cash and cash equivalents, including cash in CIEs, end of period	1,039	1,850
Total cash and cash equivalents, including cash in CIEs	1,039	$ 1,850
Excluding consolidated VIEs
Cash and cash equivalents	954
VIEs
Cash and cash equivalents	$ 85

Business, Basis of Presentation

Business, Basis of Presentation and Significant Accounting Policies	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
Business, Basis of Presentation and Significant Accounting Policies	Business, Basis of Presentation and Significant Accounting Policies Business Voya Financial, Inc. and its subsidiaries (collectively the "Company") is a financial services organization in the United States that offers a broad range of retirement services, investment management services, mutual funds, group insurance and supplemental health products. P roducts and services are provided by the Company through three segments: Wealth Solutions, Health Solutions and Investment Management . Activities not directly related to the Company's segments and certain run-off activities that are not meaningful to the Company's business strategy are included within Corporate. See the Segments Note to these Condensed Consolidated Financial Statements. On January 4, 2021, the Company completed a series of transactions pursuant to a Master Transaction Agreement (the “Resolution MTA”) entered into on December 18, 2019 with Resolution Life U.S. Holdings Inc., a Delaware corporation (“Resolution Life US”), pursuant to which Resolution Life US acquired all of the shares of the capital stock of Security Life of Denver Company ("SLD") and Security Life of Denver International Limited ("SLDI"), including the capital stock of several subsidiaries of SLD and SLDI. The Company will continue to hold an insignificant number of Individual Life, and non-Wealth Solutions annuity policies which together with the businesses sold through divestment or reinsurance will be referred to as "divested businesses". Concurrently with the sale, SLD entered into reinsurance agreements with insurance subsidiaries of the Company. Pursuant to these agreements, the Company's subsidiaries reinsured to SLD certain individual life insurance and annuity businesses. The sale of SLD, SLDI and several of their subsidiaries along with the aforementioned reinsurance transactions are referred to herein as the "Individual Life Transaction". The Individual Life Transaction resulted in the disposition of substantially all of the Company's life insurance and legacy non-Wealth Solutions annuity businesses and related assets. On June 9, 2021, the Company completed the sale of the independent financial planning channel of Voya Financial Advisors (“VFA”) to Cetera Financial Group, Inc. (“Cetera”), one of the nation's largest networks of independently managed broker-dealers. In connection with this transaction, the Company transferred more than 800 independent financial professionals serving retail customers with approximately $38 billion in assets under advisement to Cetera, while retaining approximately 500 field and phone-based financial professionals who support our Wealth Solutions business. On July 25, 2022, the Company completed a series of transactions pursuant to a Combination Agreement dated June 13, 2022 (the “Agreement”) with Voya Investment Management LLC, a Delaware limited liability company and an indirect subsidiary of the Company (“Voya IM”), Allianz SE, a stock corporation organized and existing under the laws of the European Union and the Federal Republic of Germany (“Allianz”), Allianz Global Investors U.S. LLC, a Delaware limited liability company and an indirect subsidiary of Allianz (“AGI U.S.”), and VIM Holdings LLC, a newly formed Delaware limited liability company (“Newco”), pursuant to which the parties have combined Voya IM with assets and teams comprising specified transferred strategies managed by AGI U.S. Under the terms of the Agreement, AGI U.S. transferred to Newco the rights to certain assets and liabilities related to specified investment teams and strategies and the associated assets under management (the “AGI Transferred Business”). The Company transferred all of the limited liability company interests in Voya IM to Newco and in exchange, received a 76% economic stake in Newco's class A shares. Pursuant to the Amended and Restated Limited Liability Company Agreement of Newco entered into at the closing date (“A&R Newco Operating Agreement”), the Company now holds, indirectly, a 76% economic stake in Newco's class A shares and Allianz holds, indirectly, a 24% economic stake in Newco's class A shares. Furthermore, Newco holds all of the limited liability company interests in Voya IM and certain assets and liabilities transferred from AGI U.S. related to specified investment teams and strategies and the associated assets under management.. In accordance with the A&R Newco Operating Agreement, the Company has full operational control of Newco, Voya IM and the transferred assets and investment teams. The Company is in the process of determining the fair value of the identifiable assets and liabilities assumed as well as the impact of the transaction to Total shareholders’ equity. As such, an estimate of the financial impact of the acquisition cannot be currently made. On August 1, 2022, Voya Investment Management Alternative Assets, LLC (“VIMAA”), one of the Company’s indirect subsidiaries, entered into a Sale and Purchase Agreement (“SPA”) with Czech Management GP, LLC and Czech Holdings, LLC, both Delaware limited liability companies whereby VIMAA will acquire all of the issued and outstanding equity interests of Czech Asset Management, L.P., a Delaware limited partnership ("CAM"). CAM is a private credit asset manager dedicated to the U.S. middle market. The acquisition, which is expected to close for cash consideration in the fourth quarter of 2022, will expand Voya IM's private and leveraged credit business and is subject to conditions as defined in the SPA. Impairment of Long-lived Assets The carrying value of long-lived assets is reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. An impairment loss is recognized whenever the carrying amount of an asset exceeds its estimated fair value. The amount of the impairment loss is calculated as the excess of the asset’s carrying value over its fair value. During the second quarter of 2022, the Company had a triggering event related to a decrease in the market price of one of its office buildings. Consequently, the Company determined its fair value, based on an appraisal, to be lower than its carrying value. As a result, the Company recognized an impairment loss of $32, which is included in Operating expenses in the Condensed Consolidated Statement of Operations for the three and six months ended June 30, 2022. Revision of Prior Period Financial Statements During the second quarter of 2022, the Company identified a presentation error related to a misclassification in the change in cash held by consolidated investment entities within the Condensed Consolidated Statement of Cash Flows. This error resulted in the total end of period cash and cash equivalents in the Condensed Consolidated Statement of Cash Flows not to reconcile to all cash and cash equivalents line items presented in the Condensed Consolidated Balance Sheet. The Company assessed the materiality of the error on prior period financial statements in accordance with the Accounting Changes and Error Corrections guidance. The Company has corrected the presentation error in the comparative period for the six months ended June 30, 2021 and evaluated the materiality of such error based on relevant quantitative and qualitative factors in relation to the Condensed Consolidated Financial Statements. The Company’s evaluation of the qualitative factors included, but was not limited to, consideration of the users of the Condensed Consolidated Financial Statements; there was no impact to net income, comprehensive income, total stockholders' equity or amounts on the Condensed Consolidated Balance Sheet; there was no impact on regulatory capital, cash balances or any liquidity measures; and there was no impact on any contractual or regulatory requirements. Based on this evaluation, the Company concluded that the error in the Condensed Consolidated Statement of Cash Flows did not result in a material misstatement of previously issued financial statements. The following table presents the impact of the error on the specific line items in the Condensed Consolidated Statement of Cash Flows: Six Months Ended June 30, 2021 As Reported Adjustments As Adjusted Net cash provided by (used in) operating activities $ (189) $ (136) $ (325) Net decrease in cash and cash equivalents, including cash in CIEs (157) (136) (293) Cash and cash equivalents, including cash in CIEs, beginning of period 1,922 221 2,143 Cash and cash equivalents, including cash in CIEs, end of period 1,765 85 1,850 Basis of Presentation The accompanying Condensed Consolidated Financial Statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP") and are unaudited. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the Condensed Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. The inputs into the Company's estimates and assumptions consider the economic implications of COVID-19 on the Company's critical and significant accounting estimates. Those estimates are inherently subject to change and actual results could differ from those estimates, and the differences may be material to the Condensed Consolidated Financial Statements. The Condensed Consolidated Financial Statements include the accounts of Voya Financial, Inc. and its subsidiaries, as well as other voting interest entities ("VOEs") and variable interest entities ("VIEs") in which the Company has a controlling financial interest. See the Consolidated and Nonconsolidated Investment Entities Note to these Condensed Consolidated Financial Statements. Intercompany transactions and balances have been eliminated. The accompanying Condensed Consolidated Financial Statements reflect adjustments (including normal, recurring adjustments) necessary to present fairly the financial position of the Company as of June 30, 2022, its results of operations, comprehensive income and changes in shareholders' equity for the three and six months ended June 30, 2022 and 2021, and its statements of cash flows for the six months ended June 30, 2022 and 2021, in conformity with U.S. GAAP. Interim results are not necessarily indicative of full year performance. Certain reclassifications have been made to prior-period amounts to conform to current-period reporting classifications. These reclassifications had no impact on Net income (loss) or Total shareholders’ equity. The December 31, 2021 Consolidated Balance Sheet is from the audited Consolidated Financial Statements included in the Company's Annual Report on Form 10-K , filed with the SEC. Therefore, these unaudited Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and related notes included in the Company's Annual Report on Form 10-K . Future Adoption of Accounting Pronouncements The following table provides a description of future adoptions of new accounting standards that may have an impact on the Company's financial statements when adopted: Standard Description of Requirements Effective Date and Transition Provisions Effect on the Financial Statements or Other Significant Matters Accounting Standards Update (“ASU”) 2022-03, Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions This standard, issued in June 2022, clarifies that contractual restrictions on equity security sales are not considered part of the security unit of account and, therefore, are not considered in measuring fair value. In addition, the restrictions cannot be recognized and measured as separate units of account. Disclosures on such restrictions are also required. The amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, and are required to be applied prospectively, with any adjustments from the adoption recognized in earnings and disclosed. The Company is currently in the process of determining the impact of adoption of the provisions of ASU 2022-03. ASU 2022-02, Troubled Debt Restructurings ("TDRs") and Vintage Disclosures This standard, issued in March 2022, eliminates the accounting guidance on troubled debt restructurings for creditors, requires enhanced disclosures for creditors about loan modifications when a borrower is experiencing financial difficulty, and requires public business entities to include current-period gross write-offs in the vintage disclosure tables. The amendments are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Entities have the option to apply the amendments involving the recognition and measurement of TDRs using a modified retrospective transition method; the other amendments are required to be applied prospectively. The Company is currently in the process of determining the impact of adoption of the provisions of ASU 2022-02. Standard Description of Requirements Effective Date and Transition Provisions Effect on the Financial Statements or Other Significant Matters ASU 2020-04, Reference Rate Reform This standard, issued in March 2020, provides temporary optional expedients and exceptions for applying U.S. GAAP principles to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. In January, 2021, the Financial Accounting Standards Board ("FASB") issued ASU 2021-01, which clarified the scope of relief related to ASU 2020-04. The amendments are effective as of March 12, 2020, the issuance date of the ASU. An entity may elect to apply the amendments prospectively through December 31, 2022. The Company expects that it may elect to apply some of the expedients and exceptions provided in ASU 2020-04; however, the Company is still evaluating its options under this guidance as the reference rate reform adoption process continues. To date, adoption of the ASU has not had an impact on the Company’s financial condition and results of operations. The Company will continue to evaluate the impacts of reference rate reform on contract modifications and hedging relationships as transition progresses. ASU 2018-12 This standard, issued in August 2018, changes the measurement and disclosures of insurance liabilities and deferred acquisition costs ("DAC") for long-duration contracts issued by insurers. In addition to expanded disclosures, the standard’s requirements include: • Annual review and, if necessary, update of cash flow assumptions used to measure the liability for future policy benefits for nonparticipating traditional and limited payment insurance contracts. The effect of updating cash flow assumptions will be measured on a retrospective catch-up basis and presented in the Statement of Operations in the period in which the update is made. The rate used to discount these liabilities will be required to be updated quarterly, with related changes in the liability recorded in Accumulated other comprehensive income ("AOCI"). The amendments are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Initial adoption for the liability for future policy benefits and DAC is required to be reported using either a full retrospective or modified retrospective approach. For market risk benefits, full retrospective application is required. Evaluation of the implications of these requirements and related potential financial statement impacts is continuing, in accordance with an established governance framework and implementation plan, which includes design and testing of internal controls related to new processes. The Company does not plan to early adopt the ASU and expects to apply a modified retrospective transition method for the liability of future policy benefits and DAC. The Company expects the January 1, 2021 transition impact will increase Total shareholders’ equity by $0.1 billion to $0.3 billion, primarily driven by a positive impact to AOCI resulting from the reversal of DAC, value of business acquired ("VOBA"), and other adjustment balances of approximately $1.3 billion after tax, offset by an unfavorable impact to AOCI of between $1.0 billion and $1.2 billion after tax resulting from the remeasurement of Future policy benefits and Reinsurance recoverables using January 1, 2021 discount rates. The expected transition effect on Total shareholders’ equity will also include an unfavorable impact on Retained earnings (deficit) of approximately $0.1 billion after tax associated with the establishment of MRB liabilities related to guaranteed minimum benefits on certain deferred annuity contracts. Standard Description of Requirements Effective Date and Transition Provisions Effect on the Financial Statements or Other Significant Matters ASU 2018-12 • Fair value measurement of contract guarantee features qualifying as Market Risk Benefits (“MRB”), with changes in fair value recognized in the Statement of Operations, except for changes in the instrument-specific credit risk, which will be recorded in AOCI. • Amortization of DAC on a constant level basis over the expected term of the contracts, without reference to revenue or profitability. Elimination of adjustments in AOCI related to DAC and balances amortized on a basis consistent with DAC. DAC will no longer be subjected to loss recognition testing. The majority of the ASU 2018-12 transition impact of between $1.0 billion and $1.2 billion associated with Future policy benefits and Reinsurance recoverables and approximately 50% of the $0.1 billion transition impact associated with the establishment of MRB liabilities are related to business that was reinsured to Resolution Life US in January 2021. The ultimate effects the standard will have on the financial statements are highly dependent on policyholder behavior, actuarial assumptions and macroeconomic conditions, particularly interest rates and spreads, which may materially change ASU 2018-12-related equity impacts in periods subsequent to transition. The Company estimates the impact of ASU 2018-12 will shift to a reduction of Total shareholders’ equity as of June 30, 2022, primarily related to a negative impact in AOCI resulting from the reversal of DAC, VOBA, and other adjustment balances, which have declined significantly since January 2021 due to increases in interest rates and spreads. While rising interest rates since January 1, 2021 will result in a less unfavorable impact on AOCI due to remeasurement of liability for Future policy benefits, this will be materially offset by the impact from remeasurement of Reinsurance recoverables .

Discontinued Operations

Discontinued Operations	6 Months Ended
	Jun. 30, 2022
Discontinued Operations and Disposal Groups [Abstract]
Discontinued Operations	Discontinued Operations As noted in the Business, Basis of Presentation and Significant Accounting Policies Note, on January 4, 2021, the Company sold several of its subsidiaries and the related Individual Life and fixed and variable annuities businesses within these subsidiaries to Resolution Life US pursuant to the Resolution MTA entered into on December 18, 2019. The Company determined that the entities disposed of met the criteria to be classified as discontinued operations and that the sale represented a strategic shift that had a major effect on the Company’s operations. Income (loss) from discontinued operations, net of tax, for the six months ended June 30, 2021 included a reduction to loss on sale, net of tax of $8 associated with the transaction. For more information related to this transaction, refer to the Discontinued Operations Note to the Consolidated Financial Statements included in Part II, Item 8 of the Annual Report on form 10-K. Subsequent to the close of the transaction, the Company incurred loss recognition of $523, which is inclusive of $302 of DAC/VOBA write down and $221 of premium deficiency reserve. The DAC/VOBA write down and the premium deficiency reserve were recorded in Net amortization of DAC/VOBA and Policyholder benefits, respectively in the Condensed Consolidated Financial Statements for the six months ended June 30, 2021.

Investments (excluding Consolid

Investments (excluding Consolidated Investment Entities)	6 Months Ended
	Jun. 30, 2022
Investments, Debt and Equity Securities [Abstract]
Investments (excluding Consolidated Investment Entities)	50% - 60% >60% - 70% >70% - 80% >80% and above Total 2022 $ 151 $ 101 $ 59 $ — $ — $ 311 2021 247 314 206 10 — 777 2020 115 244 34 10 — 403 2019 194 173 65 — — 432 2018 161 46 3 — — 210 2017 648 203 4 — — 855 2016 and prior 2,014 390 23 — — 2,427 Total $ 3,530 $ 1,471 $ 394 $ 20 $ — $ 5,415 As of December 31, 2021 Loan-to-Value Ratios Year of Origination 0% - 50% >50% - 60% >60% - 70% >70% - 80% >80% and above Total 2021 $ 269 $ 315 $ 201 $ — $ — $ 785 2020 140 240 77 — — 457 2019 201 192 69 — — 462 2018 169 50 2 — — 221 2017 656 214 4 — — 874 2016 and prior 2,220 584 24 — — 2,828 Total $ 3,655 $ 1,595 $ 377 $ — $ — $ 5,627 The following tables present commercial mortgage loans by year of origination and DSC ratio as of the dates indicated. The information is updated as of June 30, 2022 and December 31, 2021, respectively. As of June 30, 2022 Debt Service Coverage Ratios Year of Origination >1.5x >1.25x - 1.5x >1.0x - 1.25x <1.0x Commercial mortgage loans secured by land or construction loans Total 2022 $ 311 $ — $ — $ — $ — $ 311 2021 650 26 36 65 — 777 2020 310 36 33 24 — 403 2019 254 13 106 59 — 432 2018 127 7 53 23 — 210 2017 495 61 114 185 — 855 2016 and prior 1,829 311 193 94 — 2,427 Total $ 3,976 $ 454 $ 535 $ 450 $ — $ 5,415 As of December 31, 2021 Debt Service Coverage Ratios Year of Origination >1.5x >1.25x - 1.5x >1.0x - 1.25x <1.0x Commercial mortgage loans secured by land or construction loans Total 2021 $ 652 $ 27 $ 38 $ 68 $ — $ 785 2020 396 21 34 6 — 457 2019 278 49 108 27 — 462 2018 131 5 54 31 — 221 2017 414 156 111 193 — 874 2016 and prior 2,237 242 242 107 — 2,828 Total $ 4,108 $ 500 $ 587 $ 432 $ — $ 5,627 The following tables present the commercial mortgage loans by year of origination and U.S. region as of the dates indicated. The information is updated as of June 30, 2022 and December 31, 2021, respectively. As of June 30, 2022 U.S. Region Year of Origination Pacific South Atlantic Middle Atlantic West South Central Mountain East North Central New England West North Central East South Central Total 2022 $ 38 $ 49 $ 18 $ 60 $ 85 $ 38 $ 4 $ 1 $ 18 $ 311 2021 98 72 138 139 110 142 9 47 22 777 2020 74 176 22 24 32 40 2 8 25 403 2019 59 143 14 109 47 10 15 13 22 432 2018 50 63 57 10 14 10 — 6 — 210 2017 126 92 349 137 54 55 5 37 — 855 2016 and prior 683 550 477 118 183 207 51 123 35 2,427 Total $ 1,128 $ 1,145 $ 1,075 $ 597 $ 525 $ 502 $ 86 $ 235 $ 122 $ 5,415 As of December 31, 2021 U.S. Region Year of Origination Pacific South Atlantic Middle Atlantic West South Central Mountain East North Central New England West North Central East South Central Total 2021 $ 98 $ 79 $ 143 $ 137 $ 110 $ 140 $ 9 $ 47 $ 22 $ 785 2020 84 187 31 35 39 39 3 14 25 457 2019 59 145 14 130 47 17 15 13 22 462 2018 54 68 59 10 14 10 — 6 — 221 2017 128 94 360 139 56 56 5 36 — 874 2016 and prior 718 617 590 159 256 239 71 142 36 2,828 Total $ 1,141 $ 1,190 $ 1,197 $ 610 $ 522 $ 501 $ 103 $ 258 $ 105 $ 5,627 The following tables present the commercial mortgage loans by year of origination and property type as of the dates indicated. The information is updated as of June 30, 2022 and December 31, 2021, respectively. As of June 30, 2022 Property Type Year of Origination Retail Industrial Apartments Office Hotel/Motel Other Mixed Use Total 2022 $ 24 $ 118 $ 155 $ 14 $ — $ — $ — $ 311 2021 38 172 412 128 — 18 9 777 2020 58 74 111 160 — — — 403 2019 46 94 200 66 26 — — 432 2018 37 86 56 13 — 18 — 210 2017 108 403 193 147 4 — — 855 2016 and prior 819 401 529 390 76 159 53 2,427 Total $ 1,130 $ 1,348 $ 1,656 $ 918 $ 106 $ 195 $ 62 $ 5,415 As of December 31, 2021 Property Type Year of Origination Retail Industrial Apartments Office Hotel/Motel Other Mixed Use Total 2021 $ 39 $ 185 $ 405 $ 129 $ — $ 18 $ 9 $ 785 2020 58 90 140 169 — — — 457 2019 46 96 211 82 27 — — 462 2018 38 88 57 16 4 18 — 221 2017 110 417 195 149 3 — — 874 2016 and prior 936 566 576 398 93 205 54 2,828 Total $ 1,227 $ 1,442 $ 1,584 $ 943 $ 127 $ 241 $ 63 $ 5,627 The following table summarizes the activity in the allowance for losses for commercial mortgage loans for the periods indicated: June 30, 2022 December 31, 2021 Allowance for credit losses, beginning of period $ 15 $ 89 Credit losses on mortgage loans for which credit losses were not previously recorded — 1 Change in allowance due to transfer of loans from Voya Reinsurance portfolios to Resolution — (14) Increase (decrease) on mortgage loans with allowance recorded in previous period (3) (61) Provision for expected credit losses 12 15 Write-offs — — Recoveries of amounts previously written-off — — Allowance for credit losses, end of period $ 12 $ 15 The following table presents past due commercial mortgage loans as of the dates indicated: June 30, 2022 December 31, 2021 Delinquency: Current $ 5,415 $ 5,627 30-59 days past due — — 60-89 days past due — — Greater than 90 days past due — — Total $ 5,415 $ 5,627 Commercial mortgage loans are placed on non-accrual status when 90 days in arrears if the Company has concerns regarding the collectability of future payments, or if a loan has matured without being paid off or extended. As of June 30, 2022 and December 31, 2021, the Company had no commercial mortgage loan in non-accrual status. There was no interest income recognized on loans in non-accrual status for the six months ended June 30, 2022 and year ended December 31, 2021. Net Investment Income The following table summarizes Net investment income for the periods indicated: Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Fixed maturities $ 495 $ 497 $ 974 $ 1,012 Equity securities 5 6 9 11 Mortgage loans on real estate 60 64 119 125 Policy loans 5 5 11 11 Short-term investments and cash equivalents 2 4 3 5 Limited partnerships and other 29 97 125 240 Gross investment income 596 673 1,241 1,404 Less: Investment expenses 15 17 30 34 Net investment income $ 581 $ 656 $ 1,211 $ 1,370 As of June 30, 2022, the Company had $32 of investments in fixed maturities that did not produce net investment income. As of December 31, 2021, the Company had no investments in fixed maturities that did not produce net investment income. Fixed maturities are moved to a non-accrual status when the investment defaults. Interest income on fixed maturities is recorded when earned using an effective yield method, giving effect to amortization of premiums and accretion of discounts. Such interest income is recorded in Net investment income in the Condensed Consolidated Statements of Operations. Net Gains (Losses) Net gains (losses) comprise the difference between the amortized cost of investments and proceeds from sale and redemption, as well as losses incurred due to the credit-related and intent-related impairment of investments. Realized investment gains and losses are also primarily generated from changes in fair value of embedded derivatives within products and fixed maturities, changes in fair value of fixed maturities recorded at FVO and changes in fair value including accruals on derivative instruments, except for effective cash flow hedges. Net gains (losses) also include changes in fair value of trading debt securities and changes in fair value of equity securities. The cost of the investments on disposal is generally determined based on first-in-first-out ("FIFO") methodology. Net gains (losses) were as follows for the periods indicated: Three Months Ended June 30, 2022 2021 Fixed maturities, available-for-sale, including securities pledged $ (6) $ 15 Fixed maturities, at fair value option (245) (129) Equity securities, at fair value (24) 5 Derivatives 32 (39) Embedded derivatives - fixed maturities (2) — Guaranteed benefit derivatives 12 (9) Mortgage loans 1 25 Other investments 5 95 Net gains (losses) $ (227) $ (37) Six Months Ended June 30, 2022 2021 Fixed maturities, available-for-sale, including securities pledged $ (79) $ 1,783 Fixed maturities, at fair value option (550) (377) Equity securities, at fair value (32) 11 Derivatives 126 (16) Embedded derivatives - fixed maturities (6) (5) Guaranteed benefit derivatives 18 48 Mortgage Loans 5 163 Other investments 6 98 Net gains (losses) $ (512) $ 1,705 On June 1, 2021, the Company fully disposed of a 9.99% equity interest in VA Capital which was originally acquired as part of a Master Transaction Agreement dated December 20, 2017, related to the sale of substantially all of our Closed Block Variable Annuity (CBVA) and Annuity business. The disposition resulted in a net realized gain of $95 reported as Other net gains (losses) in the Condensed Consolidated Statements. Proceeds from the sale of fixed maturities, available-for-sale and trading, and equity securities and the related gross realized gains and losses, before tax, were as follows for the periods indicated: Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 (1) 2021 Proceeds on sales $ 971 $ 608 $ 2,220 $ 10,213 Gross gains 15 14 30 1,711 Gross losses 12 — 44 2 (1) Decrease from prior year is the result of the transfer of assets to support the life reinsurance transaction with Resolution." id="sjs-B4">Investments (excluding Consolidated Investment Entities) Fixed Maturities Available-for-sale and fair value option ("FVO") fixed maturities were as follows as of June 30, 2022: Amortized Cost Gross Unrealized Capital Gains Gross Unrealized Capital Losses Embedded Derivatives (2) Fair Value Allowance for credit losses Fixed maturities: U.S. Treasuries $ 800 $ 93 $ 9 $ — $ 884 $ — U.S. Government agencies and authorities 58 6 1 — 63 — State, municipalities and political subdivisions 993 4 69 — 928 — U.S. corporate public securities 10,211 265 933 — 9,541 2 U.S. corporate private securities 4,993 38 289 — 4,742 — Foreign corporate public securities and foreign governments (1) 3,356 42 317 — 3,057 24 Foreign corporate private securities (1) 3,391 15 166 — 3,222 18 Residential mortgage-backed securities 4,330 53 205 6 4,183 1 Commercial mortgage-backed securities 4,351 9 317 — 4,042 1 Other asset-backed securities 2,146 3 144 — 2,004 1 Total fixed maturities, including securities pledged 34,629 528 2,450 6 32,666 47 Less: Securities pledged 1,265 22 104 — 1,183 — Total fixed maturities $ 33,364 $ 506 $ 2,346 $ 6 $ 31,483 $ 47 (1) Primarily U.S. dollar denominated. (2) Embedded derivatives within fixed maturity securities are reported with the host investment. The changes in fair value of embedded derivatives are reported in Other net gains (losses) in the Condensed Consolidated Statements of Operations. Available-for-sale and FVO fixed maturities were as follows as of December 31, 2021: Amortized Cost Gross Unrealized Capital Gains Gross Unrealized Capital Losses Embedded Derivatives (2) Fair Value Allowance for credit losses Fixed maturities: U.S. Treasuries $ 764 $ 239 $ — $ — $ 1,003 $ — U.S. Government agencies and authorities 69 12 — — 81 — State, municipalities and political subdivisions 1,000 112 1 — 1,111 — U.S. corporate public securities 10,402 1,580 41 — 11,941 — U.S. corporate private securities 4,889 459 23 — 5,325 — Foreign corporate public securities and foreign governments (1) 3,373 368 18 — 3,723 — Foreign corporate private securities (1) 3,320 238 1 — 3,501 56 Residential mortgage-backed securities 4,183 139 31 12 4,302 1 Commercial mortgage-backed securities 4,032 173 22 — 4,183 — Other asset-backed securities 2,069 25 12 — 2,081 1 Total fixed maturities, including securities pledged 34,101 3,345 149 12 37,251 58 Less: Securities pledged 1,091 107 — — 1,198 — Total fixed maturities $ 33,010 $ 3,238 $ 149 $ 12 $ 36,053 $ 58 (1) Primarily U.S. dollar denominated. (2) Embedded derivatives within fixed maturity securities are reported with the host investment. The changes in fair value of embedded derivatives are reported in Other net gains (losses) in the Condensed Consolidated Statements of Operations. The amortized cost and fair value of fixed maturities, including securities pledged, as of June 30, 2022, are shown below by contractual maturity. Actual maturities may differ from contractual maturities as securities may be restructured, called or prepaid. Mortgage-backed securities ("MBS") and Other asset-backed securities ("ABS") are shown separately because they are not due at a single maturity date. Amortized Fair Due to mature: One year or less $ 766 $ 742 After one year through five years 4,212 4,102 After five years through ten years 5,129 4,886 After ten years 13,695 12,707 Mortgage-backed securities 8,681 8,225 Other asset-backed securities 2,146 2,004 Fixed maturities, including securities pledged $ 34,629 $ 32,666 As of June 30, 2022 and December 31, 2021, the Company did not have any investments in a single issuer, other than obligations of the U.S. Government and government agencies, with a carrying value in excess of 10% of the Company’s Total shareholders' equity. The following tables present the composition of the U.S. and foreign corporate securities within the fixed maturity portfolio by industry category as of the dates indicated: Amortized Gross Gross Fair June 30, 2022 Communications $ 1,313 $ 46 $ 90 $ 1,269 Financial 4,056 60 364 3,752 Industrial and other companies 9,187 114 754 8,547 Energy 1,879 66 113 1,832 Utilities 3,757 63 235 3,585 Transportation 1,150 7 94 1,063 Total $ 21,342 $ 356 $ 1,650 $ 20,048 December 31, 2021 Communications $ 1,261 $ 238 $ 3 $ 1,496 Financial 3,752 394 13 4,133 Industrial and other companies 9,600 1,058 32 10,626 Energy 1,907 314 18 2,203 Utilities 3,782 499 11 4,270 Transportation 1,130 93 1 1,222 Total $ 21,432 $ 2,596 $ 78 $ 23,950 The Company invests in various categories of collateralized mortgage obligations (CMOs), including CMOs that are not agency-backed, that are subject to different degrees of risk from changes in interest rates and defaults. The principal risks inherent in holding CMOs are prepayment and extension risks related to significant decreases and increases in interest rates resulting in the prepayment of principal from the underlying mortgages, either earlier or later than originally anticipated. As of June 30, 2022 and December 31, 2021, approximately 38.9% and 40.6%, respectively, of the Company's CMO holdings, were invested in the above mentioned types of CMOs such as interest-only or principal-only strips, that are subject to more prepayment and extension risk than traditional CMOs. Public corporate fixed maturity securities are distinguished from private corporate fixed maturity securities based upon the manner in which they are transacted. Public corporate fixed maturity securities are issued initially through market intermediaries on a registered basis or pursuant to Rule 144A under the Securities Act of 1933 (the "Securities Act") and are traded on the secondary market through brokers acting as principal. Private corporate fixed maturity securities are originally issued by borrowers directly to investors pursuant to Section 4(a)(2) of the Securities Act, and are traded in the secondary market directly with counterparties, either without the participation of a broker or in agency transactions. Repurchase Agreements As of June 30, 2022 and December 31, 2021, the Company did not have any securities pledged in dollar rolls or reverse repurchase agreements. As of June 30, 2022, the carrying value of securities pledged and obligation to repay loans related to repurchase agreement transactions were $108 and included in Securities pledged and Payables under securities loan and repurchase agreements, including collateral held on the Condensed Consolidated Balance Sheets. As of December 31, 2021, the carrying value of securities pledged and obligation to repay loans related to repurchase agreement transactions were $105. Securities pledged related to repurchase agreements are comprised of other asset-backed securities. Securities Pledged The Company engages in securities lending whereby the initial collateral is required at a rate of 102% of the market value of the loaned securities. The lending agent retains the collateral and invests it in high quality liquid assets on behalf of the Company. The market value of the loaned securities is monitored on a daily basis with additional collateral obtained or refunded as the market value of the loaned securities fluctuates. The lending agent indemnifies the Company against losses resulting from the failure of a counterparty to return securities pledged where collateral is insufficient to cover the loss. As of June 30, 2022 and December 31, 2021, the fair value of loaned securities was $913 and $969, respectively, and is included in Securities pledged on the Condensed Consolidated Balance Sheets. If cash is received as collateral, the lending agent retains the cash collateral and invests it in short-term liquid assets on behalf of the Company. As of June 30, 2022 and December 31, 2021, cash collateral retained by the lending agent and invested in short-term liquid assets on the Company's behalf was $819 and $884, respectively, and is recorded in Short-term investments under securities loan agreements, including collateral delivered on the Condensed Consolidated Balance Sheets. As of June 30, 2022 and December 31, 2021, liabilities to return collateral of $819 and $884, respectively, are included in Payables under securities loan and repurchase agreements, including collateral held on the Condensed Consolidated Balance Sheets. The Company accepts non-cash collateral in the form of securities. The securities retained as collateral by the lending agent may not be sold or re-pledged, except in the event of default, and are not reflected on the Company’s Condensed Consolidated Balance Sheets. This collateral generally consists of U.S. Treasury, U.S. Government agency securities and MBS pools. As of June 30, 2022 and December 31, 2021, the fair value of securities retained as collateral by the lending agent on the Company’s behalf was $132 and $117, respectively. The following table presents borrowings under securities lending transactions by asset class pledged as of the dates indicated: June 30, 2022 December 31, 2021 U.S. Treasuries $ 41 $ 42 U.S. Government agencies and authorities 3 3 U.S. corporate public securities 605 599 Foreign corporate public securities and foreign governments 302 357 Payables under securities loan agreements $ 951 $ 1,001 The Company's securities lending activities are conducted on an overnight basis, and all securities loaned can be recalled at any time. The Company does not offset assets and liabilities associated with its securities lending program. Allowance for credit losses The following table presents a rollforward of the allowance for credit losses on available-for-sale fixed maturity securities for the periods presented: Six Months Ended June 30, 2022 U.S. corporate private securities Residential mortgage-backed securities Commercial mortgage-backed securities Foreign corporate public securities and foreign governments Foreign corporate private securities Other asset-backed securities Total Balance as of January 1 $ — $ 1 $ — $ — $ 56 $ 1 $ 58 Credit losses on securities for which credit losses were not previously recorded 2 1 1 24 — 1 29 Initial allowance for credit losses recognized on financial assets accounted for as PCD — — — — — — — Reductions for securities sold during the period — — — — (41) — (41) Reductions for intent to sell or more likely than not will be required to sell securities prior to recovery of amortized cost — — — — — — — Change in allowance due to transfer of loans from Voya Reinsurance portfolios to Resolution — — — — — — — Increase (decrease) on securities with allowance recorded in previous period — (1) — — 3 (1) 1 Write-offs — — — — — — — Recoveries of amounts previously written-off — — — — — — — Balance as of June 30 $ 2 $ 1 $ 1 $ 24 $ 18 $ 1 $ 47 Year Ended December 31, 2021 Residential mortgage-backed securities Commercial mortgage-backed securities Foreign corporate private securities Other asset-backed securities Total Balance as of January 1 $ 2 $ 1 $ 15 $ 8 $ 26 Credit losses on securities for which credit losses were not previously recorded 1 — 40 — 41 Initial allowance for credit losses recognized on financial assets accounted for as PCD — — — — — Reductions for securities sold during the period — (1) — — (1) Reductions for intent to sell or more likely than not will be required to sell securities prior to recovery of amortized cost — — — — — Change in allowance due to transfer of loans from Voya Reinsurance portfolios to Resolution — — — — — Increase (decrease) on securities with allowance recorded in previous period (2) — 1 (7) (8) Write-offs — — — — — Recoveries of amounts previously written-off — — — — — Balance as of December 31 $ 1 $ — $ 56 $ 1 $ 58 Unrealized Capital Losses The following table presents available-for-sale fixed maturities, including securities pledged, for which an allowance for credit losses has not been recorded by market sector and duration as of June 30, 2022: Twelve Months or Less More Than Twelve Total Fair Value Unrealized Capital Losses Number of securities Fair Value Unrealized Capital Losses Number of securities Fair Value Unrealized Capital Losses Number of securities U.S. Treasuries $ 59 $ 8 19 $ 14 $ 1 4 $ 73 $ 9 23 U.S. Government agencies and authorities 8 1 1 — — — 8 1 1 State, municipalities and political subdivisions 739 69 255 1 — * 1 740 69 256 U.S. corporate public securities 5,725 812 1,111 358 121 175 6,083 933 1,286 U.S. corporate private securities 3,337 253 356 230 36 9 3,567 289 365 Foreign corporate public securities and foreign governments 2,071 261 392 175 56 46 2,246 317 438 Foreign corporate private securities 2,455 165 199 13 1 3 2,468 166 202 Residential mortgage-backed 1,808 172 530 353 33 163 2,161 205 693 Commercial mortgage-backed 3,468 282 561 261 35 47 3,729 317 608 Other asset-backed 1,751 127 422 144 17 74 1,895 144 496 Total $ 21,421 $ 2,150 3,846 $ 1,549 $ 300 522 $ 22,970 $ 2,450 4,368 *Less than $1 The Company concluded that an allowance for credit losses was unnecessary for these securities because the unrealized losses are interest rate related. The following table presents available-for-sale fixed maturities, including securities pledged, for which an allowance for credit losses has not been recorded by market sector and duration as of December 31, 2021: Twelve Months or Less More Than Twelve Total Fair Value Unrealized Capital Losses Number of securities Fair Value Unrealized Capital Losses Number of securities Fair Value Unrealized Capital Losses Number of securities U.S. Treasuries $ 16 $ — * 8 $ 12 $ — * 2 $ 28 $ — * 10 State, municipalities and political subdivisions 58 1 22 — — — 58 1 22 U.S. corporate public securities 1,425 35 292 115 6 119 1,540 41 411 U.S. corporate private securities 447 5 34 122 18 9 569 23 43 Foreign corporate public securities and foreign governments 534 16 97 28 2 14 562 18 111 Foreign corporate private securities 70 1 7 11 — * 1 81 1 8 Residential mortgage-backed 704 18 244 294 13 116 998 31 360 Commercial mortgage-backed 1,137 12 191 228 10 32 1,365 22 223 Other asset-backed 922 8 221 98 4 56 1,020 12 277 Total $ 5,313 $ 96 1,116 $ 908 $ 53 349 $ 6,221 $ 149 1,465 *Less than $1 Based on the Company's quarterly evaluation of its securities in an unrealized loss position, described below, the Company concluded that these securities were not impaired as of June 30, 2022. The Company does not intend to sell the investments and it is not more likely than not that the Company will be required to sell the investments before recovery of their amortized cost bases. Gross unrealized capital losses on fixed maturities, including securities pledged, increased $2,301 from $149 to $2,450 for the six months ended June 30, 2022. The increase in unrealized losses was driven by materially higher interest rates across the yield curve and moderately wider credit spreads. As of June 30, 2022, $5 of the total $2,450 of gross unrealized losses were from 5 available-for-sale fixed maturity securities with an unrealized loss position of 20% or more of amortized cost for 12 months or greater. Evaluating Securities for Impairments The Company performs a regular evaluation, on a security-by-security basis, of its available-for-sale securities holdings, including fixed maturity securities, in accordance with its impairment policy in order to evaluate whether such investments are impaired. The following table identifies the Company's intent impairments included in the Condensed Consolidated Statements of Operations, excluding impairments included in Other comprehensive income (loss) by type for the periods indicated: Three Months Ended June 30, 2022 2021 Impairment No. of Impairment No. of Residential mortgage-backed $ 2 17 $ — * 4 Commercial mortgage-backed — * 1 — — Total $ 2 18 $ — * 4 (1) Primarily U.S. dollar denominated. *Less than $1 Six Months Ended June 30, 2022 2021 Impairment No. of Impairment No. of Residential mortgage-backed $ 9 27 $ — * 10 Commercial mortgage-backed — * 1 — * 1 Total $ 9 28 $ — * 11 (1) Primarily U.S. dollar denominated. *Less than $1 The Company may sell securities during the period in which fair value has declined below amortized cost for fixed maturities. In certain situations, new factors, including changes in the business environment, can change the Company’s previous intent to continue holding a security. Accordingly, these factors may lead the Company to record additional intent related capital losses. Troubled Debt Restructuring The Company invests in high quality, well performing portfolios of commercial mortgage loans and private placements. Under certain circumstances, modifications are granted to these contracts. Each modification is evaluated as to whether a troubled debt restructuring has occurred. A modification is a troubled debt restructuring when the borrower is in financial difficulty and the creditor makes concessions. Generally, the types of concessions may include reducing the face amount or maturity amount of the debt as originally stated, reducing the contractual interest rate, extending the maturity date at an interest rate lower than current market interest rates and/or reducing accrued interest. The Company considers the amount, timing and extent of the concession granted in determining any impairment or changes in the specific valuation allowance recorded in connection with the troubled debt restructuring. A valuation allowance may have been recorded prior to the quarter when the loan is modified in a troubled debt restructuring. Accordingly, the carrying value (net of the valuation allowance) before and after modification through a troubled debt restructuring may not change significantly or may increase if the expected recovery is higher than the pre-modification recovery assessment. For the three months and six months ended June 30, 2022, the Company had no new commercial mortgage loan troubled debt restructurings. For the three months ended June 30, 2022, the Company had three new private placement troubled debt restructurings with a pre and post modification carrying value of $74 and $65, respectively. For the six months ended June 30, 2022, the Company had six new private placement troubled debt restructurings with a pre and post modification carrying value of $102 and $75, respectively. For the three months ended June 30, 2021, the Company did not have any commercial mortgage loan troubled debt restructurings. For the six months ended June 30, 2021, the Company had one commercial mortgage loan trouble debt restructuring with a pre and post modification carrying value of $5. For the three and six months ended June 30, 2021, the Company did not have any private placement troubled debt restructurings. For the three and six months ended June 30, 2022 and June 30, 2021, the Company did not have any commercial mortgage loans or private placements modified in a troubled debt restructuring with a subsequent payment default. Mortgage Loans on Real Estate The Company diversifies its commercial mortgage loan portfolio by geographic region and property type to reduce concentration risk. The Company manages risk when originating commercial mortgage loans by generally lending only up to 75% of the estimated fair value of the underlying real estate. Subsequently, the Company continuously evaluates mortgage loans based on relevant current information including a review of loan-specific performance, property characteristics and market trends. Loan performance is monitored on a loan specific basis through the review of submitted appraisals, operating statements, rent revenues and annual inspection reports, among other items. This review ensures properties are performing at a consistent and acceptable level to secure the debt. The components to evaluate debt service coverage are received and reviewed at least annually to determine the level of risk. Loan-to-value ("LTV") and debt service coverage ("DSC") ratios are measures commonly used to assess the risk and quality of mortgage loans. The LTV ratio, calculated at time of origination, is expressed as a percentage of the amount of the loan relative to the value of the underlying property. A LTV ratio in excess of 100% indicates the unpaid loan amount exceeds the underlying collateral. The DSC ratio, based upon the most recently received financial statements, is expressed as a percentage of the amount of a property’s net income to its debt service payments. A DSC ratio of less than 1.0 indicates that a property’s operations do not generate sufficient income to cover debt payments. These ratios are utilized as part of the review process described above. The following tables present commercial mortgage loans by year of origination and LTV ratio as of the dates indicated. The information is updated as of June 30, 2022 and December 31, 2021, respectively. As of June 30, 2022 Loan-to-Value Ratios Year of Origination 0% - 50% >50% - 60% >60% - 70% >70% - 80% >80% and above Total 2022 $ 151 $ 101 $ 59 $ — $ — $ 311 2021 247 314 206 10 — 777 2020 115 244 34 10 — 403 2019 194 173 65 — — 432 2018 161 46 3 — — 210 2017 648 203 4 — — 855 2016 and prior 2,014 390 23 — — 2,427 Total $ 3,530 $ 1,471 $ 394 $ 20 $ — $ 5,415 As of December 31, 2021 Loan-to-Value Ratios Year of Origination 0% - 50% >50% - 60% >60% - 70% >70% - 80% >80% and above Total 2021 $ 269 $ 315 $ 201 $ — $ — $ 785 2020 140 240 77 — — 457 2019 201 192 69 — — 462 2018 169 50 2 — — 221 2017 656 214 4 — — 874 2016 and prior 2,220 584 24 — — 2,828 Total $ 3,655 $ 1,595 $ 377 $ — $ — $ 5,627 The following tables present commercial mortgage loans by year of origination and DSC ratio as of the dates indicated. The information is updated as of June 30, 2022 and December 31, 2021, respectively. As of June 30, 2022 Debt Service Coverage Ratios Year of Origination >1.5x >1.25x - 1.5x >1.0x - 1.25x <1.0x Commercial mortgage loans secured by land or construction loans Total 2022 $ 311 $ — $ — $ — $ — $ 311 2021 650 26 36 65 — 777 2020 310 36 33 24 — 403 2019 254 13 106 59 — 432 2018 127 7 53 23 — 210 2017 495 61 114 185 — 855 2016 and prior 1,829 311 193 94 — 2,427 Total $ 3,976 $ 454 $ 535 $ 450 $ — $ 5,415 As of December 31, 2021 Debt Service Coverage Ratios Year of Origination >1.5x >1.25x - 1.5x >1.0x - 1.25x <1.0x Commercial mortgage loans secured by land or construction loans Total 2021 $ 652 $ 27 $ 38 $ 68 $ — $ 785 2020 396 21 34 6 — 457 2019 278 49 108 27 — 462 2018 131 5 54 31 — 221 2017 414 156 111 193 — 874 2016 and prior 2,237 242 242 107 — 2,828 Total $ 4,108 $ 500 $ 587 $ 432 $ — $ 5,627 The following tables present the commercial mortgage loans by year of origination and U.S. region as of the dates indicated. The information is updated as of June 30, 2022 and December 31, 2021, respectively. As of June 30, 2022 U.S. Region Year of Origination Pacific South Atlantic Middle Atlantic West South Central Mountain East North Central New England West North Central East South Central Total 2022 $ 38 $ 49 $ 18 $ 60 $ 85 $ 38 $ 4 $ 1 $ 18 $ 311 2021 98 72 138 139 110 142 9 47 22 777 2020 74 176 22 24 32 40 2 8 25 403 2019 59 143 14 109 47 10 15 13 22 432 2018 50 63 57 10 14 10 — 6 — 210 2017 126 92 349 137 54 55 5 37 — 855 2016 and prior 683 550 477 118 183 207 51 123 35 2,427 Total $ 1,128 $ 1,145 $ 1,075 $ 597 $ 525 $ 502 $ 86 $ 235 $ 122 $ 5,415 As of December 31, 2021 U.S. Region Year of Origination Pacific South Atlantic Middle Atlantic West South Central Mountain East North Central New England West North Central East South Central Total 2021 $ 98 $ 79 $ 143 $ 137 $ 110 $ 140 $ 9 $ 47 $ 22 $ 785 2020 84 187 31 35 39 39 3 14 25 457 2019 59 145 14 130 47 17 15 13 22 462 2018 54 68 59 10 14 10 — 6 — 221 2017 128 94 360 139 56 56 5 36 — 874 2016 and prior 718 617 590 159 256 239 71 142 36 2,828 Total $ 1,141 $ 1,190 $ 1,197 $ 610 $ 522 $ 501 $ 103 $ 258 $ 105 $ 5,627 The following tables present the commercial mortgage loans by year of origination and property type as of the dates indicated. The information is updated as of June 30, 2022 and December 31, 2021, respectively. As of June 30, 2022 Property Type Year of Origination Retail Industrial Apartments Office Hotel/Motel Other Mixed Use Total 2022 $ 24 $ 118 $ 155 $ 14 $ — $ — $ — $ 311 2021 38 172 412 128 — 18 9 777 2020 58 74 111 160 — — — 403 2019 46 94 200 66 26 — — 432 2018 37 86 56 13 — 18 — 210 2017 108 403 193 147 4 — — 855 2016 and prior 819 401 529 390 76 159 53 2,427 Total $ 1,130 $ 1,348 $ 1,656 $ 918 $ 106 $ 195 $ 62 $ 5,415 As of December 31, 2021 Property Type Year of Origination Retail Industrial Apartments Office Hotel/Motel Other Mixed Use Total 2021 $ 39 $ 185 $ 405 $ 129 $ — $ 18 $ 9 $ 785 2020 58 90 140 169 — — — 457 2019 46 96 211 82 27 — — 462 2018 38 88 57 16 4 18 — 221 2017 110 417 195 149 3 — — 874 2016 and prior 936 566 576 398 93 205 54 2,828 Total $ 1,227 $ 1,442 $ 1,584 $ 943 $ 127 $ 241 $ 63 $ 5,627 The following table summarizes the activity in the allowance for losses for commercial mortgage loans for the periods indicated: June 30, 2022 December 31, 2021 Allowance for credit losses, beginning of period $ 15 $ 89 Credit losses on mortgage loans for which credit losses were not previously recorded — 1 Change in allowance due to transfer of loans from Voya Reinsurance portfolios to Resolution — (14) Increase (decrease) on mortgage loans with allowance recorded in previous period (3) (61) Provision for expected credit losses 12 15 Write-offs — — Recoveries of amounts previously written-off — — Allowance for credit losses, end of period $ 12 $ 15 The following table presents past due commercial mortgage loans as of the dates indicated: June 30, 2022 December 31, 2021 Delinquency: Current $ 5,415 $ 5,627 30-59 days past due — — 60-89 days past due — — Greater than 90 days past due — — Total $ 5,415 $ 5,627 Commercial mortgage loans are placed on non-accrual status when 90 days in arrears if the Company has concerns regarding the collectability of future payments, or if a loan has matured without being paid off or extended. As of June 30, 2022 and December 31, 2021, the Company had no commercial mortgage loan in non-accrual status. There was no interest income recognized on loans in non-accrual status for the six months ended June 30, 2022 and year ended December 31, 2021. Net Investment Income The following table summarizes Net investment income for the periods indicated: Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Fixed maturities $ 495 $ 497 $ 974 $ 1,012 Equity securities 5 6 9 11 Mortgage loans on real estate 60 64 119 125 Policy loans 5 5 11 11 Short-term investments and cash equivalents 2 4 3 5 Limited partnerships and other 29 97 125 240 Gross investment income 596 673 1,241 1,404 Less: Investment expenses 15 17 30 34 Net investment income $ 581 $ 656 $ 1,211 $ 1,370 As of June 30, 2022, the Company had $32 of investments in fixed maturities that did not produce net investment income. As of December 31, 2021, the Company had no investments in fixed maturities that did not produce net investment income. Fixed maturities are moved to a non-accrual status when the investment defaults. Interest income on fixed maturities is recorded when earned using an effective yield method, giving effect to amortization of premiums and accretion of discounts. Such interest income is recorded in Net investment income in the Condensed Consolidated Statements of Operations. Net Gains (Losses) Net gains (losses) comprise the difference between the amortized cost of investments and proceeds from sale and redemption, as well as losses incurred due to the credit-related and intent-related impairment of investments. Realized investment gains and losses are also primarily generated from changes in fair value of embedded derivatives within products and fixed maturities, changes in fair value of fixed maturities recorded at FVO and changes in fair value including accruals on derivative instruments, except for effective cash flow hedges. Net gains (losses) also include changes in fair value of trading debt securities and changes in fair value of equity securities. The cost of the investments on disposal is generally determined based on first-in-first-out ("FIFO") methodology. Net gains (losses) were as follows for the periods indicated: Three Months Ended June 30, 2022 2021 Fixed maturities, available-for-sale, including securities pledged $ (6) $ 15 Fixed maturities, at fair value option (245) (129) Equity securities, at fair value (24) 5 Derivatives 32 (39) Embedded derivatives - fixed maturities (2) — Guaranteed benefit derivatives 12 (9) Mortgage loans 1 25 Other investments 5 95 Net gains (losses) $ (227) $ (37) Six Months Ended June 30, 2022 2021 Fixed maturities, available-for-sale, including securities pledged $ (79) $ 1,783 Fixed maturities, at fair value option (550) (377) Equity securities, at fair value (32) 11 Derivatives 126 (16) Embedded derivatives - fixed maturities (6) (5) Guaranteed benefit derivatives 18 48 Mortgage Loans 5 163 Other investments 6 98 Net gains (losses) $ (512) $ 1,705 On June 1, 2021, the Company fully disposed of a 9.99% equity interest in VA Capital which was originally acquired as part of a Master Transaction Agreement dated December 20, 2017, related to the sale of substantially all of our Closed Block Variable Annuity (CBVA) and Annuity business. The disposition resulted in a net realized gain of $95 reported as Other net gains (losses) in the Condensed Consolidated Statements. Proceeds from the sale of fixed maturities, available-for-sale and trading, and equity securities and the related gross realized gains and losses, before tax, were as follows for the periods indicated: Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 (1) 2021 Proceeds on sales $ 971 $ 608 $ 2,220 $ 10,213 Gross gains 15 14 30 1,711 Gross losses 12 — 44 2 (1) Decrease from prior year is the result of the transfer of assets to support the life reinsurance transaction with Resolution.

Derivative Financial Instrument

Derivative Financial Instruments	6 Months Ended
	Jun. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments The Company primarily enters into the following types of derivatives: Interest rate swaps: Interest rate swaps are used by the Company primarily to reduce market risks from changes in interest rates and to alter interest rate exposure arising from mismatches between assets and/or liabilities. Interest rate swaps are also used to hedge the interest rate risk associated with the value of assets it owns or in an anticipation of acquiring them. Using interest rate swaps, the Company agrees with another party to exchange, at specified intervals, the difference between fixed rate and floating rate interest payments, calculated by reference to an agreed upon notional principal amount. These transactions are entered into pursuant to master agreements that provide for a single net payment to be made to/from the counterparty at each due date. The Company utilizes these contracts in qualifying hedging relationships as well as non-qualifying hedging relationships. Foreign exchange swaps: The Company uses foreign exchange or currency swaps to reduce the risk of change in the value, yield or cash flows associated with certain foreign denominated invested assets. Foreign exchange swaps represent contracts that require the exchange of foreign currency cash flows against U.S. dollar cash flows at regular periods, typically quarterly or semi-annually. The Company utilizes these contracts in qualifying hedging relationships as well as non-qualifying hedging relationships. Total return swaps: The Company uses total return swaps as a hedge of interest related risks within various Legacy Annuity and Retirement products. Total return swaps are also used as a hedge of other corporate liabilities. Using total return swaps, the Company agrees with another party to exchange, at specified intervals, the difference between the economic performance of assets or a market index and a fixed or variable funding multiplied by reference to an agreed upon notional amount. No cash is exchanged at the onset of the contracts. Cash is paid and received over the life of the contract based upon the terms of the swaps. The Company utilized these contracts in non-qualifying hedging relationships. Futures: Futures contracts are used to hedge against a decrease in certain equity indices. Such decreases may correlate to a decrease in variable annuity account values which would increase the possibility of the Company incurring an expense for guaranteed benefits in excess of account values. The Company also uses interest rate futures contracts to hedge its exposure to market risks due to changes in interest rates. The Company enters into exchange traded futures with regulated futures commissions that are members of the exchange. The Company also posts initial and variation margins, with the exchange, on a daily basis. The Company utilizes exchange-traded futures in non-qualifying hedging relationships. The Company may also use futures contracts as a hedge against an increase in certain equity indices. Embedded derivatives: The Company also invests in certain fixed maturity instruments and has issued certain products that contain embedded derivatives for which market value is at least partially determined by, among other things, levels of or changes in domestic and/or foreign interest rates (short-term or long-term), exchange rates, prepayment rates, equity rates or credit ratings/spreads. In addition, the Company has entered into coinsurance with funds withheld arrangements, which contain embedded derivatives. The notional amounts and fair values of derivatives were as follows as of the dates indicated: June 30, 2022 December 31, 2021 Notional Asset Liability Notional Asset Liability Derivatives: Qualifying for hedge accounting (1) Fair value hedges: Foreign exchange contracts $ 88 $ 3 $ — $ 94 $ 2 $ — Cash flow hedges: Interest rate contracts 22 — — 22 — — Foreign exchange contracts 699 62 — 683 16 16 Derivatives: Non-qualifying for hedge accounting (1) Interest rate contracts 17,585 207 301 13,382 147 209 Foreign exchange contracts 183 4 3 146 1 3 Equity contracts 248 1 — 299 4 2 Credit contracts 179 — 3 135 1 1 Embedded derivatives and Managed custody guarantees: Within fixed maturity investments (2) N/A 6 — N/A 12 — Within products (3) N/A — 25 N/A — 47 Within reinsurance agreements (4) N/A 21 41 N/A — 196 Managed custody guarantees (3) N/A — 4 N/A — 1 Total $ 304 $ 377 $ 183 $ 475 (1) Open derivative contracts are reported as Derivatives assets or liabilities on the Condensed Consolidated Balance Sheets at fair value. (2) Included in Fixed maturities, available-for-sale, at fair value on the Condensed Consolidated Balance Sheets. (3) Included in Future policy benefits on the Condensed Consolidated Balance Sheets. (4) Included in Other liabilities and Premium receivable and reinsurance recoverable on the Condensed Consolidated Balance Sheets. N/A - Not applicable Based on the notional amounts, a substantial portion of the Company’s derivative positions was not designated or did not qualify for hedge accounting as part of a hedging relationship as of June 30, 2022 and December 31, 2021. The Company utilizes derivative contracts mainly to hedge exposure to variability in cash flows, interest rate risk, credit risk, foreign exchange risk and equity market risk. The majority of derivatives used by the Company are designated as product hedges, which hedge the exposure arising from insurance liabilities or guarantees embedded in the contracts the Company offers through various product lines. These derivatives do not qualify for hedge accounting as they do not meet the criteria of being "highly effective" as outlined in ASC Topic 815, but do provide an economic hedge, which is in line with the Company’s risk management objectives. The Company also uses derivatives contracts to hedge its exposure to various risks associated with the investment portfolio. The Company does not seek hedge accounting treatment for certain of these derivatives as they generally do not qualify for hedge accounting due to the criteria required under the portfolio hedging rules outlined in ASC Topic 815. The Company also uses credit default swaps coupled with other investments in order to produce the investment characteristics of otherwise permissible investments that do not qualify as effective accounting hedges under ASC Topic 815. Although the Company has not elected to net its derivative exposures, the notional amounts and fair values of Over-The-Counter ("OTC") and cleared derivatives excluding exchange traded contracts are presented in the tables below as of the dates indicated: June 30, 2022 Notional Amount Asset Fair Value Liability Fair Value Credit contracts $ 179 $ — $ 3 Equity contracts 201 1 — Foreign exchange contracts 970 69 3 Interest rate contracts 10,838 207 288 277 294 Counterparty netting (1) (208) (208) Cash collateral netting (1) (59) (81) Securities collateral netting (1) (6) (1) Net receivables/payables $ 4 $ 4 (1) Represents the netting of receivable balances with payable balances, net of collateral, for the same counterparty under eligible netting agreements. December 31, 2021 Notional Amount Asset Fair Value Liability Fair Value Credit contracts $ 135 $ 1 $ 1 Equity contracts 239 4 2 Foreign exchange contracts 923 19 19 Interest rate contracts 12,003 147 209 171 231 Counterparty netting (1) (156) (156) Cash collateral netting (1) (12) (70) Securities collateral netting (1) (2) (2) Net receivables/payables $ 1 $ 3 (1) Represents the netting of receivable balances with payable balances, net of collateral, for the same counterparty under eligible netting agreements. Collateral Under the terms of the OTC Derivative International Swaps and Derivatives Association, Inc. ("ISDA") agreements, the Company may receive from, or deliver to, counterparties collateral to assure that terms of the ISDA agreements will be met with regard to the Credit Support Annex ("CSA"). The terms of the CSA call for the Company to pay interest on any cash received equal to the Federal Funds rate. To the extent cash collateral is received and delivered, it is included in Payables under securities loan and repurchase agreements, including collateral held and Short-term investments under securities loan agreements, including collateral delivered, respectively, on the Condensed Consolidated Balance Sheets and is reinvested in short-term investments. Collateral held is used in accordance with the CSA to satisfy any obligations. Investment grade bonds owned by the Company are the source of noncash collateral posted, which is reported in Securities pledged on the Condensed Consolidated Balance Sheets. As of June 30, 2022, the Company held $59 and pledged $82 of net cash collateral related to OTC derivative contracts and cleared derivative contracts, respectively. As of December 31, 2021, the Company held $17 and pledged $71 of net cash collateral related to OTC derivative contracts and cleared derivative contracts, respectively. In addition, as of June 30, 2022, the Company delivered $162 of securities and held $6 of securities as collateral. As of December 31, 2021, the Company delivered $124 of securities and held $2 of securities as collateral. The location and effect of derivatives qualifying for hedge accounting on the Condensed Consolidated Statements of Operations and Condensed Consolidated Statements of Comprehensive Income are as follows for the periods indicated: Three Months Ended June 30, 2022 2021 Interest Rate Contracts Foreign Exchange Contracts Interest Rate Contracts Foreign Exchange Contracts Derivatives: Qualifying for hedge accounting Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income into Income Net investment income Net investment income and Other net gains/(losses) Net investment income Net investment income and Other net gains/(losses) Amount of Gain or (Loss) Recognized in Other Comprehensive Income $ (1) $ 55 $ — $ 6 Amount of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income — 2 — 2 Six Months Ended June 30, 2022 2021 Interest Rate Contracts Foreign Exchange Contracts Interest Rate Contracts Foreign Exchange Contracts Derivatives: Qualifying for hedge accounting Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income into Income Net investment income Net investment income and Other net gains/(losses) Net investment income Net investment income and Other net gains/(losses) Amount of Gain or (Loss) Recognized in Other Comprehensive Income $ (2) $ 62 $ (1) $ 12 Amount of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income — 5 — (1) The location and amount of gain (loss) recognized in the Condensed Consolidated Statements of Operations for derivatives qualifying for hedge accounting are as follows for the period indicated: Three Months Ended June 30, 2022 2021 Net investment income Other net gains/(losses) Net investment income Other net gains/(losses) Total amounts of line items presented in the statement of operations in which the effects of fair value or cash flow hedges are recorded $ 581 $ (225) $ 656 $ (37) Derivatives: Qualifying for hedge accounting Fair value hedges: Foreign exchange contracts: Hedged items — (5) — (1) Derivatives designated as hedging instruments (1) — 6 — 1 Cash flow hedges: Foreign exchange contracts: Gain (loss) reclassified from accumulated other comprehensive income into income 2 — 2 — Six Months Ended June 30, 2022 2021 Net investment income Other net gains/(losses) Net investment income Other net gains/(losses) Total amounts of line items presented in the statement of operations in which the effects of fair value or cash flow hedges are recorded $ 1,211 $ (503) $ 1,370 $ 1,705 Derivatives: Qualifying for hedge accounting Fair value hedges: Foreign exchange contracts: Hedged items — (7) — (1) Derivatives designated as hedging instruments (1) — 8 — 1 Cash flow hedges: Foreign exchange contracts: Gain (loss) reclassified from accumulated other comprehensive income into income 5 — 4 (5) (1) For the three and six months ended June 30, 2022, $1 of the change in derivative instruments designated and qualifying as fair value hedges was excluded from the assessment of hedge effectiveness and recognized currently in earning. For the three and six months ended June 30, 2022 and June 30, 2021, an immaterial portion of the change in derivative instruments designated and qualifying as fair value hedges was excluded from the assessment of hedge effectiveness and recognized currently in earning. The location and effect of derivatives not designated as hedging instruments on the Condensed Consolidated Statements of Operations are as follows for the periods indicated: Location of Gain or (Loss) Recognized in Income on Derivative Three Months Ended June 30, 2022 2021 Derivatives: Non-qualifying for hedge accounting Interest rate contracts Other net gains (losses) $ 52 $ (48) Foreign exchange contracts Other net gains (losses) (1) (2) Equity contracts Other net gains (losses) (20) 9 Credit contracts Other net gains (losses) (4) 1 Embedded derivatives and Managed custody guarantees: Within fixed maturity investments Other net gains (losses) (2) — Within products Other net gains (losses) 12 (4) Within reinsurance agreements (1) Policyholder benefits 84 (29) Managed custody guarantees Other net gains (losses) 1 — Total $ 122 $ (73) Location of Gain or (Loss) Recognized in Income on Derivative Six Months Ended June 30, 2022 2021 Derivatives: Non-qualifying for hedge accounting Interest rate contracts Other net gains (losses) $ 152 $ (23) Foreign exchange contracts Other net gains (losses) (2) (2) Equity contracts Other net gains (losses) (28) 12 Credit contracts Other net gains (losses) (4) 1 Embedded derivatives and Managed custody guarantees: Within fixed maturity investments Other net gains (losses) (6) (5) Within products Other net gains (losses) 22 31 Within reinsurance agreements (1) Policyholder benefits 176 23 Managed custody guarantees Other net gains (losses) (2) 4 Total $ 308 $ 41 (1) For the three months ended June 30, 2022, no gains (losses) from standalone derivatives were recognized. For the six months ended June 30, 2022, the amount excluded gains (losses) of $1 from standalone derivatives recognized in Other net gains (losses). For the three and six months ended June 30, 2021, the amount excluded gains (losses) of $3 and $4, respectively, from standalone derivatives recognized in Other net gains (losses).

Fair Value Measurements (exclud

Fair Value Measurements (excluding Consolidated Investment Entities)	6 Months Ended
	Jun. 30, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements (excluding Consolidated Investment Entities)	Fair Value Measurements (excluding Consolidated Investment Entities) Fair Value Measurement The following table presents the Company's hierarchy for its assets and liabilities measured at fair value on a recurring basis as of June 30, 2022: Level 1 Level 2 Level 3 Total Assets: Fixed maturities, including securities pledged: U.S. Treasuries $ 653 $ 231 $ — $ 884 U.S. Government agencies and authorities — 63 — 63 State, municipalities and political subdivisions — 928 — 928 U.S. corporate public securities — 9,522 19 9,541 U.S. corporate private securities — 2,962 1,780 4,742 Foreign corporate public securities and foreign governments (1) — 3,053 4 3,057 Foreign corporate private securities (1) — 2,819 403 3,222 Residential mortgage-backed securities — 4,152 31 4,183 Commercial mortgage-backed securities — 4,042 — 4,042 Other asset-backed securities — 1,941 63 2,004 Total fixed maturities, including securities pledged 653 29,713 2,300 32,666 Equity securities 23 8 203 234 Derivatives: Interest rate contracts — 207 — 207 Foreign exchange contracts — 69 — 69 Equity contracts — 1 — 1 Embedded derivative on reinsurance — 21 — 21 Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements 2,106 7 — 2,113 Assets held in separate accounts 74,144 5,524 349 80,017 Total assets $ 76,926 $ 35,550 $ 2,852 $ 115,328 Percentage of Level to total 67 % 31 % 2 % 100 % Liabilities: Derivatives: Guaranteed benefit derivatives (2) — — 29 29 Other derivatives: Interest rate contracts 13 288 — 301 Foreign exchange contracts — 3 — 3 Credit contracts — 3 — 3 Embedded derivative on reinsurance — (45) (3) 86 41 Total liabilities $ 13 $ 249 $ 115 $ 377 (1) Primarily U.S. dollar denominated. (2) Includes GMWBL, GMWB, FIA, Stabilizer and MCGs. (3) The Company classifies these embedded derivatives within liabilities given the underlying nature of the balances and the right-of-offset. The following table presents the Company's hierarchy for its assets and liabilities measured at fair value on a recurring basis as of December 31, 2021: Level 1 Level 2 Level 3 Total Assets: Fixed maturities, including securities pledged: U.S. Treasuries $ 745 $ 258 $ — $ 1,003 U.S. Government agencies and authorities — 81 — 81 State, municipalities and political subdivisions — 1,111 — 1,111 U.S. corporate public securities — 11,925 16 11,941 U.S. corporate private securities — 3,415 1,910 5,325 Foreign corporate public securities and foreign governments (1) — 3,723 — 3,723 Foreign corporate private securities (1) — 3,148 353 3,501 Residential mortgage-backed securities — 4,259 43 4,302 Commercial mortgage-backed securities — 4,183 — 4,183 Other asset-backed securities — 2,037 44 2,081 Total fixed maturities, including securities pledged 745 34,140 2,366 37,251 Equity securities 37 — 203 240 Derivatives: Interest rate contracts — 147 — 147 Foreign exchange contracts — 19 — 19 Equity contracts — 4 — 4 Credit contracts — 1 — 1 Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements 2,525 82 — 2,607 Assets held in separate accounts 94,943 5,174 316 100,433 Total assets $ 98,250 $ 39,567 $ 2,885 $ 140,702 Percentage of Level to total 70 % 28 % 2 % 100 % Liabilities: Derivatives: Guaranteed benefit derivatives (2) — — 48 48 Other derivatives: Interest rate contracts — 209 — 209 Foreign exchange contracts — 19 — 19 Equity contracts — 2 — 2 Credit contracts — 1 — 1 Embedded derivative on reinsurance — 109 87 196 Total liabilities $ — $ 340 $ 135 $ 475 (1) Primarily U.S. dollar denominated. (2) Includes GMWBL, GMWB, FIA, Stabilizer and MCGs. Valuation of Financial Assets and Liabilities at Fair Value Certain assets and liabilities are measured at estimated fair value on the Company’s Consolidated Balance Sheets. The Company defines fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The exit price and the transaction (or entry) price will be the same at initial recognition in many circumstances. However, in certain cases, the transaction price may not represent fair value. The fair value of a liability is based on the amount that would be paid to transfer a liability to a third-party with an equal credit standing. Fair value is required to be a market-based measurement that is determined based on a hypothetical transaction at the measurement date, from a market participant’s perspective. The Company considers three broad valuation approaches when a quoted price is unavailable: (i) the market approach, (ii) the income approach and (iii) the cost approach. The Company determines the most appropriate valuation technique to use, given the instrument being measured and the availability of sufficient inputs. The Company prioritizes the inputs to fair valuation approaches and allows for the use of unobservable inputs to the extent that observable inputs are not available. The Company utilizes a number of valuation methodologies to determine the fair values of its financial assets and liabilities in conformity with the concepts of exit price and the fair value hierarchy as prescribed in ASC Topic 820. Valuations are obtained from third-party commercial pricing services, brokers and industry-standard, vendor-provided software that models the value based on market observable inputs. The valuations obtained from third-party commercial pricing services are non-binding. The Company reviews the assumptions and inputs used by third-party commercial pricing services for each reporting period in order to determine an appropriate fair value hierarchy level. The documentation and analysis obtained from third-party commercial pricing services are reviewed by the Company, including in-depth validation procedures confirming the observability of inputs. The valuations are reviewed and validated monthly through the internal valuation committee price variance review, comparisons to internal pricing models, back testing to recent trades or monitoring of trading volumes. The valuation approaches and key inputs for each category of assets or liabilities that are classified within Level 2 and Level 3 of the fair value hierarchy are presented below. For fixed maturities classified as Level 2 assets, fair values are determined using a matrix-based market approach, based on prices obtained from third-party commercial pricing services and the Company’s matrix and analytics-based pricing models, which in each case incorporate a variety of market observable information as valuation inputs. The market observable inputs used for these fair value measurements, by fixed maturity asset class, are as follows: U.S. Treasuries: Fair value is determined using third-party commercial pricing services, with the primary inputs being stripped interest and principal U.S. Treasury yield curves that represent a U.S. Treasury zero-coupon curve. U.S. government agencies and authorities, State, municipalities and political subdivisions: Fair value is determined using third-party commercial pricing services, with the primary inputs being U.S. Treasury yield curves, trades of comparable securities, credit spreads off benchmark yields and issuer ratings. U.S. corporate public securities, Foreign corporate public securities and foreign governments: Fair value is determined using third-party commercial pricing services, with the primary inputs being benchmark yields, trades of comparable securities, issuer ratings, bids and credit spreads off benchmark yields. U.S. corporate private securities and Foreign corporate private securities: Fair values are determined using a matrix and analytics-based pricing model. The model incorporates the current level of risk-free interest rates, current corporate credit spreads, credit quality of the issuer and cash flow characteristics of the security. The model also considers a liquidity spread, the value of any collateral, the capital structure of the issuer, the presence of guarantees, and prices and quotes for comparably rated publicly traded securities. RMBS, CMBS and ABS: Fair value is determined using third-party commercial pricing services, with the primary inputs being credit spreads off benchmark yields, prepayment speed assumptions, current and forecasted loss severity, debt service coverage ratios, collateral type, payment priority within tranche and the vintage of the loans underlying the security. Generally, the Company does not obtain more than one vendor price from pricing services per instrument. The Company uses a hierarchy process in which prices are obtained from a primary vendor and, if that vendor is unable to provide the price, the next vendor in the hierarchy is contacted until a price is obtained or it is determined that a price cannot be obtained from a commercial pricing service. When a price cannot be obtained from a commercial pricing service, independent broker quotes are solicited. Securities priced using independent broker quotes are classified as Level 3. Fair values of privately placed bonds are determined primarily using a matrix-based pricing model and are generally classified as Level 2 assets. The model considers the current level of risk-free interest rates, current corporate spreads, the credit quality of the issuer and cash flow characteristics of the security. Also considered are factors such as the net worth of the borrower, the value of collateral, the capital structure of the borrower, the presence of guarantees and the Company’s evaluation of the borrower’s ability to compete in its relevant market. Using this data, the model generates estimated market values, which the Company considers reflective of the fair value of each privately placed bond. Equity securities: Level 2 and Level 3 equity securities, typically private equities or equity securities not traded on an exchange, are valued by other sources such as analytics or brokers. Derivatives: Derivatives are carried at fair value, which is determined using the Company’s derivative accounting system in conjunction with observable key financial data from third-party sources, such as yield curves, exchange rates, S&P 500 Index prices, London Interbank Offered Rates ("LIBOR"), Overnight Index Swap ("OIS") rates, and Secured Overnight Financing Rate ("SOFR"). The Company uses SOFR discounting for valuations of interest rate derivatives; however, certain legacy positions may continue to be discounted on OIS. The Company uses OIS for valuations of collateralized interest rate derivatives, which are obtained from third-party sources. For those derivatives that are unable to be valued by the accounting system, the Company typically utilizes values established by third-party brokers. Counterparty credit risk is considered and incorporated in the Company’s valuation process through counterparty credit rating requirements and monitoring of overall exposure. It is the Company’s policy to transact only with investment grade counterparties with a credit rating of A- or better. The Company’s nonperformance risk is also considered and incorporated in the Company’s valuation process. The Company also has certain credit default swaps and options that are priced by third party vendors or by using models that primarily use market observable inputs, but contain inputs that are not observable to market participants, which have been classified as Level 3. The remaining derivative instruments are valued based on market observable inputs and are classified as Level 2. Guaranteed benefit derivatives: The Company records reserves for annuity contracts containing GMWBL and GMWB riders. The guarantee is an embedded derivative and is required to be accounted for separately from the host variable annuity contract. The fair value of the obligation is calculated based on actuarial and capital market assumptions related to the projected cash flows, including benefits and related contract charges, over the anticipated life of the related contracts. The cash flow estimates are produced by using stochastic techniques under a variety of market return scenarios and other market implied assumptions. These derivatives are classified as Level 3 liabilities in the fair value hierarchy. The index-crediting feature in the Company's FIA contracts is an embedded derivative that is required to be accounted for separately from the host contract. The fair value of the obligation is calculated based on actuarial and capital market assumptions related to the projected cash flows, including benefits and related contract charges, over the anticipated life of the related contracts for FIAs. The cash flow estimates are produced by market implied assumptions. These derivatives are classified as Level 3 liabilities in the fair value hierarchy. The Company records reserves for Stabilizer and MCG contracts containing guaranteed credited rates. The guarantee is treated as an embedded derivative or a stand-alone derivative (depending on the underlying product) and is required to be reported at fair value. The estimated fair value is determined based on the present value of projected future claims, minus the present value of future guaranteed premiums. At inception of the contract, the Company projects a guaranteed premium to be equal to the present value of the projected future claims. The income associated with the contracts is projected using relevant actuarial and capital market assumptions, including benefits and related contract charges, over the anticipated life of the related contracts. The cash flow estimates are produced by using stochastic techniques under a variety of risk neutral scenarios and other market implied assumptions. These derivatives are classified as Level 3 liabilities. The discount rate used to determine the fair value of the Company's GMWBL, GMWB, FIA, and Stabilizer embedded derivative liabilities and the stand-alone derivative for MCG includes an adjustment to reflect the risk that these obligations will not be fulfilled ("nonperformance risk"). The nonperformance risk adjustment incorporates a blend of observable, similarly rated peer holding company credit spreads, adjusted to reflect the credit quality of the individual insurance subsidiary that issued the guarantee, as well as an adjustment to reflect the non-default spreads and the priority and recovery rates of policyholder claims. Embedded derivatives on reinsurance: The carrying value of embedded derivatives is estimated based upon the change in the fair value of the assets supporting the funds withheld payable under reinsurance agreements. The fair value of the embedded derivative is based on market observable inputs and is classified as Level 2. The remaining derivative instruments are classified as Level 3 and are estimated using the income approach. The fair value is calculated by estimating future cash flows for a certain discrete projection period, estimating the terminal value, if appropriate, and discounting these amounts to present value at a rate of return that considers the relative risk of the cash flows and the time value of money. Level 3 Financial Instruments The fair values of certain assets and liabilities are determined using prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement (i.e., Level 3 as defined by ASC Topic 820), including but not limited to liquidity spreads for investments within markets deemed not currently active. These valuations, whether derived internally or obtained from a third-party, use critical assumptions that are not widely available to estimate market participant expectations in valuing the asset or liability. In addition, the Company has determined, for certain financial instruments, an active market is such a significant input to determine fair value that the presence of an inactive market may lead to classification in Level 3. In light of the methodologies employed to obtain the fair values of financial assets and liabilities classified as Level 3, additional information is presented below. The following tables summarize the change in fair value of the Company's Level 3 assets and liabilities and transfers in and out of Level 3 for the periods indicated: Three Months Ended June 30, 2022 Fair Value as of April 1 Total Purchases Issuances Sales Settlements Transfers Transfers Fair Value as of June 30 Change In Unrealized Gains (Losses) Included in Earnings (3) Change In (3) Net OCI Fixed maturities, including securities pledged: U.S. corporate public securities $ 71 $ — $ (1) $ 1 $ — $ — $ — $ — $ (52) $ 19 $ — $ (1) U.S. corporate private securities 1,925 (1) (134) 89 — — (58) — (41) 1,780 (1) (133) Foreign corporate public securities and foreign governments (1) 11 — — 4 — — — — (11) 4 — — Foreign corporate private securities (1) 496 (3) (7) 51 — — (15) — (119) 403 (4) (7) Residential mortgage-backed securities 45 (6) — 2 — — (9) 1 (2) 31 (6) — Other asset-backed securities 49 — (2) 35 — — (5) — (14) 63 — (2) Total fixed maturities, including securities pledged 2,597 (10) (144) 182 — — (87) 1 (239) 2,300 (11) (143) Equity securities, at fair value 203 (17) — 26 — — — — (9) 203 (17) — Derivatives: Guaranteed benefit derivatives (2)(5) (42) 13 — — — — — — — (29) — — Embedded derivatives on reinsurance (86) — — — — — — — — (86) — — Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements 8 — — — — — (8) — — — — — Assets held in separate accounts (4) 334 (12) — 67 — (3) — — (37) 349 — — (1) Primarily U.S. dollar denominated. (2) All gains and losses on Level 3 liabilities are classified as realized gains (losses) for the purpose of this disclosure because it is impracticable to track realized and unrealized gains (losses) separately on a contract by contract basis. These amounts are included in Other net (losses) in the Condensed Consolidated Statements of Operations. (3) For financial instruments still held as of June 30 amounts are included in Net investment income and Total net gains (losses) in the Condensed Consolidated Statements of Operations or Unrealized gains (losses) on securities in the Condensed Consolidated Statements of Comprehensive Income. (4) The investment income and realized gains (losses) and change in unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on Net income (loss) for the Company. (5) Includes GMWBL, GMWB, FIA, Stabilizer and MCGs. Six Months Ended June 30, 2022 Fair Value as of January 1 Realized/Unrealized Purchases Issuances Sales Settlements Transfers Transfers Fair Value as of June 30 Change In (3) Change In Unrealized Gains (Losses) Included in OCI (3) Net OCI Fixed maturities, including securities pledged: U.S. corporate public securities $ 16 $ — $ (1) $ 5 $ — $ — $ — $ — $ (1) $ 19 $ — $ (1) U.S. corporate private securities 1,910 (2) (277) 158 — — (120) 121 (10) 1,780 (2) (276) Foreign corporate public securities and foreign governments (1) — — — 4 — — — — — 4 — — Foreign corporate private securities (1) 353 (22) (31) 97 — — (28) 148 (114) 403 (4) (31) Residential mortgage-backed securities 43 (15) — 4 — — — 1 (2) 31 (15) — Other asset-backed securities 44 — (4) 39 — (10) (6) — — 63 — (4) Total fixed maturities, including securities pledged 2,366 (39) (313) 307 — (10) (154) 270 (127) 2,300 (21) (312) Equity securities, at fair value 203 (26) — 26 — — — — — 203 (26) — Derivatives: Guaranteed benefit derivatives (2)(5) (48) 20 — — (1) — — — — (29) — — Embedded derivatives on reinsurance (87) 1 — — — — — — — (86) — — Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements — — — 8 — — (8) — — — — — Assets held in separate accounts (4) 316 (26) — 132 — (4) — 6 (75) 349 — — (1) Primarily U.S. dollar denominated. (2) All gains and losses on Level 3 liabilities are classified as realized gains (losses) for the purpose of this disclosure because it is impracticable to track realized and unrealized gains (losses) separately on a contract by contract basis. These amounts are included in Other net (losses) in the Condensed Consolidated Statements of Operations. (3) For financial instruments still held as of June 30 amounts are included in Net investment income and Total net gains (losses) in the Condensed Consolidated Statements of Operations or Unrealized gains (losses) on securities in the Condensed Consolidated Statements of Comprehensive Income. (4) The investment income and realized gains (losses) and change in unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on Net income (loss) for the Company. (5) Includes GMWBL, GMWB, FIA, Stabilizer and MCGs. Three Months Ended June 30, 2021 Fair Value as of April 1 Total Purchases Issuances Sales Settlements Transfers Transfers Fair Value as of June 30 Change In (3) Change In Unrealized Gains (Losses) Included in OCI (3) Net OCI Fixed maturities, including securities pledged: U.S. corporate public securities $ 60 $ — $ 1 $ — $ — $ — $ (1) $ — $ (37) $ 23 $ — $ 5 U.S. corporate private securities 1,584 1 40 23 — — (93) 504 (48) 2,011 — (2) Foreign corporate public securities and foreign governments (1) 7 — — 10 — — — — (7) 10 — — Foreign corporate private securities (1) 380 1 8 1 — (34) (4) — — 352 1 5 Residential mortgage-backed securities 47 (4) — 12 — — — 3 (12) 46 (4) — Commercial mortgage-backed securities — — — 2 — — — — — 2 — — Other asset-backed securities 69 — — 15 — — (7) 1 — 78 — — Total fixed maturities, including securities pledged 2,147 (2) 49 63 — (34) (105) 508 (104) 2,522 (3) 8 Fixed maturities, trading, at fair value — — — 45 — — — — — 45 — — Equity securities, at fair value 257 3 — — — (11) — — — 249 3 — Derivatives: Guaranteed benefit derivatives (2)(5) (26) (19) — — — — 1 — — (44) — — Embedded derivatives on reinsurance (88) 3 — — — — — — — (85) — — Assets held in separate accounts (4) 237 2 — 71 — — — — (17) 293 — — (1) Primarily U.S. dollar denominated. (2) All gains and losses on Level 3 liabilities are classified as realized gains (losses) for the purpose of this disclosure because it is impracticable to track realized and unrealized gains (losses) separately on a contract by contract basis. These amounts are included in Other net (losses) in the Condensed Consolidated Statements of Operations. (3) For financial instruments still held as of June 30, amounts are included in Net investment income and Total net gains (losses) in the Condensed Consolidated Statements of Operations or Unrealized gains (losses) on securities in the Condensed Consolidated Statements of Comprehensive Income. (4) The investment income and realized gains (losses) and change in unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on Net income (loss) for the Company. (5) Includes GMWBL, GMWB, FIA, Stabilizer and MCGs. Six Months Ended June 30, 2021 Fair Value as of January 1 Realized/Unrealized Purchases Issuances Sales Settlements Transfers Transfers Fair Value as of June 30 Change In (3) Change In Unrealized Gains (Losses) Included in OCI (3) Net OCI Fixed maturities, including securities pledged: U.S. corporate public securities $ 93 $ 1 $ — $ — $ — $ (25) $ (1) $ — $ (45) $ 23 $ — $ — U.S. corporate private securities 1,900 51 (96) 77 — (328) (137) 621 (77) 2,011 (1) (96) Foreign corporate public securities and foreign governments (1) — — — 10 — — — — — 10 — — Foreign corporate private securities (1) 457 9 (2) 1 — (81) (32) — — 352 2 (5) Residential mortgage-backed securities 43 (7) — 15 — (7) — 2 — 46 (7) — Commercial mortgage-backed securities — — — 1 — (1) (4) 6 — 2 — — Other asset-backed securities 61 — (2) 22 — (4) (22) 23 — 78 — (2) Total fixed maturities, including securities pledged 2,554 54 (100) 126 — (446) (196) 652 (122) 2,522 (6) (103) Fixed maturities, trading, at fair value — — — 45 — — — — — 45 — — Equity securities, at fair value 172 13 — 225 — (152) (9) — — 249 (2) — Derivatives: Guaranteed benefit derivatives (2)(5) (84) 38 — — — — 2 — — (44) — — Other derivatives, net 1 — — — — — (1) — — — (1) — Embedded derivatives on reinsurance — 4 — — (89) — — — — (85) — — Assets held in separate accounts (4) 222 3 — 104 — (1) — — (35) 293 — — For the three and six months ended June 30, 2022 and 2021, the transfers in and out of Level 3 for fixed maturities were due to the variation in inputs relied upon for valuation each quarter. Securities that are primarily valued using independent broker quotes when prices are not available from one of the commercial pricing services are reflected as transfers into Level 3. When securities are valued using more widely available information, the securities are transferred out of Level 3 and into Level 1 or 2, as appropriate. Significant Unobservable Inputs The Company's Level 3 fair value measurements of its fixed maturities, equity securities and equity and credit derivative contracts are primarily based on broker quotes for which the quantitative detail of the unobservable inputs is neither provided nor reasonably corroborated, thus negating the ability to perform a sensitivity analysis. The Company performs a review of broker quotes by performing a monthly price variance comparison and back tests broker quotes to recent trade prices. Other Financial Instruments The following disclosures are made in accordance with the requirements of ASC Topic 825 which requires disclosure of fair value information about financial instruments, whether or not recognized at fair value on the Condensed Consolidated Balance Sheets. ASC Topic 825 excludes certain financial instruments, including insurance contracts and all nonfinancial instruments from its disclosure requirements. Accordingly, the aggregate fair value amounts presented do not represent the underlying value of the Company. The carrying values and estimated fair values of the Company's financial instruments as of the dates indicated: June 30, 2022 December 31, 2021 Carrying Fair Carrying Fair Assets: Fixed maturities, including securities pledged $ 32,666 $ 32,666 $ 37,251 $ 37,251 Equity securities 234 234 240 240 Mortgage loans on real estate 5,415 5,239 5,627 5,982 Policy loans 373 373 392 392 Cash, cash equivalents, short-term investments and short-term investments under securities loan agreements 2,113 2,113 2,607 2,607 Derivatives 277 277 171 171 Embedded derivative on reinsurance 21 21 — — Other investments 76 76 79 79 Assets held in separate accounts 80,017 80,017 100,433 100,433 Liabilities: Investment contract liabilities: Funding agreements without fixed maturities and deferred annuities (1) $ 36,125 $ 37,982 $ 35,334 $ 43,407 Funding agreements with fixed maturities 1,462 1,457 1,460 1,461 Supplementary contracts, immediate annuities and other 791 653 829 775 Derivatives: Guaranteed benefit derivatives (2) 29 29 48 48 Other derivatives 307 307 231 231 Embedded derivative on reinsurance 41 41 196 196 Short-term debt 1 1 1 1 Long-term debt 2,385 2,316 2,595 2,991 (1) Certain amounts included in Funding agreements without fixed maturities and deferred annuities are also reflected within the Guaranteed benefit derivatives section of the table above. (2) Includes GMWBL, GMWB, FIA, Stabilizer and MCGs. The following table presents the classifications of financial instruments which are not carried at fair value on the Condensed Consolidated Balance Sheets: Financial Instrument Classification Mortgage loans on real estate Level 3 Policy loans Level 2 Other investments Level 2 Funding agreements without fixed maturities and deferred annuities Level 3 Funding agreements with fixed maturities Level 2 Supplementary contracts and immediate annuities Level 3 Short-term debt and Long-term debt Level 2

Deferred Policy Acquisition Cos

Deferred Policy Acquisition Costs and Value of Business Acquired	6 Months Ended
	Jun. 30, 2022
Deferred Policy Acquisition Costs and Present Value of Future Insurance Profits, Net [Abstract]
Deferred Policy Acquisition Costs and Value of Business Acquired	Deferred Policy Acquisition Costs and Value of Business Acquired The following tables present a rollforward of DAC and VOBA for the periods indicated: 2022 DAC VOBA Total Balance as of January 1, 2022 $ 1,217 $ 161 $ 1,378 Deferrals of commissions and expenses 56 3 59 Amortization: Amortization, excluding unlocking (116) (10) (126) Unlocking (1) (41) (45) (86) Interest accrued 49 16 (3) 65 Net amortization included in Condensed Consolidated Statements of Operations (108) (39) (147) Change due to unrealized capital gains/(losses) on available-for-sale securities 700 490 1,190 Balance as of June 30, 2022 $ 1,865 $ 615 $ 2,480 2021 DAC VOBA Total Balance as of January 1, 2021 $ 1,440 $ 70 $ 1,510 Deferrals of commissions and expenses 50 3 53 Amortization: Amortization, excluding unlocking (2) (479) (158) (637) Unlocking (1) (9) 7 (2) Interest accrued 56 18 (3) 74 Net amortization included in Condensed Consolidated Statements of Operations (432) (133) (565) Change due to unrealized capital gains/(losses) on available-for-sale securities 181 267 448 Balance as of June 30, 2021 $ 1,239 $ 207 $ 1,446 (1) Includes the impacts of annual review of assumptions which typically occurs in the third quarter; and retrospective and prospective unlocking. (2) There was no loss recognition during 2022. During 2021, the Company recorded loss recognition of $301 and $1 for DAC and VOBA, respectively. (3) Interest accrued at the following rates for VOBA: 3.5% to 7.2% during 2022 and 2021.

Share-based Incentive Compensat

Share-based Incentive Compensation Plans	6 Months Ended
	Jun. 30, 2022
Share-Based Payment Arrangement [Abstract]
Share-based Incentive Compensation Plans	Share-based Incentive Compensation Plans The Company has provided equity-based compensation awards to its employees under the ING U.S., Inc. 2013 Omnibus Employee Incentive Plan (the "2013 Omnibus Plan"), the Voya Financial, Inc. 2014 Omnibus Employee Incentive Plan (the "2014 Omnibus Plan") and the Voya Financial, Inc. 2019 Omnibus Employee Incentive Plan (the "2019 Omnibus Plan") (together, the "Omnibus Plans"). As of June 30, 2022, common stock reserved and available for issuance under the 2013 Omnibus Plan, the 2014 Omnibus Plan and the 2019 Omnibus Plan was 347,663, 3,027,864 and 8,028,432 shares, respectively. The Company offers equity-based awards to Voya Financial, Inc. non-employee directors under the Voya Financial, Inc. 2013 Omnibus Non-Employee Director Incentive Plan ("Director Plan"). Compensation Cost The following table summarizes share-based compensation expense, which includes expenses related to awards granted under the Omnibus Plans and Director Plan for the periods indicated: Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Restricted Stock Unit (RSU) awards $ 8 $ 8 $ 30 $ 26 Performance Stock Unit (PSU) awards 7 11 31 30 Stock options — 1 — 1 Total share-based compensation expense 15 20 61 57 Income tax benefit 3 4 18 15 After-tax share-based compensation expense $ 12 $ 16 $ 43 $ 42 Awards Outstanding The following table summarizes RSU and PSU awards activity under the Omnibus Plans and the Director Plan for the periods indicated: RSU Awards PSU Awards (awards in millions) Number of Awards Weighted Average Grant Date Fair Value Number of Awards Weighted Average Grant Date Fair Value Outstanding as of January 1, 2022 1.4 $ 57.53 2.0 $ 54.05 Adjustment for PSU performance factor — — 0.2 59.13 Granted 0.7 66.03 0.6 66.32 Vested (0.7) 56.62 (0.9) 51.34 Forfeited — * 60.87 — * 58.14 Outstanding as of June 30, 2022 1.4 $ 62.18 1.9 $ 58.85 *Less than 0.1 The following table summarizes the number of options under the Omnibus Plans for the periods indicated: Stock Options (awards in millions) Number of Awards Weighted Average Exercise Price Outstanding as of January 1, 2022 1.8 $ 42.91 Granted — — Exercised (0.1) 39.91 Forfeited — — Outstanding as of June 30, 2022 1.7 $ 43.15 Vested, exercisable, as of June 30, 2022 1.7 $ 43.15

Shareholders' Equity

Shareholders' Equity	6 Months Ended
	Jun. 30, 2022
Equity [Abstract]
Shareholder's Equity	Shareholders' Equity Noncontrolling Interest Noncontrolling interest in limited partnerships increased as a result of favorable market appreciation in limited partnership investments, net of contributions and distributions. See the Consolidated and Nonconsolidated Investment Entities Note to these Condensed Consolidated Financial Statements for additional details over changes in noncontrolling interest during the year and impacting Shareholders' Equity. Common Shares The following table presents the rollforward of common shares used in calculating the weighted average shares utilized in the basic earnings per common share calculation for the periods indicated: Common Shares (shares in millions) Issued Held in Treasury Outstanding Balance, January 1, 2021 143.3 19.1 124.2 Common shares issued 0.1 — 0.1 Common shares acquired - share repurchase — 17.9 (17.9) Share-based compensation 2.4 1.0 1.4 Treasury Stock retirement (36.8) (36.8) — Balance, December 31, 2021 109.0 1.2 107.8 Common shares issued — — — Common shares acquired - share repurchase — 10.9 (10.9) Share-based compensation 1.6 0.6 1.0 Balance, June 30, 2022 110.6 12.7 97.9 Dividends declared per share of Common Stock were as follows for the periods indicated: Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Dividends declared per share of Common Stock $ 0.20 $ 0.165 $ 0.40 $ 0.33 Share Repurchase Program From time to time, the Company's Board of Directors authorizes the Company to repurchase shares of its common stock. These authorizations permit stock repurchases up to a prescribed dollar amount and generally may be accomplished through various means, including, without limitation, open market transactions, privately negotiated transactions, forward, derivative, or accelerated repurchase, or automatic repurchase transactions, including 10b5-1 plans, or tender offers. Share repurchase authorizations typically expire if unused by a prescribed date. On April 28, 2022, the Board of Directors provided its most recent share repurchase authorization, increasing the aggregate amount of the Company's common stock authorized for repurchase by $500. The share repurchase authorization expires on June 30, 2023 (unless extended), and does not obligate the Company to purchase any shares. The authorization for the share repurchase program may be terminated, increased or decreased by the Board of Directors at any time. The following table presents repurchases of the Company's common stock through share repurchase agreements with third-party financial institutions during the six months ended June 30, 2022. 2022 Execution Date Payment Initial Shares Delivered Closing Date Additional Shares Delivered Total Shares Repurchased June 21, 2022 $ 250 3,382,950 (1) (1) (1) March 17, 2022 $ 275 3,305,786 May 11, 2022 890,112 4,195,898 (1) This arrangement is scheduled to terminate no later than the end of the third quarter 2022, at which time the Company will settle any positive or negative share balances based on the daily volume-weighted average price of the Company's common stock. Warrants On May 7, 2013, the Company issued to ING Group warrants to purchase up to 26,050,846 shares of the Company's common stock equal in the aggregate to 9.99% of the issued and outstanding shares of common stock at that date. The exercise price of the warrants at the time of issuance was $48.75 per share of common stock, subject to adjustments, including for stock dividends, cash dividends in excess of $0.01 per share a quarter, subdivisions, combinations, reclassifications and non-cash distributions. The warrants also provide for, upon the occurrence of certain change of control events affecting the Company, an increase in the number of shares to which a warrant holder will be entitled upon payment of the aggregate exercise price of the warrant. The warrants became exercisable to ING Group and its affiliates on January 1, 2017 and to all other holders starting on the first anniversary of the completion of the IPO (May 7, 2014). The warrants expire on the tenth anniversary of the completion of the IPO (May 7, 2023). The warrants are net share settled, which means that no cash will be payable by a warrant holder in respect of the exercise price of a warrant upon exercise, and are classified as permanent equity. They have been recorded at their fair value determined on the issuance date of May 7, 2013 in the amount of $94 as an addition and reduction to Additional-paid-in-capital. Warrant holders are not entitled to receive dividends. On March 12, 2018, ING Group sold its remaining interests in the warrants and no longer owns any warrants. On June 29, 2022, the Company paid a quarterly dividend of $0.20 per share on its common stock. As a consequence, the exercise price of the warrants to purchase shares of common stock was adjusted to $47.21 per share of common stock and the number of shares of common stock for which each warrant is exercisable has been adjusted to 1.032523411. As of June 30, 2022, no warrants have been exercised. Preferred Stock As of June 30, 2022 and December 31, 2021, there were 100,000,000 shares of preferred stock authorized. Preferred stock issued and outstanding are as follows: June 30, 2022 December 31, 2021 Series Issued Outstanding Issued Outstanding 6.125% Non-cumulative Preferred Stock, Series A 325,000 325,000 325,000 325,000 5.35% Non-cumulative Preferred Stock, Series B 300,000 300,000 300,000 300,000 Total 625,000 625,000 625,000 625,000 The declaration of dividends on preferred stock per share and in the aggregate were as follows for the periods indicated: Series A Series B Three Months Ended June 30, Per Share Aggregate Per Share Aggregate 2022 $ — $ — $ 13.375 $ 4 2021 — — 13.375 4 Six Months Ended June 30, 2022 $ 30.625 $ 10 $ 26.750 $ 8 2021 30.625 10 26.750 8 As of June 30, 2022, there were no preferred stock dividends in arrears.

Earnings per Common Share

Earnings per Common Share	6 Months Ended
	Jun. 30, 2022
Earnings Per Share [Abstract]
Earnings per Common Share	Earnings per Common Share The following table presents a reconciliation of Net income (loss) and shares used in calculating basic and diluted net income (loss) per common share for the periods indicated: Three Months Ended June 30, Six Months Ended June 30, (in millions, except for per share data) 2022 2021 2022 2021 Earnings Net income (loss) available to common shareholders: Income (loss) from continuing operations $ 143 $ 916 $ 227 $ 2,002 Less: Preferred stock dividends 4 4 18 18 Less: Net income (loss) attributable to noncontrolling interest 75 447 118 447 Income (loss) from continuing operations available to common shareholders 64 465 91 1,537 Income (loss) from discontinued operations, net of tax — (6) — 8 Net income (loss) available to common shareholders $ 64 $ 459 $ 91 $ 1,545 Weighted average common shares outstanding Basic 101.7 120.6 103.9 121.6 Dilutive Effects (1) : Warrants 7.1 7.3 7.7 6.3 RSU awards 0.8 0.9 0.9 1.0 PSU awards 0.6 0.7 0.8 0.9 Stock Options 0.6 0.7 0.6 0.7 Diluted 110.8 130.2 113.9 130.5 Basic (2) Income (loss) from continuing operations available to Voya Financial, Inc.'s common shareholders $ 0.62 $ 3.86 $ 0.88 $ 12.64 Income (loss) from discontinued operations, net of taxes available to Voya Financial, Inc.'s common shareholders $ — $ (0.05) $ — $ 0.06 Income (loss) available to Voya Financial, Inc.'s common shareholders $ 0.62 $ 3.81 $ 0.88 $ 12.71 Diluted (2) Income (loss) from continuing operations available to Voya Financial, Inc.'s common shareholders $ 0.57 $ 3.58 $ 0.80 $ 11.78 Income (loss) from discontinued operations, net of taxes available to Voya Financial, Inc.'s common shareholders $ — $ (0.04) $ — $ 0.06 Income (loss) available to Voya Financial, Inc.'s common shareholders $ 0.57 $ 3.53 $ 0.80 $ 11.84 (1) For the six months ended June 30, 2022 and June 30, 2021, weighted average shares used for calculating earnings per share excludes the impact of forward contracts related to the share repurchase agreement entered into on June 21, 2022 and June 30, 2021, respectively, as the inclusion of these instruments would be antidilutive to the earnings per share calculation. For more information on the share repurchase agreement, see the Shareholders' Equity Note to these Condensed Consolidated Financial Statements. (2) Basic and diluted earnings per share are calculated using unrounded, actual amounts. Therefore, the components of earnings per share may not sum to its corresponding total.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income (Loss)	6 Months Ended
	Jun. 30, 2022
Equity [Abstract]
Accumulated Other Comprehensive Income (Loss)	Accumulated Other Comprehensive Income (Loss) Shareholders' equity included the following components of AOCI as of the dates indicated: June 30, 2022 2021 Fixed maturities, net of impairment $ (1,926) $ 3,739 Derivatives (1) 129 63 DAC/VOBA adjustment on available-for-sale securities (2) 422 (877) (3) Premium deficiency reserve adjustment (2) — (15) Other intangibles adjustment on available-for-sale securities (2) (4) 5 Other — 2 Unrealized capital gains (losses), before tax (1,379) 2,917 Deferred income tax asset (liability) 413 (490) Net unrealized capital gains (losses) (966) 2,427 Pension and other postretirement benefits liability, net of tax 3 4 AOCI $ (963) $ 2,431 (1) Gains and losses reported in Accumulated Other Comprehensive Income (AOCI) from hedge transactions that resulted in the acquisition of an identified asset are reclassified into earnings in the same period or periods during which the asset acquired affects earnings. As of June 30, 2022, the portion of the AOCI that is expected to be reclassified into earnings within the next 12 months is $20. (2) Upon adoption of ASU 2018-12 on January 1, 2023, the DAC/VOBA adjustments on available-for-sale securities, Premium deficiency reserve adjustment and Other intangibles adjustment on available-for-sale securities will be reversed as of the January 1, 2021 transition date and in subsequent periods. (3) In connection with the closing of the Individual Life Transaction on January 4, 2021, the Company released stranded AOCI and reversed unrealized capital gains (losses) on available-for-sale securities associated with DAC for the disposed entities. In addition, the Company released the unrealized gains for the investments transferred associated with the reinsurance transactions entered into at closing. Changes in AOCI, including the reclassification adjustments recognized in the Condensed Consolidated Statements of Operations were as follows for the periods indicated: Three Months Ended June 30, 2022 Before-Tax Amount Income Tax (Benefit) After-Tax Amount Available-for-sale securities: Fixed maturities $ (2,548) $ 535 $ (2,013) Adjustments for amounts recognized in Net gains (losses) in the Condensed Consolidated Statements of Operations 20 (4) 16 DAC/VOBA 593 (125) 468 Premium deficiency reserve adjustment 5 (1) 4 Other intangibles (5) 1 (4) Change in unrealized gains (losses) on available-for-sale securities (1,935) 406 (1,529) Derivatives: Derivatives 54 (1) (11) 43 Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Condensed Consolidated Statements of Operations (5) 1 (4) Change in unrealized gains (losses) on derivatives 49 (10) 39 Change in Accumulated other comprehensive income (loss) $ (1,886) $ 396 $ (1,490) (1) See the Derivative Financial Instruments Note to these Condensed Consolidated Financial Statements for additional information. Six Months Ended June 30, 2022 Before-Tax Amount Income Tax (Benefit) After-Tax Amount Available-for-sale securities: Fixed maturities $ (5,211) $ 1,094 $ (4,117) Adjustments for amounts recognized in Net gains (losses) in the Condensed Consolidated Statements of Operations 90 (19) 71 DAC/VOBA 1,190 (1) (250) 940 Premium deficiency reserve adjustment 14 (3) 11 Other intangibles (9) 2 (7) Change in unrealized gains (losses) on available-for-sale securities (3,926) 824 (3,102) Derivatives: Derivatives 59 (2) (12) 47 Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Condensed Consolidated Statements of Operations (10) 2 (8) Change in unrealized gains (losses) on derivatives 49 (10) 39 Change in Accumulated other comprehensive income (loss) $ (3,877) $ 814 $ (3,063) (1) See the Deferred Policy Acquisition Costs and Value of Business Acquired Note to these Condensed Consolidated Financial Statements for additional information. (2) See the Derivative Financial Instruments Note to these Condensed Consolidated Financial Statements for additional information Three Months Ended June 30, 2021 Before-Tax Amount Income Tax (Benefit) After-Tax Amount Available-for-sale securities: Fixed maturities $ 826 $ (173) $ 653 Other (2) — (2) Adjustments for amounts recognized in Net gains (losses) in the Condensed Consolidated Statements of Operations (15) 3 (12) DAC/VOBA (149) 31 (118) Premium deficiency reserve adjustment (1) 1 — Change in unrealized gains (losses) on available-for-sale securities 659 (138) 521 Derivatives: Derivatives 7 (1) (2) 5 Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Condensed Consolidated Statements of Operations (5) 1 (4) Change in unrealized gains (losses) on derivatives 2 (1) 1 Pension and other postretirement benefits liability: Amortization of prior service cost recognized in Operating expenses in the Condensed Consolidated Statements of Operations (1) — (1) Change in pension and other postretirement benefits liability (1) — (1) Change in Accumulated other comprehensive income (loss) $ 660 $ (139) $ 521 (1) See the Derivative Financial Instruments Note to these Condensed Consolidated Financial Statements for additional information . Six Months Ended June 30, 2021 Before-Tax Amount Income Tax (Benefit) After-Tax Amount Available-for-sale securities: Fixed maturities $ (3,099) $ 420 $ (2,679) Adjustments for amounts recognized in Net gains (losses) in the Condensed Consolidated Statements of Operations (1,775) 373 (1,402) DAC/VOBA 1,194 (1) (251) 943 Premium deficiency reserve adjustment 445 (93) 352 Other intangibles 419 (88) 331 Change in unrealized gains (losses) on available-for-sale securities (2,816) 361 (2,455) Derivatives: Derivatives (2) (2) — (2) Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Condensed Consolidated Statements of Operations (11) 2 (9) Change in unrealized gains (losses) on derivatives (13) 2 (11) Pension and other postretirement benefits liability: Amortization of prior service cost recognized in Operating expenses in the Condensed Consolidated Statements of Operations (1) — (1) Change in pension and other postretirement benefits liability (1) — (1) Change in Accumulated other comprehensive income (loss) $ (2,830) $ 363 $ (2,467) (1) See the Deferred Policy Acquisition Costs and Value of Business Acquired Note to these Condensed Consolidated Financial Statements for additional information. (2) See the Derivative Financial Instruments Note to these Condensed Consolidated Financial Statements for additional information.

Income Taxes

Income Taxes	6 Months Ended
	Jun. 30, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company uses the estimated annual effective tax rate method in computing its interim tax provision. Certain items, including changes in the realizability of deferred tax assets and changes in liabilities for uncertain tax positions, are excluded from the estimated annual effective tax rate and the actual tax expense or benefit is reported in the period the related item is incurred. The Company's effective tax rate for the three and six months ended June 30, 2022 was 6.5% and 7.0%. The effective tax rate differed from the statutory rate of 21% primarily due to noncontrolling interest, the effect of the dividends received deduction ("DRD") and tax credits. The Company's effective tax rate for the three months ended June 30, 2021 was 10.9%. The effective tax rate differed from the statutory rate of 21% primarily due to noncontrolling interest and the effect of the DRD. The Company's effective tax rate for the six months ended June 30, 2021 was 3.1%. The effective tax rate differed from the statutory rate of 21% primarily due to the effect of the release of a stranded tax benefit in Other Comprehensive Income due to the Individual Life Transaction, noncontrolling interest and the effect of the DRD. Valuation allowances are provided when it is considered more likely than not that some portion or all of the deferred tax assets ("DTAs") will not be realized. The Company reviews all available positive and negative evidence to determine if a valuation allowance is recorded, including historical and projected pre-tax book income, tax planning strategies and reversals of temporary differences. As of June 30, 2022, the Company had year-to-date losses on securities of $3,877 in Other comprehensive income primarily driven by increases in interest rates. The Company determined that the increase in unrealized losses on fixed income investments will be offset in future years by the ordinary income produced from these investments as they reach maturity. Additionally, operating income remained positive for the period and was largely consistent with the 2021 year-end valuation allowance analysis. After evaluating the positive and negative evidence, the Company did not change its judgement regarding the realization of DTAs. For more information related to the valuation allowance, refer to the Income Taxes Note to the Consolidated Financial Statements included in Part II, Item 8 of the Annual Report on form 10-K . Tax Regulatory Matters For the tax years 2020 through 2022, the Company participated in the Internal Revenue Service ("IRS") Compliance Assurance Process ("CAP"), which is a continuous audit program provided by the IRS. For the 2020 tax year, the Company was in the Compliance Maintenance Bridge ("Bridge") phase of CAP. In the Bridge phase, the IRS did not conduct any review or provide any letters of assurance for that tax year.

Reinsurance

Reinsurance	6 Months Ended
	Jun. 30, 2022
Insurance [Abstract]
Reinsurance	ReinsuranceThe Company reinsures its business through a diversified group of reinsurers. However, the Company remains liable to the extent its reinsurers do not meet their obligations under the reinsurance agreements. The Company monitors trends in arbitration and any litigation outcomes with its reinsurers. Collectability of reinsurance balances are evaluated by monitoring ratings and evaluating the financial strength of its reinsurers. Large reinsurance recoverable balances with offshore or other non-accredited reinsurers are secured through various forms of collateral, including secured trusts, funds withheld accounts and irrevocable letters of credit ("LOC"). Information regarding the effect of reinsurance on the Condensed Consolidated Balance Sheets is as follows as of the periods indicated: June 30, 2022 Direct Assumed Ceded Total, Assets Premiums receivable $ 195 $ 10 $ (205) $ — Reinsurance recoverable, net of allowance for credit losses — — 13,079 13,079 Total $ 195 $ 10 $ 12,874 $ 13,079 Liabilities Future policy benefits and contract owner account balances $ 52,076 $ 1,075 $ — $ 53,151 Liability for funds withheld under reinsurance agreements 71 — — 71 Total $ 52,147 $ 1,075 $ — $ 53,222 December 31, 2021 Direct Assumed Ceded Total, Assets Premiums receivable $ 169 $ 8 $ (213) $ (36) Reinsurance recoverable — — 13,671 13,671 Total $ 169 $ 8 $ 13,458 $ 13,635 Liabilities Future policy benefits and contract owner account balances $ 51,648 $ 1,110 $ — $ 52,758 Liability for funds withheld under reinsurance agreements 203 — — 203 Total $ 51,851 $ 1,110 $ — $ 52,961 Information regarding the effect of reinsurance on the Condensed Consolidated Statement of Operations is as follows for the periods indicated: Three Months Ended June 30, 2022 2021 Premiums: Direct premiums $ 814 $ 760 Reinsurance assumed 4 5 Reinsurance ceded (223) (249) Net premiums $ 595 $ 516 Fee income: Gross fee income $ 510 $ 537 Reinsurance assumed 4 4 Reinsurance ceded (103) (105) Net fee income $ 411 $ 436 Interest credited and other benefits to contract owners / policyholders: Direct interest credited and other benefits to contract owners / policyholders $ 1,076 $ 1,037 Reinsurance assumed 14 20 Reinsurance ceded (1) (447) (371) Net interest credited and other benefits to contract owners / policyholders $ 643 $ 686 (1) Includes $72 and $56 for amounts paid and accrued to reinsurers in connection with the Company's UL contracts for the Life segment for the three months ended June 30, 2022 and 2021, respectively. Six Months Ended June 30, 2022 2021 Premiums: Direct premiums $ 1,628 $ 1,532 Reinsurance assumed 13 14 Reinsurance ceded (433) (6,017) Net premiums $ 1,208 $ (4,471) Fee income: Gross fee income $ 1,043 $ 1,097 Reinsurance assumed 9 9 Reinsurance ceded (208) (212) Net fee income $ 844 $ 894 Interest credited and other benefits to contract owners / policyholders: Direct interest credited and other benefits to contract owners / policyholders $ 1,954 $ 3,004 Reinsurance assumed 22 41 Reinsurance ceded (1) (668) (6,549) Net interest credited and other benefits to contract owners / policyholders $ 1,308 $ (3,504) (1) Includes $150 and $5,845 for amounts paid and accrued to reinsurers in connection with the Company's UL contracts for the Life segment for the six months ended June 30, 2022 and 2021, respectively.

Financing Agreements

Financing Agreements	6 Months Ended
	Jun. 30, 2022
Debt Disclosure [Abstract]
Financing Agreements	Financing Agreements Short-term and Long-term Debt The following table summarizes the carrying value of the Company’s debt securities issued and outstanding as of June 30, 2022 and December 31, 2021: Issuer Maturity June 30, 2022 December 31, 2021 3.65% Senior Notes, due 2026 (2)(3) Voya Financial, Inc. 06/15/2026 $ 445 $ 445 5.7% Senior Notes, due 2043 (2)(3) Voya Financial, Inc. 07/15/2043 395 395 4.8% Senior Notes, due 2046 (2)(3) Voya Financial, Inc. 06/15/2046 297 297 4.7% Fixed-to-Floating Rate Junior Subordinated Notes, due 2048 Voya Financial, Inc. 01/23/2048 345 345 5.65% Fixed-to-Floating Rate Junior Subordinated Notes, due 2053 (4) Voya Financial, Inc. 05/15/2053 530 740 7.25% Voya Holdings Inc. debentures, due 2023 (1) Voya Holdings, Inc. 08/15/2023 140 140 7.63% Voya Holdings Inc. debentures, due 2026 (1) Voya Holdings, Inc. 08/15/2026 139 139 6.97% Voya Holdings Inc. debentures, due 2036 (1) Voya Holdings, Inc. 08/15/2036 79 79 8.42% Equitable of Iowa Companies Capital Trust II Notes, due 2027 Equitable of Iowa Capital Trust II 04/01/2027 13 13 1.00% Windsor Property Loan Voya Retirement Insurance and Annuity Company 06/14/2027 3 3 Subtotal 2,386 2,596 Less: Current portion of long-term debt 1 1 Total $ 2,385 $ 2,595 (1) Guaranteed by ING Group. (2) Interest is paid semi-annually in arrears. (3) Guaranteed by Voya Holdings. (4) See the Junior Subordinated Notes section below. As of June 30, 2022, the Company was in compliance with its debt covenants. Aetna Notes As of June 30, 2022, the outstanding principal amount of the Aetna Notes was $358, which is guaranteed by ING Group. As of June 30, 2022, the Company provided $363 of collateral benefiting ING Group, comprised of a deposit of $200 to a control account with a third-party collateral agent and $163 of letter of credit. The collateral may be exchanged at any time upon the posting of any other form of acceptable collateral to the account. Junior Subordinated Notes During the six months ended June 30, 2022, the Company repurchased $214 par value of its 5.65% Fixed-to-Floating Rate Junior Subordinated Note, due 2053, on the open market, resulting in loss on debt extinguishment of $4, which is included in Interest expense on the Condensed Consolidated Statements of Operations. Senior Unsecured Credit Facility Agreement As of June 30, 2022, the Company had a $500 senior unsecured credit facility with a syndicate of banks which expires November 1, 2024. The facility provides $500 of committed capacity for issuing letters of credit and the full $500 may be utilized for direct borrowings. As of June 30, 2022, there were no amounts outstanding as revolving credit borrowings and no amounts of LOCs outstanding under the senior unsecured credit facility. Under the terms of the facility, the Company is required to maintain a minimum net worth of $6,150, which may increase upon any future equity issuances by the Company.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Leases During the six months ended June 30, 2022, the Company recorded an impairment of $3 on its right-of-use asset associated with leased office space, which is included in Operating expenses in the Condensed Consolidated Statements of Operations. There was no impairment on the Company's right-of-use asset associated with leased office space during the three months ended June 30, 2022. During the three and six months ended June 30, 2021, the Company recorded an impairment of $13 on its right-of-use asset associated with leased office space, which is included in Operating expenses in the Condensed Consolidated Statements of Operations. Commitments Through the normal course of investment operations, the Company commits to either purchase or sell securities, mortgage loans, or money market instruments, at a specified future date and at a specified price or yield. The inability of counterparties to honor these commitments may result in either a higher or lower replacement cost. Also, there is likely to be a change in the value of the securities underlying the commitments. As of June 30, 2022, the Company had off-balance sheet commitments to acquire mortgage loans of $200 and purchase limited partnerships and private placement investments of $1,094, of which $393 related to consolidated investment entities. Restricted Assets The Company is required to maintain assets on deposit with various regulatory authorities to support its insurance operations. The Company may also post collateral in connection with certain securities lending, repurchase agreements, funding agreements, credit facilities and derivative transactions. The components of the fair value of the restricted assets were as follows as of the dates indicated: June 30, 2022 December 31, 2021 Fixed maturity collateral pledged to FHLB (1) $ 1,990 $ 1,881 FHLB restricted stock (2) 75 78 Other fixed maturities-state deposits 43 46 Cash and cash equivalents 35 31 Securities pledged (3) 1,183 1,198 Total restricted assets $ 3,326 $ 3,234 (1) Included in Fixed maturities, available for sale, at fair value on the Condensed Consolidated Balance Sheets. (2) Included in Other investments on the Condensed Consolidated Balance Sheets. (3) Includes the fair value of loaned securities of $913 and $969 as of June 30, 2022 and December 31, 2021, respectively. In addition, as of June 30, 2022 and December 31, 2021, the Company delivered securities as collateral of $162 and $124 and repurchase agreements of $108 and $105, respectively. Loaned securities and securities delivered as collateral are included in Securities pledged on the Condensed Consolidated Balance Sheets. Federal Home Loan Bank Funding Agreements The Company is a member of the FHLB of Des Moines and the FHLB of Boston and is required to pledge collateral to back funding agreements issued to the FHLB. As of June 30, 2022 and December 31, 2021, the Company had $1,462 and $1,461 respectively, in non-putable funding agreements, which are included in Contract owner account balances on the Condensed Consolidated Balance Sheets. As of June 30, 2022 and December 31, 2021, assets with a market value of approximately $1,990 and $1,881, respectively, collateralized the FHLB funding agreements. Assets pledged to the FHLB are included in Fixed maturities, available-for-sale, at fair value on the Condensed Consolidated Balance Sheets. Litigation, Regulatory Matters and Contingencies Litigation, regulatory and other loss contingencies arise in connection with the Company's activities as a diversified financial services firm. The Company is a defendant in a number of litigation matters arising from the conduct of its business, both in the ordinary course and otherwise. In some of these matters, claimants seek to recover very large or indeterminate amounts, including compensatory, punitive, treble and exemplary damages. Modern pleading practice in the U.S. permits considerable variation in the assertion of monetary damages and other relief. Claimants are not always required to specify the monetary damages they seek or they may be required only to state an amount sufficient to meet a court's jurisdictional requirements. Moreover, some jurisdictions allow claimants to allege monetary damages that far exceed any reasonably possible verdict. The variability in pleading requirements and past experience demonstrates that the monetary and other relief that may be requested in a lawsuit or claim often bears little relevance to the merits or potential value of a claim. Litigation against the Company includes a variety of claims including negligence, breach of contract, fraud, violation of regulation or statute, breach of fiduciary duty, negligent misrepresentation, failure to supervise, elder abuse and other torts. As with other financial services companies, the Company periodically receives informal and formal requests for information from various state and federal governmental agencies and self-regulatory organizations in connection with inquiries and investigations of the products and practices of the Company or the financial services industry. It is the practice of the Company to cooperate fully in these matters. While it is possible that an adverse outcome in certain cases could have a material adverse effect upon the Company's financial position, based on information currently known, management believes that neither the outcome of pending litigation and regulatory matters nor potential liabilities associated with other loss contingencies, are likely to have such an effect. However, given the large and indeterminate amounts sought in certain litigation and the inherent unpredictability of all such matters, it is possible that an adverse outcome in certain of the Company's litigation or regulatory matters, or liabilities arising from other loss contingencies, could, from time to time, have a material adverse effect upon the Company's results of operations or cash flows in a particular quarterly or annual period. For some matters, the Company is able to estimate a possible range of loss. For such matters in which a loss is probable, an accrual has been made. For matters where the Company, however, believes a loss is reasonably possible, but not probable, no accrual is required. For matters for which an accrual has been made, but there remains a reasonably possible range of loss in excess of the amounts accrued or for matters where no accrual is required, the Company develops an estimate of the unaccrued amounts of the reasonably possible range of losses. As of June 30, 2022, the Company estimates the aggregate range of reasonably possible losses, in excess of any amounts accrued for these matters as of such date, to be up to approximately $25. For other matters, the Company is currently not able to estimate the reasonably possible loss or range of loss. The Company is often unable to estimate the possible loss or range of loss until developments in such matters have provided sufficient information to support an assessment of the range of possible loss, such as quantification of a damage demand from plaintiffs, discovery from plaintiffs and other parties, investigation of factual allegations, rulings by a court on motions or appeals, analysis by experts and the progress of settlement discussions. On a quarterly and annual basis, the Company reviews relevant information with respect to litigation and regulatory contingencies and updates the Company's accruals, disclosures and reasonably possible losses or ranges of loss based on such reviews. Litigation includes Henkel of America v. ReliaStar Life Insurance Company, et al. (USDC District of Connecticut, No. 1:18-cv-00965)(filed June 8, 2018). Plaintiff alleges that ReliaStar breached the terms of a stop loss policy it issued to Plaintiff by refusing to reimburse Plaintiff for more than $47 in claims incurred by participants in prior years and submitted for coverage under the stop loss policy. Plaintiff alleges a breach of contract claim or, in the alternative, that the stop loss policy be declared to cover the submitted claims, and also asserts that ReliaStar engaged in unfair trade practices and unfair insurance practices in violation of state statutes, and did so willfully and intentionally to warrant an award of punitive damages under state law. The Company denies the allegations, which it believes are without merit, and intends to defend the case vigorously. Litigation also includes Ravarino, et al. v. Voya Financial, Inc., et al. (USDC District of Connecticut, No. 3:21-cv-01658) (filed December 14, 2021). In this putative class action, the plaintiffs allege that the named defendants breached their fiduciary duties of prudence and loyalty in the administration of the Voya 401(k) Savings Plan. The plaintiffs claim that the named defendants did not exercise proper prudence in their management of allegedly poorly performing investment options, including proprietary funds, and passed excessive investment-management and other administrative fees for proprietary and non-proprietary funds onto plan participants. The plaintiffs also allege that the defendants engaged in self-dealing through the inclusion of the Voya Stable Value Option into the plan offerings and by setting the “crediting rate” for participants’ investment in the Stable Value Fund artificially low in relation to Voya’s general account investment returns in order to maximize the spread and Voya’s profits at the participants’ expense. The complaint seeks disgorgement of unjust profits as well as costs incurred. The Company denies the allegations, which it believes are without merit, and intends to defend the case vigorously. Finally, industry wide, life insurers continue to be exposed to class action litigation related to the cost of insurance rates and periodic deductions from cash value. Common allegations include that insurance companies have breached the terms of their universal life insurance policies by establishing or increasing the cost of insurance rates using cost factors not permitted by the contract, thereby unjustly enriching themselves. This litigation is generally known as cost of insurance litigation. Cost of insurance litigation for the Company includes Advance Trust & Life Escrow Services, LTA v. ReliaStar Life Insurance Company (USDC District of Minnesota, No. 1:18-cv-02863) (filed October 5, 2018), a putative class action in which Plaintiff alleges that the Company’s universal life insurance policies only permitted the Company to rely upon the policyholders’ expected future mortality experience to establish the cost of insurance, and that as projected mortality experience improved, the policy language required the Company to decrease the cost of insurance. Plaintiff alleges that the Company did not decrease the cost of insurance as required, thereby breaching its contract with the policyholders, and seeks class certification. On March 29, 2022, the district court granted the Plaintiff’s motion for class certification and denied the Company’s motion for summary judgment. The Company denies the allegations in the complaint, believes the complaint to be without merit, and will defend the lawsuit vigorously. Contingencies related to Performance-based Capital Allocations on Private Equity Funds Certain performance-based capital allocations related to sponsored private equity funds ("carried interest") are not final until the conclusion of an investment term specified in the relevant asset management contract. As a result, such carried interest, if accrued or paid to the Company during such term, is subject to later adjustment based on subsequent fund performance. If the fund’s cumulative investment return falls below specified investment return hurdles, some or all of the previously accrued carried interest is reversed to the extent that the Company is no longer entitled to the performance-based capital allocation. Should the fund’s cumulative investment return subsequently increase above specified investment return hurdles in future periods, previous reversals could be fully or partially recovered. As of June 30, 2022, approximately $136 of previously accrued carried interest would be subject to full or partial reversal in future periods if cumulative fund performance hurdles are not maintained throughout the remaining life of the affected funds.

Consolidated and Nonconsolidate

Consolidated and Nonconsolidated Investment Entities	6 Months Ended
	Jun. 30, 2022
Consolidated Investment Entities [Abstract]
Consolidated and Nonconsolidated Investment Entities	Consolidated and Nonconsolidated Investment Entities The Company holds variable interests in certain investment entities in the form of debt or equity investments, as well as the right to receive management fees, performance fees, and carried interest. The Company consolidates certain entities under the VIE guidance when it is determined that the Company is the primary beneficiary. Alternatively, certain entities are consolidated under the VOE guidance when control is obtained through voting rights. Refer to the Condensed Consolidated Balance Sheets for the assets and liabilities of the Company's consolidated investment entities. The Company has no right to the benefits from, nor does it bear the risks associated with consolidated investment entities beyond the Company’s direct equity and debt investments in and management fees generated from these entities. Such direct investments amounted to approximately $314 and $317 as of June 30, 2022 and December 31, 2021, respectively. If the Company were to liquidate, the assets held by consolidated investment entities would not be available to the general creditors of the Company as a result of the liquidation. Consolidated VIEs and VOEs Collateral Loan Obligations Entities ("CLOs") The Company is involved in the design, creation, and the ongoing management of CLOs. These entities are created for the purpose of acquiring diversified portfolios of senior secured floating rate leveraged loans, and securitizing these assets by issuing multiple tranches of collateralized debt; thereby providing investors with a broad array of risk and return profiles. Also known as collateralized financing entities under Topic 810, CLOs are variable interest entities by definition. In return for providing collateral management services, the Company earns investment management fees and contingent performance fees. In addition to earning fee income, the Company often invests in the subordinated debt of entities formed to be the issuers of CLO offerings during their warehouse periods. The Company’s investments in these CLOs are repaid when the CLOs’ warehouse periods are closed and the CLO offerings are issued. The Company performs ongoing monitoring of the consolidation assessment for CLOs during and after their warehouse periods to determine if Voya remains the primary beneficiary of the CLOs. The fee income earned and investments held are included in the Company's ongoing consolidation assessment for each CLO. The Company was the primary beneficiary of 8 and 7 CLOs as of June 30, 2022 and December 31, 2021, respectively. The one additional CLO was consolidated during the first half of 2022 with impacts reflected within the Cash and cash equivalents and CLO notes, at fair value using the fair value option within the CIE sections of the Company's Condensed Consolidated Balance Sheet. There was no impact to the Company's Condensed Consolidated Statement of Operations during the three and six months ended June 30, 2022. Limited Partnerships ("LPs") The Company invests in and manages various limited partnerships, including private equity funds and hedge funds. The LPs generally have a ten-year life and have specified period during which investors can subscribe for limited partnership interests. Once the investors are admitted as limited partners, the investors are required to contribute capital when called by the general partners. The purpose of the LPs is to obtain subscriptions from limited partners and maximize the return to their partners by assembling a diversified portfolio of investments in private equity funds and other securities or assets with similar risk and return characteristics primarily through secondary market purchases. The majority of the investors in the LPs are unrelated parties to the Company. In return for subscriptions, each partner receives an equity interest in the LPs in proportion to its respective investment. These entities have been evaluated by the Company and are determined to be VIEs due to the equity holders, as a group, lacking the characteristics of a controlling financial interest. In return for serving as the general partner of and providing investment management services to these entities, the Company earns management fees and carried interest in the normal course of business. Additionally, the Company often holds an investment in each limited partnership it manages, generally in the form of general partner and limited partner interests. The fee income, carried interest, and investments held are included in the Company’s ongoing consolidation analysis for each limited partnership. The Company consolidated 11 funds, which were structured as partnerships, as of June 30, 2022 and December 31, 2021. The noncontrolling interest related to these partnerships increased from $1,568 at December 31, 2021 to $1,697 at June 30, 2022. Changes in market value, contributions and distributions related to these investments in partnerships directly impact the noncontrolling interest component of Shareholders' Equity on the Company's Condensed Consolidated Balance Sheets. The change in noncontrolling interest was primarily driven by favorable market appreciation in limited partnership investments, adjusted for contributions and distributions. The Company records the noncontrolling interest using a lag methodology relying on the most recent financial information available. The following table summarizes the components of the consolidated investment entities as of the dates indicated: June 30, 2022 December 31, 2021 Assets of Consolidated Investment Entities VIEs Cash and cash equivalents $ 85 $ 171 Corporate loans, at fair value using the fair value option 1,122 1,111 Limited partnerships/corporations, at fair value 2,943 2,469 Other assets 15 28 Total VIE assets 4,165 3,779 Total assets of consolidated investment entities $ 4,165 $ 3,779 Liabilities and Shareholders' Equity of Consolidated Investment Entities VIEs CLO notes, at fair value using the fair value option $ 1,019 $ 880 Other liabilities 1,135 1,013 Total VIE liabilities 2,154 1,893 Total liabilities of consolidated investment entities 2,154 1,893 Noncontrolling interest 1,697 1,568 Total VIE shareholders' equity 1,697 1,568 Total liabilities and shareholders' equity of consolidated investment entities $ 3,851 $ 3,461 Fair Value Measurement Upon consolidation, the Company elected to apply the FVO for financial assets and financial liabilities held by CLOs and continued to measure these assets (primarily corporate loans) and liabilities (debt obligations issued by CLOs) at fair value in subsequent periods. The Company has elected the FVO to more closely align its accounting with the economics of its transactions and allows the Company to more effectively align changes in the fair value of CLO assets with a commensurate change in the fair value of CLO liabilities. Investments held by consolidated private equity funds are measured and reported at fair value in the Company's Condensed Consolidated Financial Statements. Changes in the fair value of consolidated investment entities are recorded as a separate line item within Income (loss) related to consolidated investment entities in the Company's Condensed Consolidated Statements of Operations. The methodology for measuring the fair value of financial assets and liabilities of consolidated investment entities, and the classification of these measurements in the fair value hierarchy is consistent with the methodology and classification applied by the Company to its investment portfolio, as discussed within the Fair Value Measurements (excluding Consolidated Investment Entities) Note to these Condensed Consolidated Financial Statements. As discussed in more detail below, the Company utilizes valuations obtained from third-party commercial pricing services, brokers and investment sponsors or third-party administrators that supply NAV (or its equivalent) per share used as a practical expedient. The valuations obtained from brokers and third-party commercial pricing services are non-binding. These valuations are reviewed on a monthly or quarterly basis depending on the entity and its underlying investments. Procedures include, but are not limited to, a review of underlying fund investor reports, review of top and worst performing funds requiring further scrutiny, review of variance from prior periods and review of variance from benchmarks, where applicable. In addition, the Company considers both macro and fund specific events that may impact the latest NAV supplied and determines if further adjustments of value should be made. Such changes, if any, are subject to senior management review. When a price cannot be obtained from a commercial pricing service, independent broker quotes are solicited. Securities priced using independent broker quotes are classified as Level 3. Broker quotes and prices obtained from pricing services are reviewed and validated through an internal valuation committee price variance review, comparisons to internal pricing models, back testing to recent trades or monitoring of trading volumes. Cash and Cash Equivalents The carrying amounts for cash reflect the assets’ fair values. The fair value for cash equivalents is determined based on quoted market prices. These assets are classified as Level 1. CLOs Corporate loans : Corporate loan investments, which comprise the majority of consolidated CLO portfolio collateral, are senior secured corporate loans maturing at various dates between 2023 and 2030, paying interest at LIBOR, SOFR, EURIBOR or PRIME plus a spread of up to 10.0%. As of June 30, 2022 and December 31, 2021, the unpaid principal balance exceeded the fair value of the corporate loans by approximately $55 and $8, respectively. Less than 1.0% of the collateral assets were in default as of June 30, 2022 and December 31, 2021. The fair values for corporate loans are determined using independent commercial pricing services. Fair value measurement based on pricing services may be classified in Level 2 or Level 3 depending on the type, complexity, observability and liquidity of the asset being measured. The inputs used by independent commercial pricing services, such as benchmark yields and credit risk adjustments, are those that are derived principally from or corroborated by observable market data. Hence, the fair value measurement of corporate loans priced by independent pricing service providers is classified within Level 2 of the fair value hierarchy. In addition, there are assets held with CLO portfolios that represent senior level debt of other third party CLOs. These CLO investments are classified within Level 3 of the fair value hierarchy. See description of fair value process for CLO notes below. CLO notes : The CLO notes are backed by diversified loan portfolios consisting primarily of senior secured floating rate leveraged loans. Repayment risk is segmented into tranches with credit ratings of these tranches reflecting both the credit quality of underlying collateral as well as how much protection a given tranche is afforded by tranches that are subordinate to it. The most subordinated tranche bears the first loss and receives the residual payments, if any. The interest rates are generally variable rates based on LIBOR or EURIBOR plus a pre-defined spread, which varies from 1.0% for the more senior tranches to 8.8% for the more subordinated tranches. CLO notes mature in 2026 and 2034, and have a weighted average maturity of 12 years as of June 30, 2022. The investors in this debt are not affiliated with the Company and have no recourse to the general credit of the Company for this debt. The fair values of the CLO notes are measured based on the fair value of the CLO's corporate loans, as the Company uses the measurement alternative available under ASU 2014-13 and determined that the inputs for measuring financial assets are more observable. The CLO notes are classified within Level 2 of the fair value hierarchy, consistent with the classification of the majority of the CLO financial assets. The Company reviews the detailed prices including comparisons to prior periods for reasonableness. The Company utilizes a formal pricing challenge process to request a review of any price during which time the vendor examines its assumptions and relevant market inputs to determine if a price change is warranted. The following narrative indicates the sensitivity of inputs: • Default Rate: An increase (decrease) in the expected default rate would likely increase (decrease) the discount margin (increase risk premium) used to value the CLO investments and CLO notes and, as a result, would potentially decrease the value of the CLO investments and CLO notes. • Recovery Rate: A decrease (increase) in the expected recovery of defaulted assets would potentially decrease (increase) the valuation of CLO investments and CLO notes. • Prepayment Rate: A decrease (increase) in the expected rate of collateral prepayments would potentially decrease (increase) the valuation of CLO investments and CLO notes as the expected weighted average life ("WAL") would increase (decrease). • Discount Margin (spread over LIBOR): An increase (decrease) in the discount margin used to value the CLO investments and CLO notes would decrease (increase) the value of the CLO investments and CLO notes. Private Equity Funds As prescribed in ASC Topic 820, the unit of account for these investments is the interest in the investee fund. The Company owns an undivided interest in the fund portfolio and does not have the ability to dispose of individual assets and liabilities in the fund portfolio. Rather, the Company would be required to redeem or dispose of its entire interest in the investee fund. There is no current active market for interests in underlying private equity funds. Valuation is generally based on the valuations provided by the fund's general partner or investment manager. The valuations typically reflect the fair value of the Company's capital account balance of each fund investment, including unrealized capital gains (losses), as reported in the financial statements of the respective investee fund as of the respective year end or the latest available date. In circumstances where fair values are not provided, the Company seeks to determine the fair value of fund investments based upon other information provided by the fund's general partner or investment manager or from other sources. The fair value of securities received in-kind from fund investments is determined based on the restrictions around the securities. • Unrestricted, publicly traded securities are valued at the closing public market price on the reporting date; • Restricted, publicly traded securities may be valued at a discount from the closing public market price on the reporting date, depending on the circumstances; and • Privately held securities are valued by the directors/general partner of the investee fund, based on a variety of factors, including the price of recent transactions in the company's securities and the company's earnings, revenue and book value. In the case of direct investments or co-investments in private equity companies, the Company initially recognizes investments at cost and subsequently adjusts investments to fair value. On a quarterly basis, the Company reviews the general partner or lead investor's valuation of the investee company, taking into account other available information, such as indications of a market value through subsequent issues of capital or transactions between third parties, performance of the investee company during the period and public, comparable companies' analysis, where appropriate. Investments in these funds typically may not be fully redeemed at net asset value ("NAV") within 90 days because of inherent restriction on near term redemptions. As of June 30, 2022 and December 31, 2021, certain private equity funds maintained term loans and revolving lines of credit of $1,204 and $1,214, respectively. The term loans mature in three The following table summarizes the fair value hierarchy levels of consolidated investment entities as of June 30, 2022: Level 1 Level 2 Level 3 NAV Total Assets Cash and cash equivalents $ 85 $ — $ — $ — $ 85 Corporate loans, at fair value using the fair value option — 1,122 — — 1,122 Limited partnerships/corporations, at fair value — — — 2,943 2,943 Total assets, at fair value $ 85 $ 1,122 $ — $ 2,943 $ 4,150 Liabilities CLO notes, at fair value using the fair value option $ — $ 1,019 $ — $ — $ 1,019 Total liabilities, at fair value $ — $ 1,019 $ — $ — $ 1,019 The following table summarizes the fair value hierarchy levels of consolidated investment entities as of December 31, 2021: Level 1 Level 2 Level 3 NAV Total Assets Cash and cash equivalents $ 171 $ — $ — $ — $ 171 Corporate loans, at fair value using the fair value option — 1,111 — — 1,111 Limited partnerships/corporations, at fair value — — — 2,469 2,469 Total assets, at fair value $ 171 $ 1,111 $ — $ 2,469 $ 3,751 Liabilities CLO notes, at fair value using the fair value option $ — $ 880 $ — $ — $ 880 Total liabilities, at fair value $ — $ 880 $ — $ — $ 880 Transfers of investments out of Level 3 and into Level 2 or Level 1, if any, are recorded as of the beginning of the period in which the transfer occurred. For the three and six months ended June 30, 2022 and 2021, there were no transfers in or out of Level 3 or transfers between Level 1 and Level 2. Deconsolidation of Certain Investment Entities Certain investment entities that have historically been consolidated in the financial statements may require deconsolidation as of the reporting period because: (a) such funds have been liquidated or dissolved; or (b) the Company is no longer deemed to be the primary beneficiary of the VIEs as it no longer has a controlling financial interest. The change in CLO’s consolidation status due to the close of the warehouse and the launch of the CLO do not meet the criteria described above as this transaction represents normal business operations of the entity. Refer to the CLO life cycle described above. During the three and six months ended June 30, 2022 and 2021, the Company had no deconsolidations. Nonconsolidated VIEs The Company also holds variable interest in certain CLOs and LPs that are not consolidated as it has been determined that the Company is not the primary beneficiary. CLOs As of June 30, 2022 and December 31, 2021, the Company held $358 and $415 ownership interests, respectively, in unconsolidated CLOs, which also represents the Company's maximum exposure to loss. LPs As of June 30, 2022 and December 31, 2021, the Company held $1,848 and $1,739 ownership interests, respectively, in unconsolidated limited partnerships, which also represents the Company's maximum exposure to loss. Securitizations The Company invests in various tranches of securitization entities, including RMBS, CMBS and ABS. Through its investments, the Company is not obligated to provide any financial or other support to these entities. Each of the RMBS, CMBS and ABS entities are thinly capitalized by design and considered VIEs. The Company's involvement with these entities is limited to that of a passive investor. The Company has no unilateral right to appoint or remove the servicer, special servicer or investment manager, which are generally viewed to have the power to direct the activities that most significantly impact the securitization entities' economic performance, in any of these entities, nor does the Company function in any of these roles. The Company, through its investments or other arrangements, does not have the obligation to absorb losses or the right to receive benefits from the entity that could potentially be significant to the entity. Therefore, the Company is not the primary beneficiary and does not consolidate any of the RMBS, CMBS and ABS entities in which it holds investments. These investments are accounted for as investments available-for-sale as described in the Fair Value Measurements (excluding Consolidated Investment Entities) Note to these Condensed Consolidated Financial Statements and unrealized capital gains (losses) on these securities are recorded directly in AOCI, except for certain RMBS which are accounted for under the FVO whose change in fair value is reflected in Other net gains (losses) in the Condensed Consolidated Statements of Operations. The Company’s maximum exposure to loss on these structured investments is limited to the amount of its investment. Refer to the Investments (excluding Consolidated Investment Entities) Note to these Condensed Consolidated Financial Statements for details regarding the carrying amounts and classifications of these assets.

Restructuring

Restructuring	6 Months Ended
	Jun. 30, 2022
Restructuring and Related Activities [Abstract]
Restructuring	Restructuring Organizational Restructuring Pursuant to the Company executing the Resolution MTA and the Individual Life Transaction, the Company sold five of its legal subsidiaries, SLD, SLDI, RRII, MUL and VAE to Resolution Life US, which is an insurance holding company newly formed by RLGH, a Bermuda-based limited partnership. The Company also executed an agreement with Cetera on June 9, 2021, where Cetera acquired the independent financial planning channel of VFA. Additionally, the Company transferred or ceased usage of a substantial number of administrative systems and is undertaking restructuring efforts to reduce stranded expenses associated with its Individual Life business and independent financial planning channel as well as its corporate and shared services functions. The Company anticipates incurring additional restructuring expenses directly and indirectly related to these dispositions beyond the second quarter of 2022, o f $20 to $40 in addition to the $91 incurred during 2021 and $19 incurred for the six months ended June 30, 2022. The restructuring activities related to the Individual Life Transaction and the sale of the independent financial planning channel have resulted in recognition of severance and organizational transition costs that are reflected in both continuing operations and discontinued operations. Amounts reflected in continuing operations are reported in Operating expenses in the Condensed Consolidated Statements of Operations, but excluded from Adjusted operating earnings before income taxes. These expenses are classified as a component of Other adjustments to Income (loss) from continuing operations before income taxes and consequently are not included in the adjusted operating results of the Company's segments. The summary below presents Organizational Restructuring expenses, pre-tax, by type of costs incurred, for the periods indicated: Three Months Ended June 30, Six Months Ended June 30, Cumulative Amounts Incurred to Date (1) 2022 2021 2022 2021 Severance benefits $ 2 $ 9 $ 2 $ 13 $ 86 Organizational transition costs 6 32 17 39 409 Total restructuring expenses $ 8 $ 41 $ 19 $ 52 $ 495 Continuing operations $ 8 $ 41 $ 19 $ 52 $ 430 Discontinued operations $ — $ — $ — $ — $ 65 (1) Includes expenses incurred during 2017-2022. The following table presents the accrued liability associated with Organizational Restructuring expenses as of June 30, 2022: Severance Benefits Organizational Transition Costs Total Accrued liability as of January 1, 2022 $ 30 $ 22 $ 52 Provision 2 17 19 Payments (6) (30) (36) Accrued liability as of June 30, 2022 $ 26 $ 9 $ 35

Segments

Segments	6 Months Ended
	Jun. 30, 2022
Segment Reporting [Abstract]
Segments	Segments On January 4, 2021, the Company completed a series of transactions pursuant to the Resolution MTA entered into on December 18, 2019 with Resolution Life US to sell several of its subsidiaries and the related Individual Life and fixed and variable annuities businesses within these subsidiaries. See the Business Held for Sale and Discontinued Operations Note to these Condensed Consolidated Financial Statements. On March 15, 2021, the Company announced several updates to our operating model and leadership team. In conjunction with those updates, the Retirement and Employee Benefits segments were renamed to Wealth Solutions and Health Solutions, respectively. The Company will continue to provide its principal products and services through three segments: Wealth Solutions, Health Solutions and Investment Management. Measurement Adjusted operating earnings before income taxes is a measure used by management to evaluate segment performance. The Company believes that Adjusted operating earnings before income taxes provides a meaningful measure of its business and segment performances and enhances the understanding of the Company’s financial results by focusing on the operating performance and trends of the underlying business segments and excluding items that tend to be highly variable from period to period based on capital market conditions and/or other factors. The Company uses the same accounting policies and procedures to measure segment Adjusted operating earnings before income taxes as it does for the directly comparable U.S. GAAP measure Income (loss) from continuing operations before income taxes. Adjusted operating earnings before income taxes does not replace Income (loss) from continuing operations before income taxes as the U.S. GAAP measure of the Company’s consolidated results of operations. Therefore, the Company believes that it is useful to evaluate both Income (loss) from continuing operations before income taxes and Adjusted operating earnings before income taxes when reviewing the Company’s financial and operating performance. Each segment’s Adjusted operating earnings before income taxes is calculated by adjusting Income (loss) from continuing operations before income taxes for the following items: • Net investment gains (losses), net of related amortization of DAC, VOBA, sales inducements and unearned revenue, which are significantly influenced by economic and market conditions, including interest rates and credit spreads, and are not indicative of normal operations. Net investment gains (losses) include gains (losses) on the sale of securities, impairments, changes in the fair value of investments using the FVO unrelated to the implied loan-backed security income recognition for certain mortgage-backed obligations and changes in the fair value of derivative instruments, excluding realized gains (losses) associated with swap settlements and accrued interest; • Net guaranteed benefit gains (losses), which are significantly influenced by economic and market conditions and are not indicative of normal operations, include changes in the fair value of derivatives related to guaranteed benefits, net of related reserve increases (decreases) and net of related amortization of DAC, VOBA and sales inducements, less the estimated cost of these benefits. The estimated cost, which is reflected in Adjusted operating results, reflects the expected cost of these benefits if markets perform in line with the Company's long-term expectations and includes the cost of hedging. Other derivative and reserve changes related to guaranteed benefits are excluded from adjusted operating earnings, including the impacts related to changes in the Company's nonperformance spread; • Income (loss) related to businesses exited or to be exited through reinsurance or divestment, which includes gains and (losses) associated with transactions to exit blocks of business within continuing operations (including net investment gains (losses) on securities sold and expenses directly related to these transactions) and residual run-off activity (including an insignificant number of Individual Life, and non-Wealth Solution annuities policies that were not part of the divested businesses). Excluding this activity, which also includes amortization of intangible assets related to businesses exited or to be exited, better reveals trends in the Company's core business and more closely aligns Adjusted operating earnings before income taxes with how the Company manages its segments; • Income (loss) attributable to noncontrolling interest, which represents the interest of shareholders, other than those of the Company, in consolidated entities. Income (loss) attributable to noncontrolling interest represents such shareholders' interests in the gains and (losses) of those entities, or the attribution of results from consolidated VIEs or VOEs to which the Company is not economically entitled; • Dividend payments made to preferred shareholders are included as reductions to reflect the Adjusted operating earnings that is available to common shareholders; • Income (loss) related to early extinguishment of debt, which includes losses incurred as a result of transactions where the Company repurchases outstanding principal amounts of debt; these losses are excluded from Adjusted operating earnings before income taxes since the outcome of decisions to restructure debt are not indicative of normal operations; • Impairment of goodwill, value of management contract rights and value of customer relationships acquired, which includes losses as a result of impairment analysis; these represent losses related to infrequent events and do not reflect normal, cash-settled expenses; • Immediate recognition of net actuarial gains (losses) related to the Company's pension and other postretirement benefit obligations and gains (losses) from plan amendments and curtailments, which includes actuarial gains and losses as a result of differences between actual and expected experience on pension plan assets or projected benefit obligation during a given period. The Company immediately recognizes actuarial gains and (losses) related to pension and other postretirement benefit obligations and gains and losses from plan adjustments and curtailments. These amounts do not reflect normal, cash-settled expenses and are not indicative of current Operating expense fundamentals; and • Other items not indicative of normal operations or performance of the Company's segments or related to events such as capital or organizational restructurings undertaken to achieve long-term economic benefits, including certain costs related to debt and equity offerings, acquisition / merger integration expenses, severance and other expenses associated with such activities, and expenses attributable to vacant real estate. These items vary widely in timing, scope and frequency between periods as well as between companies to which the Company is compared. Accordingly, the Company adjusts for these items as management believes that these items distort the ability to make a meaningful evaluation of the current and future performance of the Company's segments. The summary below reconciles Adjusted operating earnings before income taxes for the segments to Income (loss) from continuing operations before income taxes for the periods indicated: Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Income (loss) from continuing operations before income taxes $ 153 $ 1,028 $ 244 $ 2,066 Less Adjustments: Net investment gains (losses) and related charges and adjustments (52) 29 (139) 67 Net guaranteed benefit gains (losses) and related charges and adjustments 3 (5) (19) 5 Income (loss) related to businesses exited or to be exited through reinsurance or divestment (50) 247 (97) 971 Income (loss) attributable to noncontrolling interest 75 447 118 447 Income (loss) related to early extinguishment of debt 1 — (4) (10) Immediate recognition of net actuarial gains (losses) related to pension and other post-employment benefit obligations and gains (losses) from plan amendments and curtailments — — 4 — Dividend payments made to preferred shareholders 4 4 18 18 Other adjustments (51) (46) (68) (57) Total adjustments to income (loss) from continuing operations (70) 675 (188) 1,441 Adjusted operating earnings before income taxes by segment: Wealth Solutions $ 186 $ 295 $ 391 $ 550 Health Solutions 47 63 68 100 Investment Management 40 66 79 118 Corporate (49) (71) (107) (142) Total $ 223 $ 353 $ 431 $ 626 Adjusted operating revenues is a measure of the Company's segment revenues. Each segment's Operating revenues are calculated by adjusting Total revenues to exclude the following items: • Net investment gains (losses) and related charges and adjustments, which are significantly influenced by economic and market conditions, including interest rates and credit spreads and are not indicative of normal operations. Net investment gains (losses) include gains (losses) on the sale of securities, impairments, changes in the fair value of investments using the FVO unrelated to the implied loan-backed security income recognition for certain mortgage-backed obligations and changes in the fair value of derivative instruments, excluding realized gains (losses) associated with swap settlements and accrued interest. These are net of related amortization of unearned revenue; • Gains (losses) on changes in fair value of derivatives related to guaranteed benefits, which is significantly influenced by economic and market conditions and not indicative of normal operations, includes changes in the fair value of derivatives related to guaranteed benefits, less the estimated cost of these benefits. The estimated cost, which is reflected in Adjusted operating revenues, reflects the expected cost of these benefits if markets perform in line with the Company's long-term expectations and includes the cost of hedging. Other derivative and reserve changes related to guaranteed benefits are excluded from Adjusted operating revenues, including the impacts related to changes in the Company's nonperformance spread; • Revenues related to businesses exited or to be exited through reinsurance or divestment, which includes revenues associated with transactions to exit blocks of business within continuing operations (including net investment gains (losses) on securities sold related to these transactions) and residual run-off activity (including an insignificant number of Individual Life, and non-Wealth Solution annuities policies that were not part of the divested businesses). Excluding this activity better reveals trends in the Company's core business and more closely aligns Adjusted operating revenues with how the Company manages its segments; • Revenues attributable to noncontrolling interest, which represents the interests of shareholders, other than the Company, in consolidated entities. Revenues attributable to noncontrolling interest represents such shareholders' interests in the gains and losses of those entities, or the attribution of results from consolidated VIEs or VOEs to which the Company is not economically entitled; and • Other adjustments to Total revenues primarily reflect fee income earned by the Company's broker-dealers for sales of non-proprietary products, which are reflected net of commission expense in the Company's segments’ operating revenues, other items where the income is passed on to third parties and the elimination of intercompany investment expenses included in Adjusted operating revenues. The summary below reconciles Adjusted operating revenues for the segments to Total revenues for the periods indicated: Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Total revenues $ 1,519 $ 2,503 $ 3,033 $ 546 Adjustments: Net investment gains (losses) and related charges and adjustments (60) (71) (157) (39) Gains (losses) on change in fair value of derivatives related to guaranteed benefits 3 (5) (19) 5 Revenues related to businesses exited or to be exited through reinsurance or divestment (58) 296 (104) (3,413) Revenues attributable to noncontrolling interest 93 464 142 470 Other adjustments 8 205 36 315 Total adjustments to revenues $ (14) $ 889 $ (102) $ (2,663) Adjusted operating revenues by segment: Wealth Solutions $ 706 $ 807 $ 1,460 $ 1,589 Health Solutions 640 591 1,287 1,190 Investment Management 171 193 349 382 Corporate 17 24 39 48 Total $ 1,534 $ 1,614 $ 3,135 $ 3,209 Other Segment Information The Investment Management segment revenues include the following intersegment revenues, primarily consisting of asset-based management and administration fees for the periods indicated: Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Investment Management intersegment revenues $ 23 $ 22 $ 45 $ 45 The summary below presents Total assets for the Company’s segments as of the dates indicated: June 30, 2022 December 31, 2021 Wealth Solutions $ 115,202 $ 137,544 Health Solutions 2,901 3,002 Investment Management 970 1,226 Corporate 24,595 26,025 Total assets, before consolidation (1) 143,668 167,797 Consolidation of investment entities 3,852 3,465 Total assets $ 147,520 $ 171,262 (1) Total assets, before consolidation includes the Company's direct investments in CIEs prior to consolidation, which are accounted for using the equity method or fair value option.

Business, Basis of Presentati_2

Business, Basis of Presentation and Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying Condensed Consolidated Financial Statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP") and are unaudited. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the Condensed Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. The inputs into the Company's estimates and assumptions consider the economic implications of COVID-19 on the Company's critical and significant accounting estimates. Those estimates are inherently subject to change and actual results could differ from those estimates, and the differences may be material to the Condensed Consolidated Financial Statements. The Condensed Consolidated Financial Statements include the accounts of Voya Financial, Inc. and its subsidiaries, as well as other voting interest entities ("VOEs") and variable interest entities ("VIEs") in which the Company has a controlling financial interest. See the Consolidated and Nonconsolidated Investment Entities Note to these Condensed Consolidated Financial Statements. Intercompany transactions and balances have been eliminated. The accompanying Condensed Consolidated Financial Statements reflect adjustments (including normal, recurring adjustments) necessary to present fairly the financial position of the Company as of June 30, 2022, its results of operations, comprehensive income and changes in shareholders' equity for the three and six months ended June 30, 2022 and 2021, and its statements of cash flows for the six months ended June 30, 2022 and 2021, in conformity with U.S. GAAP. Interim results are not necessarily indicative of full year performance. Certain reclassifications have been made to prior-period amounts to conform to current-period reporting classifications. These reclassifications had no impact on Net income (loss) or Total shareholders’ equity. The December 31, 2021 Consolidated Balance Sheet is from the audited Consolidated Financial Statements included in the Company's Annual Report on Form 10-K , filed with the SEC. Therefore, these unaudited Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and related notes included in the Company's Annual Report on Form 10-K .
Adoption of New Pronouncements	Future Adoption of Accounting Pronouncements The following table provides a description of future adoptions of new accounting standards that may have an impact on the Company's financial statements when adopted: Standard Description of Requirements Effective Date and Transition Provisions Effect on the Financial Statements or Other Significant Matters Accounting Standards Update (“ASU”) 2022-03, Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions This standard, issued in June 2022, clarifies that contractual restrictions on equity security sales are not considered part of the security unit of account and, therefore, are not considered in measuring fair value. In addition, the restrictions cannot be recognized and measured as separate units of account. Disclosures on such restrictions are also required. The amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, and are required to be applied prospectively, with any adjustments from the adoption recognized in earnings and disclosed. The Company is currently in the process of determining the impact of adoption of the provisions of ASU 2022-03. ASU 2022-02, Troubled Debt Restructurings ("TDRs") and Vintage Disclosures This standard, issued in March 2022, eliminates the accounting guidance on troubled debt restructurings for creditors, requires enhanced disclosures for creditors about loan modifications when a borrower is experiencing financial difficulty, and requires public business entities to include current-period gross write-offs in the vintage disclosure tables. The amendments are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Entities have the option to apply the amendments involving the recognition and measurement of TDRs using a modified retrospective transition method; the other amendments are required to be applied prospectively. The Company is currently in the process of determining the impact of adoption of the provisions of ASU 2022-02. Standard Description of Requirements Effective Date and Transition Provisions Effect on the Financial Statements or Other Significant Matters ASU 2020-04, Reference Rate Reform This standard, issued in March 2020, provides temporary optional expedients and exceptions for applying U.S. GAAP principles to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. In January, 2021, the Financial Accounting Standards Board ("FASB") issued ASU 2021-01, which clarified the scope of relief related to ASU 2020-04. The amendments are effective as of March 12, 2020, the issuance date of the ASU. An entity may elect to apply the amendments prospectively through December 31, 2022. The Company expects that it may elect to apply some of the expedients and exceptions provided in ASU 2020-04; however, the Company is still evaluating its options under this guidance as the reference rate reform adoption process continues. To date, adoption of the ASU has not had an impact on the Company’s financial condition and results of operations. The Company will continue to evaluate the impacts of reference rate reform on contract modifications and hedging relationships as transition progresses. ASU 2018-12 This standard, issued in August 2018, changes the measurement and disclosures of insurance liabilities and deferred acquisition costs ("DAC") for long-duration contracts issued by insurers. In addition to expanded disclosures, the standard’s requirements include: • Annual review and, if necessary, update of cash flow assumptions used to measure the liability for future policy benefits for nonparticipating traditional and limited payment insurance contracts. The effect of updating cash flow assumptions will be measured on a retrospective catch-up basis and presented in the Statement of Operations in the period in which the update is made. The rate used to discount these liabilities will be required to be updated quarterly, with related changes in the liability recorded in Accumulated other comprehensive income ("AOCI"). The amendments are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Initial adoption for the liability for future policy benefits and DAC is required to be reported using either a full retrospective or modified retrospective approach. For market risk benefits, full retrospective application is required. Evaluation of the implications of these requirements and related potential financial statement impacts is continuing, in accordance with an established governance framework and implementation plan, which includes design and testing of internal controls related to new processes. The Company does not plan to early adopt the ASU and expects to apply a modified retrospective transition method for the liability of future policy benefits and DAC. The Company expects the January 1, 2021 transition impact will increase Total shareholders’ equity by $0.1 billion to $0.3 billion, primarily driven by a positive impact to AOCI resulting from the reversal of DAC, value of business acquired ("VOBA"), and other adjustment balances of approximately $1.3 billion after tax, offset by an unfavorable impact to AOCI of between $1.0 billion and $1.2 billion after tax resulting from the remeasurement of Future policy benefits and Reinsurance recoverables using January 1, 2021 discount rates. The expected transition effect on Total shareholders’ equity will also include an unfavorable impact on Retained earnings (deficit) of approximately $0.1 billion after tax associated with the establishment of MRB liabilities related to guaranteed minimum benefits on certain deferred annuity contracts. Standard Description of Requirements Effective Date and Transition Provisions Effect on the Financial Statements or Other Significant Matters ASU 2018-12 • Fair value measurement of contract guarantee features qualifying as Market Risk Benefits (“MRB”), with changes in fair value recognized in the Statement of Operations, except for changes in the instrument-specific credit risk, which will be recorded in AOCI. • Amortization of DAC on a constant level basis over the expected term of the contracts, without reference to revenue or profitability. Elimination of adjustments in AOCI related to DAC and balances amortized on a basis consistent with DAC. DAC will no longer be subjected to loss recognition testing. The majority of the ASU 2018-12 transition impact of between $1.0 billion and $1.2 billion associated with Future policy benefits and Reinsurance recoverables and approximately 50% of the $0.1 billion transition impact associated with the establishment of MRB liabilities are related to business that was reinsured to Resolution Life US in January 2021. The ultimate effects the standard will have on the financial statements are highly dependent on policyholder behavior, actuarial assumptions and macroeconomic conditions, particularly interest rates and spreads, which may materially change ASU 2018-12-related equity impacts in periods subsequent to transition. The Company estimates the impact of ASU 2018-12 will shift to a reduction of Total shareholders’ equity as of June 30, 2022, primarily related to a negative impact in AOCI resulting from the reversal of DAC, VOBA, and other adjustment balances, which have declined significantly since January 2021 due to increases in interest rates and spreads. While rising interest rates since January 1, 2021 will result in a less unfavorable impact on AOCI due to remeasurement of liability for Future policy benefits, this will be materially offset by the impact from remeasurement of Reinsurance recoverables .
Derivatives	The Company primarily enters into the following types of derivatives: Interest rate swaps: Interest rate swaps are used by the Company primarily to reduce market risks from changes in interest rates and to alter interest rate exposure arising from mismatches between assets and/or liabilities. Interest rate swaps are also used to hedge the interest rate risk associated with the value of assets it owns or in an anticipation of acquiring them. Using interest rate swaps, the Company agrees with another party to exchange, at specified intervals, the difference between fixed rate and floating rate interest payments, calculated by reference to an agreed upon notional principal amount. These transactions are entered into pursuant to master agreements that provide for a single net payment to be made to/from the counterparty at each due date. The Company utilizes these contracts in qualifying hedging relationships as well as non-qualifying hedging relationships. Foreign exchange swaps: The Company uses foreign exchange or currency swaps to reduce the risk of change in the value, yield or cash flows associated with certain foreign denominated invested assets. Foreign exchange swaps represent contracts that require the exchange of foreign currency cash flows against U.S. dollar cash flows at regular periods, typically quarterly or semi-annually. The Company utilizes these contracts in qualifying hedging relationships as well as non-qualifying hedging relationships. Total return swaps: The Company uses total return swaps as a hedge of interest related risks within various Legacy Annuity and Retirement products. Total return swaps are also used as a hedge of other corporate liabilities. Using total return swaps, the Company agrees with another party to exchange, at specified intervals, the difference between the economic performance of assets or a market index and a fixed or variable funding multiplied by reference to an agreed upon notional amount. No cash is exchanged at the onset of the contracts. Cash is paid and received over the life of the contract based upon the terms of the swaps. The Company utilized these contracts in non-qualifying hedging relationships. Futures: Futures contracts are used to hedge against a decrease in certain equity indices. Such decreases may correlate to a decrease in variable annuity account values which would increase the possibility of the Company incurring an expense for guaranteed benefits in excess of account values. The Company also uses interest rate futures contracts to hedge its exposure to market risks due to changes in interest rates. The Company enters into exchange traded futures with regulated futures commissions that are members of the exchange. The Company also posts initial and variation margins, with the exchange, on a daily basis. The Company utilizes exchange-traded futures in non-qualifying hedging relationships. The Company may also use futures contracts as a hedge against an increase in certain equity indices.
Income Tax	The Company uses the estimated annual effective tax rate method in computing its interim tax provision. Certain items, including changes in the realizability of deferred tax assets and changes in liabilities for uncertain tax positions, are excluded from the estimated annual effective tax rate and the actual tax expense or benefit is reported in the period the related item is incurred.

Business, Basis of Presentati_3

Business, Basis of Presentation and Significant Accounting Policies (Tables)	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
Adoption of New Accounting Pronouncements and Future Adoption of Accounting Pronouncements	The following table provides a description of future adoptions of new accounting standards that may have an impact on the Company's financial statements when adopted: Standard Description of Requirements Effective Date and Transition Provisions Effect on the Financial Statements or Other Significant Matters Accounting Standards Update (“ASU”) 2022-03, Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions This standard, issued in June 2022, clarifies that contractual restrictions on equity security sales are not considered part of the security unit of account and, therefore, are not considered in measuring fair value. In addition, the restrictions cannot be recognized and measured as separate units of account. Disclosures on such restrictions are also required. The amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, and are required to be applied prospectively, with any adjustments from the adoption recognized in earnings and disclosed. The Company is currently in the process of determining the impact of adoption of the provisions of ASU 2022-03. ASU 2022-02, Troubled Debt Restructurings ("TDRs") and Vintage Disclosures This standard, issued in March 2022, eliminates the accounting guidance on troubled debt restructurings for creditors, requires enhanced disclosures for creditors about loan modifications when a borrower is experiencing financial difficulty, and requires public business entities to include current-period gross write-offs in the vintage disclosure tables. The amendments are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Entities have the option to apply the amendments involving the recognition and measurement of TDRs using a modified retrospective transition method; the other amendments are required to be applied prospectively. The Company is currently in the process of determining the impact of adoption of the provisions of ASU 2022-02. Standard Description of Requirements Effective Date and Transition Provisions Effect on the Financial Statements or Other Significant Matters ASU 2020-04, Reference Rate Reform This standard, issued in March 2020, provides temporary optional expedients and exceptions for applying U.S. GAAP principles to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. In January, 2021, the Financial Accounting Standards Board ("FASB") issued ASU 2021-01, which clarified the scope of relief related to ASU 2020-04. The amendments are effective as of March 12, 2020, the issuance date of the ASU. An entity may elect to apply the amendments prospectively through December 31, 2022. The Company expects that it may elect to apply some of the expedients and exceptions provided in ASU 2020-04; however, the Company is still evaluating its options under this guidance as the reference rate reform adoption process continues. To date, adoption of the ASU has not had an impact on the Company’s financial condition and results of operations. The Company will continue to evaluate the impacts of reference rate reform on contract modifications and hedging relationships as transition progresses. ASU 2018-12 This standard, issued in August 2018, changes the measurement and disclosures of insurance liabilities and deferred acquisition costs ("DAC") for long-duration contracts issued by insurers. In addition to expanded disclosures, the standard’s requirements include: • Annual review and, if necessary, update of cash flow assumptions used to measure the liability for future policy benefits for nonparticipating traditional and limited payment insurance contracts. The effect of updating cash flow assumptions will be measured on a retrospective catch-up basis and presented in the Statement of Operations in the period in which the update is made. The rate used to discount these liabilities will be required to be updated quarterly, with related changes in the liability recorded in Accumulated other comprehensive income ("AOCI"). The amendments are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Initial adoption for the liability for future policy benefits and DAC is required to be reported using either a full retrospective or modified retrospective approach. For market risk benefits, full retrospective application is required. Evaluation of the implications of these requirements and related potential financial statement impacts is continuing, in accordance with an established governance framework and implementation plan, which includes design and testing of internal controls related to new processes. The Company does not plan to early adopt the ASU and expects to apply a modified retrospective transition method for the liability of future policy benefits and DAC. The Company expects the January 1, 2021 transition impact will increase Total shareholders’ equity by $0.1 billion to $0.3 billion, primarily driven by a positive impact to AOCI resulting from the reversal of DAC, value of business acquired ("VOBA"), and other adjustment balances of approximately $1.3 billion after tax, offset by an unfavorable impact to AOCI of between $1.0 billion and $1.2 billion after tax resulting from the remeasurement of Future policy benefits and Reinsurance recoverables using January 1, 2021 discount rates. The expected transition effect on Total shareholders’ equity will also include an unfavorable impact on Retained earnings (deficit) of approximately $0.1 billion after tax associated with the establishment of MRB liabilities related to guaranteed minimum benefits on certain deferred annuity contracts. Standard Description of Requirements Effective Date and Transition Provisions Effect on the Financial Statements or Other Significant Matters ASU 2018-12 • Fair value measurement of contract guarantee features qualifying as Market Risk Benefits (“MRB”), with changes in fair value recognized in the Statement of Operations, except for changes in the instrument-specific credit risk, which will be recorded in AOCI. • Amortization of DAC on a constant level basis over the expected term of the contracts, without reference to revenue or profitability. Elimination of adjustments in AOCI related to DAC and balances amortized on a basis consistent with DAC. DAC will no longer be subjected to loss recognition testing. The majority of the ASU 2018-12 transition impact of between $1.0 billion and $1.2 billion associated with Future policy benefits and Reinsurance recoverables and approximately 50% of the $0.1 billion transition impact associated with the establishment of MRB liabilities are related to business that was reinsured to Resolution Life US in January 2021. The ultimate effects the standard will have on the financial statements are highly dependent on policyholder behavior, actuarial assumptions and macroeconomic conditions, particularly interest rates and spreads, which may materially change ASU 2018-12-related equity impacts in periods subsequent to transition. The Company estimates the impact of ASU 2018-12 will shift to a reduction of Total shareholders’ equity as of June 30, 2022, primarily related to a negative impact in AOCI resulting from the reversal of DAC, VOBA, and other adjustment balances, which have declined significantly since January 2021 due to increases in interest rates and spreads. While rising interest rates since January 1, 2021 will result in a less unfavorable impact on AOCI due to remeasurement of liability for Future policy benefits, this will be materially offset by the impact from remeasurement of Reinsurance recoverables .

Investments (excluding Consol_2

Investments (excluding Consolidated Investment Entities) (Tables)	6 Months Ended
	Jun. 30, 2022
Investments, Debt and Equity Securities [Abstract]
Marketable Securities	Available-for-sale and fair value option ("FVO") fixed maturities were as follows as of June 30, 2022: Amortized Cost Gross Unrealized Capital Gains Gross Unrealized Capital Losses Embedded Derivatives (2) Fair Value Allowance for credit losses Fixed maturities: U.S. Treasuries $ 800 $ 93 $ 9 $ — $ 884 $ — U.S. Government agencies and authorities 58 6 1 — 63 — State, municipalities and political subdivisions 993 4 69 — 928 — U.S. corporate public securities 10,211 265 933 — 9,541 2 U.S. corporate private securities 4,993 38 289 — 4,742 — Foreign corporate public securities and foreign governments (1) 3,356 42 317 — 3,057 24 Foreign corporate private securities (1) 3,391 15 166 — 3,222 18 Residential mortgage-backed securities 4,330 53 205 6 4,183 1 Commercial mortgage-backed securities 4,351 9 317 — 4,042 1 Other asset-backed securities 2,146 3 144 — 2,004 1 Total fixed maturities, including securities pledged 34,629 528 2,450 6 32,666 47 Less: Securities pledged 1,265 22 104 — 1,183 — Total fixed maturities $ 33,364 $ 506 $ 2,346 $ 6 $ 31,483 $ 47 (1) Primarily U.S. dollar denominated. (2) Embedded derivatives within fixed maturity securities are reported with the host investment. The changes in fair value of embedded derivatives are reported in Other net gains (losses) in the Condensed Consolidated Statements of Operations. Available-for-sale and FVO fixed maturities were as follows as of December 31, 2021: Amortized Cost Gross Unrealized Capital Gains Gross Unrealized Capital Losses Embedded Derivatives (2) Fair Value Allowance for credit losses Fixed maturities: U.S. Treasuries $ 764 $ 239 $ — $ — $ 1,003 $ — U.S. Government agencies and authorities 69 12 — — 81 — State, municipalities and political subdivisions 1,000 112 1 — 1,111 — U.S. corporate public securities 10,402 1,580 41 — 11,941 — U.S. corporate private securities 4,889 459 23 — 5,325 — Foreign corporate public securities and foreign governments (1) 3,373 368 18 — 3,723 — Foreign corporate private securities (1) 3,320 238 1 — 3,501 56 Residential mortgage-backed securities 4,183 139 31 12 4,302 1 Commercial mortgage-backed securities 4,032 173 22 — 4,183 — Other asset-backed securities 2,069 25 12 — 2,081 1 Total fixed maturities, including securities pledged 34,101 3,345 149 12 37,251 58 Less: Securities pledged 1,091 107 — — 1,198 — Total fixed maturities $ 33,010 $ 3,238 $ 149 $ 12 $ 36,053 $ 58 (1) Primarily U.S. dollar denominated. (2) Embedded derivatives within fixed maturity securities are reported with the host investment. The changes in fair value of embedded derivatives are reported in Other net gains (losses) in the Condensed Consolidated Statements of Operations.
Investments Classified by Contractual Maturity Date	The amortized cost and fair value of fixed maturities, including securities pledged, as of June 30, 2022, are shown below by contractual maturity. Actual maturities may differ from contractual maturities as securities may be restructured, called or prepaid. Mortgage-backed securities ("MBS") and Other asset-backed securities ("ABS") are shown separately because they are not due at a single maturity date. Amortized Fair Due to mature: One year or less $ 766 $ 742 After one year through five years 4,212 4,102 After five years through ten years 5,129 4,886 After ten years 13,695 12,707 Mortgage-backed securities 8,681 8,225 Other asset-backed securities 2,146 2,004 Fixed maturities, including securities pledged $ 34,629 $ 32,666
U.S. and Foreign Corporate Securities by Industry	The following tables present the composition of the U.S. and foreign corporate securities within the fixed maturity portfolio by industry category as of the dates indicated: Amortized Gross Gross Fair June 30, 2022 Communications $ 1,313 $ 46 $ 90 $ 1,269 Financial 4,056 60 364 3,752 Industrial and other companies 9,187 114 754 8,547 Energy 1,879 66 113 1,832 Utilities 3,757 63 235 3,585 Transportation 1,150 7 94 1,063 Total $ 21,342 $ 356 $ 1,650 $ 20,048 December 31, 2021 Communications $ 1,261 $ 238 $ 3 $ 1,496 Financial 3,752 394 13 4,133 Industrial and other companies 9,600 1,058 32 10,626 Energy 1,907 314 18 2,203 Utilities 3,782 499 11 4,270 Transportation 1,130 93 1 1,222 Total $ 21,432 $ 2,596 $ 78 $ 23,950
Schedule of Securities Borrowed Under Securities Lending Transactions	The following table presents borrowings under securities lending transactions by asset class pledged as of the dates indicated: June 30, 2022 December 31, 2021 U.S. Treasuries $ 41 $ 42 U.S. Government agencies and authorities 3 3 U.S. corporate public securities 605 599 Foreign corporate public securities and foreign governments 302 357 Payables under securities loan agreements $ 951 $ 1,001
Financing Receivable, Allowance for Credit Loss	The following table presents a rollforward of the allowance for credit losses on available-for-sale fixed maturity securities for the periods presented: Six Months Ended June 30, 2022 U.S. corporate private securities Residential mortgage-backed securities Commercial mortgage-backed securities Foreign corporate public securities and foreign governments Foreign corporate private securities Other asset-backed securities Total Balance as of January 1 $ — $ 1 $ — $ — $ 56 $ 1 $ 58 Credit losses on securities for which credit losses were not previously recorded 2 1 1 24 — 1 29 Initial allowance for credit losses recognized on financial assets accounted for as PCD — — — — — — — Reductions for securities sold during the period — — — — (41) — (41) Reductions for intent to sell or more likely than not will be required to sell securities prior to recovery of amortized cost — — — — — — — Change in allowance due to transfer of loans from Voya Reinsurance portfolios to Resolution — — — — — — — Increase (decrease) on securities with allowance recorded in previous period — (1) — — 3 (1) 1 Write-offs — — — — — — — Recoveries of amounts previously written-off — — — — — — — Balance as of June 30 $ 2 $ 1 $ 1 $ 24 $ 18 $ 1 $ 47
Schedule of Unrealized Loss on Investments	The following table presents available-for-sale fixed maturities, including securities pledged, for which an allowance for credit losses has not been recorded by market sector and duration as of June 30, 2022: Twelve Months or Less More Than Twelve Total Fair Value Unrealized Capital Losses Number of securities Fair Value Unrealized Capital Losses Number of securities Fair Value Unrealized Capital Losses Number of securities U.S. Treasuries $ 59 $ 8 19 $ 14 $ 1 4 $ 73 $ 9 23 U.S. Government agencies and authorities 8 1 1 — — — 8 1 1 State, municipalities and political subdivisions 739 69 255 1 — * 1 740 69 256 U.S. corporate public securities 5,725 812 1,111 358 121 175 6,083 933 1,286 U.S. corporate private securities 3,337 253 356 230 36 9 3,567 289 365 Foreign corporate public securities and foreign governments 2,071 261 392 175 56 46 2,246 317 438 Foreign corporate private securities 2,455 165 199 13 1 3 2,468 166 202 Residential mortgage-backed 1,808 172 530 353 33 163 2,161 205 693 Commercial mortgage-backed 3,468 282 561 261 35 47 3,729 317 608 Other asset-backed 1,751 127 422 144 17 74 1,895 144 496 Total $ 21,421 $ 2,150 3,846 $ 1,549 $ 300 522 $ 22,970 $ 2,450 4,368 *Less than $1 The Company concluded that an allowance for credit losses was unnecessary for these securities because the unrealized losses are interest rate related. The following table presents available-for-sale fixed maturities, including securities pledged, for which an allowance for credit losses has not been recorded by market sector and duration as of December 31, 2021: Twelve Months or Less More Than Twelve Total Fair Value Unrealized Capital Losses Number of securities Fair Value Unrealized Capital Losses Number of securities Fair Value Unrealized Capital Losses Number of securities U.S. Treasuries $ 16 $ — * 8 $ 12 $ — * 2 $ 28 $ — * 10 State, municipalities and political subdivisions 58 1 22 — — — 58 1 22 U.S. corporate public securities 1,425 35 292 115 6 119 1,540 41 411 U.S. corporate private securities 447 5 34 122 18 9 569 23 43 Foreign corporate public securities and foreign governments 534 16 97 28 2 14 562 18 111 Foreign corporate private securities 70 1 7 11 — * 1 81 1 8 Residential mortgage-backed 704 18 244 294 13 116 998 31 360 Commercial mortgage-backed 1,137 12 191 228 10 32 1,365 22 223 Other asset-backed 922 8 221 98 4 56 1,020 12 277 Total $ 5,313 $ 96 1,116 $ 908 $ 53 349 $ 6,221 $ 149 1,465 *Less than $1
Other than Temporary Impairment, Credit Losses Recognized in Earnings	The following table identifies the Company's intent impairments included in the Condensed Consolidated Statements of Operations, excluding impairments included in Other comprehensive income (loss) by type for the periods indicated: Three Months Ended June 30, 2022 2021 Impairment No. of Impairment No. of Residential mortgage-backed $ 2 17 $ — * 4 Commercial mortgage-backed — * 1 — — Total $ 2 18 $ — * 4 (1) Primarily U.S. dollar denominated. *Less than $1 Six Months Ended June 30, 2022 2021 Impairment No. of Impairment No. of Residential mortgage-backed $ 9 27 $ — * 10 Commercial mortgage-backed — * 1 — * 1 Total $ 9 28 $ — * 11 (1) Primarily U.S. dollar denominated. *Less than $1
Mortgage Loans by Loan to Value Ratio	The following tables present commercial mortgage loans by year of origination and LTV ratio as of the dates indicated. The information is updated as of June 30, 2022 and December 31, 2021, respectively. As of June 30, 2022 Loan-to-Value Ratios Year of Origination 0% - 50% >50% - 60% >60% - 70% >70% - 80% >80% and above Total 2022 $ 151 $ 101 $ 59 $ — $ — $ 311 2021 247 314 206 10 — 777 2020 115 244 34 10 — 403 2019 194 173 65 — — 432 2018 161 46 3 — — 210 2017 648 203 4 — — 855 2016 and prior 2,014 390 23 — — 2,427 Total $ 3,530 $ 1,471 $ 394 $ 20 $ — $ 5,415 As of December 31, 2021 Loan-to-Value Ratios Year of Origination 0% - 50% >50% - 60% >60% - 70% >70% - 80% >80% and above Total 2021 $ 269 $ 315 $ 201 $ — $ — $ 785 2020 140 240 77 — — 457 2019 201 192 69 — — 462 2018 169 50 2 — — 221 2017 656 214 4 — — 874 2016 and prior 2,220 584 24 — — 2,828 Total $ 3,655 $ 1,595 $ 377 $ — $ — $ 5,627
Mortgage Loans by Debt Service Coverage Ratio	The following tables present commercial mortgage loans by year of origination and DSC ratio as of the dates indicated. The information is updated as of June 30, 2022 and December 31, 2021, respectively. As of June 30, 2022 Debt Service Coverage Ratios Year of Origination >1.5x >1.25x - 1.5x >1.0x - 1.25x <1.0x Commercial mortgage loans secured by land or construction loans Total 2022 $ 311 $ — $ — $ — $ — $ 311 2021 650 26 36 65 — 777 2020 310 36 33 24 — 403 2019 254 13 106 59 — 432 2018 127 7 53 23 — 210 2017 495 61 114 185 — 855 2016 and prior 1,829 311 193 94 — 2,427 Total $ 3,976 $ 454 $ 535 $ 450 $ — $ 5,415 As of December 31, 2021 Debt Service Coverage Ratios Year of Origination >1.5x >1.25x - 1.5x >1.0x - 1.25x <1.0x Commercial mortgage loans secured by land or construction loans Total 2021 $ 652 $ 27 $ 38 $ 68 $ — $ 785 2020 396 21 34 6 — 457 2019 278 49 108 27 — 462 2018 131 5 54 31 — 221 2017 414 156 111 193 — 874 2016 and prior 2,237 242 242 107 — 2,828 Total $ 4,108 $ 500 $ 587 $ 432 $ — $ 5,627
Mortgage Loans by Geographic Location of Collateral	The following tables present the commercial mortgage loans by year of origination and U.S. region as of the dates indicated. The information is updated as of June 30, 2022 and December 31, 2021, respectively. As of June 30, 2022 U.S. Region Year of Origination Pacific South Atlantic Middle Atlantic West South Central Mountain East North Central New England West North Central East South Central Total 2022 $ 38 $ 49 $ 18 $ 60 $ 85 $ 38 $ 4 $ 1 $ 18 $ 311 2021 98 72 138 139 110 142 9 47 22 777 2020 74 176 22 24 32 40 2 8 25 403 2019 59 143 14 109 47 10 15 13 22 432 2018 50 63 57 10 14 10 — 6 — 210 2017 126 92 349 137 54 55 5 37 — 855 2016 and prior 683 550 477 118 183 207 51 123 35 2,427 Total $ 1,128 $ 1,145 $ 1,075 $ 597 $ 525 $ 502 $ 86 $ 235 $ 122 $ 5,415 As of December 31, 2021 U.S. Region Year of Origination Pacific South Atlantic Middle Atlantic West South Central Mountain East North Central New England West North Central East South Central Total 2021 $ 98 $ 79 $ 143 $ 137 $ 110 $ 140 $ 9 $ 47 $ 22 $ 785 2020 84 187 31 35 39 39 3 14 25 457 2019 59 145 14 130 47 17 15 13 22 462 2018 54 68 59 10 14 10 — 6 — 221 2017 128 94 360 139 56 56 5 36 — 874 2016 and prior 718 617 590 159 256 239 71 142 36 2,828 Total $ 1,141 $ 1,190 $ 1,197 $ 610 $ 522 $ 501 $ 103 $ 258 $ 105 $ 5,627
Mortgage Loans by Property Type of Collateral	The following tables present the commercial mortgage loans by year of origination and property type as of the dates indicated. The information is updated as of June 30, 2022 and December 31, 2021, respectively. As of June 30, 2022 Property Type Year of Origination Retail Industrial Apartments Office Hotel/Motel Other Mixed Use Total 2022 $ 24 $ 118 $ 155 $ 14 $ — $ — $ — $ 311 2021 38 172 412 128 — 18 9 777 2020 58 74 111 160 — — — 403 2019 46 94 200 66 26 — — 432 2018 37 86 56 13 — 18 — 210 2017 108 403 193 147 4 — — 855 2016 and prior 819 401 529 390 76 159 53 2,427 Total $ 1,130 $ 1,348 $ 1,656 $ 918 $ 106 $ 195 $ 62 $ 5,415 As of December 31, 2021 Property Type Year of Origination Retail Industrial Apartments Office Hotel/Motel Other Mixed Use Total 2021 $ 39 $ 185 $ 405 $ 129 $ — $ 18 $ 9 $ 785 2020 58 90 140 169 — — — 457 2019 46 96 211 82 27 — — 462 2018 38 88 57 16 4 18 — 221 2017 110 417 195 149 3 — — 874 2016 and prior 936 566 576 398 93 205 54 2,828 Total $ 1,227 $ 1,442 $ 1,584 $ 943 $ 127 $ 241 $ 63 $ 5,627
Allowance for Credit Losses on Financing Receivables	The following table summarizes the activity in the allowance for losses for commercial mortgage loans for the periods indicated: June 30, 2022 December 31, 2021 Allowance for credit losses, beginning of period $ 15 $ 89 Credit losses on mortgage loans for which credit losses were not previously recorded — 1 Change in allowance due to transfer of loans from Voya Reinsurance portfolios to Resolution — (14) Increase (decrease) on mortgage loans with allowance recorded in previous period (3) (61) Provision for expected credit losses 12 15 Write-offs — — Recoveries of amounts previously written-off — — Allowance for credit losses, end of period $ 12 $ 15
Financing Receivable, Past Due	The following table presents past due commercial mortgage loans as of the dates indicated: June 30, 2022 December 31, 2021 Delinquency: Current $ 5,415 $ 5,627 30-59 days past due — — 60-89 days past due — — Greater than 90 days past due — — Total $ 5,415 $ 5,627
Net Investment Income	The following table summarizes Net investment income for the periods indicated: Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Fixed maturities $ 495 $ 497 $ 974 $ 1,012 Equity securities 5 6 9 11 Mortgage loans on real estate 60 64 119 125 Policy loans 5 5 11 11 Short-term investments and cash equivalents 2 4 3 5 Limited partnerships and other 29 97 125 240 Gross investment income 596 673 1,241 1,404 Less: Investment expenses 15 17 30 34 Net investment income $ 581 $ 656 $ 1,211 $ 1,370
Realized Gain (Loss) on Investments	Net gains (losses) were as follows for the periods indicated: Three Months Ended June 30, 2022 2021 Fixed maturities, available-for-sale, including securities pledged $ (6) $ 15 Fixed maturities, at fair value option (245) (129) Equity securities, at fair value (24) 5 Derivatives 32 (39) Embedded derivatives - fixed maturities (2) — Guaranteed benefit derivatives 12 (9) Mortgage loans 1 25 Other investments 5 95 Net gains (losses) $ (227) $ (37) Six Months Ended June 30, 2022 2021 Fixed maturities, available-for-sale, including securities pledged $ (79) $ 1,783 Fixed maturities, at fair value option (550) (377) Equity securities, at fair value (32) 11 Derivatives 126 (16) Embedded derivatives - fixed maturities (6) (5) Guaranteed benefit derivatives 18 48 Mortgage Loans 5 163 Other investments 6 98 Net gains (losses) $ (512) $ 1,705
Gain (Loss) on Investments	Proceeds from the sale of fixed maturities, available-for-sale and trading, and equity securities and the related gross realized gains and losses, before tax, were as follows for the periods indicated: Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 (1) 2021 Proceeds on sales $ 971 $ 608 $ 2,220 $ 10,213 Gross gains 15 14 30 1,711 Gross losses 12 — 44 2 (1) Decrease from prior year is the result of the transfer of assets to support the life reinsurance transaction with Resolution.

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	6 Months Ended
	Jun. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Notional Amounts of Outstanding Derivative Positions	The notional amounts and fair values of derivatives were as follows as of the dates indicated: June 30, 2022 December 31, 2021 Notional Asset Liability Notional Asset Liability Derivatives: Qualifying for hedge accounting (1) Fair value hedges: Foreign exchange contracts $ 88 $ 3 $ — $ 94 $ 2 $ — Cash flow hedges: Interest rate contracts 22 — — 22 — — Foreign exchange contracts 699 62 — 683 16 16 Derivatives: Non-qualifying for hedge accounting (1) Interest rate contracts 17,585 207 301 13,382 147 209 Foreign exchange contracts 183 4 3 146 1 3 Equity contracts 248 1 — 299 4 2 Credit contracts 179 — 3 135 1 1 Embedded derivatives and Managed custody guarantees: Within fixed maturity investments (2) N/A 6 — N/A 12 — Within products (3) N/A — 25 N/A — 47 Within reinsurance agreements (4) N/A 21 41 N/A — 196 Managed custody guarantees (3) N/A — 4 N/A — 1 Total $ 304 $ 377 $ 183 $ 475 (1) Open derivative contracts are reported as Derivatives assets or liabilities on the Condensed Consolidated Balance Sheets at fair value. (2) Included in Fixed maturities, available-for-sale, at fair value on the Condensed Consolidated Balance Sheets. (3) Included in Future policy benefits on the Condensed Consolidated Balance Sheets. (4) Included in Other liabilities and Premium receivable and reinsurance recoverable on the Condensed Consolidated Balance Sheets. N/A - Not applicable
Offsetting Assets and Liabilities	Although the Company has not elected to net its derivative exposures, the notional amounts and fair values of Over-The-Counter ("OTC") and cleared derivatives excluding exchange traded contracts are presented in the tables below as of the dates indicated: June 30, 2022 Notional Amount Asset Fair Value Liability Fair Value Credit contracts $ 179 $ — $ 3 Equity contracts 201 1 — Foreign exchange contracts 970 69 3 Interest rate contracts 10,838 207 288 277 294 Counterparty netting (1) (208) (208) Cash collateral netting (1) (59) (81) Securities collateral netting (1) (6) (1) Net receivables/payables $ 4 $ 4 (1) Represents the netting of receivable balances with payable balances, net of collateral, for the same counterparty under eligible netting agreements. December 31, 2021 Notional Amount Asset Fair Value Liability Fair Value Credit contracts $ 135 $ 1 $ 1 Equity contracts 239 4 2 Foreign exchange contracts 923 19 19 Interest rate contracts 12,003 147 209 171 231 Counterparty netting (1) (156) (156) Cash collateral netting (1) (12) (70) Securities collateral netting (1) (2) (2) Net receivables/payables $ 1 $ 3 (1) Represents the netting of receivable balances with payable balances, net of collateral, for the same counterparty under eligible netting agreements.
Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance	The location and effect of derivatives qualifying for hedge accounting on the Condensed Consolidated Statements of Operations and Condensed Consolidated Statements of Comprehensive Income are as follows for the periods indicated: Three Months Ended June 30, 2022 2021 Interest Rate Contracts Foreign Exchange Contracts Interest Rate Contracts Foreign Exchange Contracts Derivatives: Qualifying for hedge accounting Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income into Income Net investment income Net investment income and Other net gains/(losses) Net investment income Net investment income and Other net gains/(losses) Amount of Gain or (Loss) Recognized in Other Comprehensive Income $ (1) $ 55 $ — $ 6 Amount of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income — 2 — 2 Six Months Ended June 30, 2022 2021 Interest Rate Contracts Foreign Exchange Contracts Interest Rate Contracts Foreign Exchange Contracts Derivatives: Qualifying for hedge accounting Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income into Income Net investment income Net investment income and Other net gains/(losses) Net investment income Net investment income and Other net gains/(losses) Amount of Gain or (Loss) Recognized in Other Comprehensive Income $ (2) $ 62 $ (1) $ 12 Amount of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income — 5 — (1) The location and amount of gain (loss) recognized in the Condensed Consolidated Statements of Operations for derivatives qualifying for hedge accounting are as follows for the period indicated: Three Months Ended June 30, 2022 2021 Net investment income Other net gains/(losses) Net investment income Other net gains/(losses) Total amounts of line items presented in the statement of operations in which the effects of fair value or cash flow hedges are recorded $ 581 $ (225) $ 656 $ (37) Derivatives: Qualifying for hedge accounting Fair value hedges: Foreign exchange contracts: Hedged items — (5) — (1) Derivatives designated as hedging instruments (1) — 6 — 1 Cash flow hedges: Foreign exchange contracts: Gain (loss) reclassified from accumulated other comprehensive income into income 2 — 2 — Six Months Ended June 30, 2022 2021 Net investment income Other net gains/(losses) Net investment income Other net gains/(losses) Total amounts of line items presented in the statement of operations in which the effects of fair value or cash flow hedges are recorded $ 1,211 $ (503) $ 1,370 $ 1,705 Derivatives: Qualifying for hedge accounting Fair value hedges: Foreign exchange contracts: Hedged items — (7) — (1) Derivatives designated as hedging instruments (1) — 8 — 1 Cash flow hedges: Foreign exchange contracts: Gain (loss) reclassified from accumulated other comprehensive income into income 5 — 4 (5) (1) For the three and six months ended June 30, 2022, $1 of the change in derivative instruments designated and qualifying as fair value hedges was excluded from the assessment of hedge effectiveness and recognized currently in earning. For the three and six months ended June 30, 2022 and June 30, 2021, an immaterial portion of the change in derivative instruments designated and qualifying as fair value hedges was excluded from the assessment of hedge effectiveness and recognized currently in earning. The location and effect of derivatives not designated as hedging instruments on the Condensed Consolidated Statements of Operations are as follows for the periods indicated: Location of Gain or (Loss) Recognized in Income on Derivative Three Months Ended June 30, 2022 2021 Derivatives: Non-qualifying for hedge accounting Interest rate contracts Other net gains (losses) $ 52 $ (48) Foreign exchange contracts Other net gains (losses) (1) (2) Equity contracts Other net gains (losses) (20) 9 Credit contracts Other net gains (losses) (4) 1 Embedded derivatives and Managed custody guarantees: Within fixed maturity investments Other net gains (losses) (2) — Within products Other net gains (losses) 12 (4) Within reinsurance agreements (1) Policyholder benefits 84 (29) Managed custody guarantees Other net gains (losses) 1 — Total $ 122 $ (73) Location of Gain or (Loss) Recognized in Income on Derivative Six Months Ended June 30, 2022 2021 Derivatives: Non-qualifying for hedge accounting Interest rate contracts Other net gains (losses) $ 152 $ (23) Foreign exchange contracts Other net gains (losses) (2) (2) Equity contracts Other net gains (losses) (28) 12 Credit contracts Other net gains (losses) (4) 1 Embedded derivatives and Managed custody guarantees: Within fixed maturity investments Other net gains (losses) (6) (5) Within products Other net gains (losses) 22 31 Within reinsurance agreements (1) Policyholder benefits 176 23 Managed custody guarantees Other net gains (losses) (2) 4 Total $ 308 $ 41 (1) For the three months ended June 30, 2022, no gains (losses) from standalone derivatives were recognized. For the six months ended June 30, 2022, the amount excluded gains (losses) of $1 from standalone derivatives recognized in Other net gains (losses). For the three and six months ended June 30, 2021, the amount excluded gains (losses) of $3 and $4, respectively, from standalone derivatives recognized in Other net gains (losses).

Fair Value Measurements (excl_2

Fair Value Measurements (excluding Consolidated Investment Entities) (Tables)	6 Months Ended
	Jun. 30, 2022
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	The following table presents the Company's hierarchy for its assets and liabilities measured at fair value on a recurring basis as of June 30, 2022: Level 1 Level 2 Level 3 Total Assets: Fixed maturities, including securities pledged: U.S. Treasuries $ 653 $ 231 $ — $ 884 U.S. Government agencies and authorities — 63 — 63 State, municipalities and political subdivisions — 928 — 928 U.S. corporate public securities — 9,522 19 9,541 U.S. corporate private securities — 2,962 1,780 4,742 Foreign corporate public securities and foreign governments (1) — 3,053 4 3,057 Foreign corporate private securities (1) — 2,819 403 3,222 Residential mortgage-backed securities — 4,152 31 4,183 Commercial mortgage-backed securities — 4,042 — 4,042 Other asset-backed securities — 1,941 63 2,004 Total fixed maturities, including securities pledged 653 29,713 2,300 32,666 Equity securities 23 8 203 234 Derivatives: Interest rate contracts — 207 — 207 Foreign exchange contracts — 69 — 69 Equity contracts — 1 — 1 Embedded derivative on reinsurance — 21 — 21 Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements 2,106 7 — 2,113 Assets held in separate accounts 74,144 5,524 349 80,017 Total assets $ 76,926 $ 35,550 $ 2,852 $ 115,328 Percentage of Level to total 67 % 31 % 2 % 100 % Liabilities: Derivatives: Guaranteed benefit derivatives (2) — — 29 29 Other derivatives: Interest rate contracts 13 288 — 301 Foreign exchange contracts — 3 — 3 Credit contracts — 3 — 3 Embedded derivative on reinsurance — (45) (3) 86 41 Total liabilities $ 13 $ 249 $ 115 $ 377 (1) Primarily U.S. dollar denominated. (2) Includes GMWBL, GMWB, FIA, Stabilizer and MCGs. (3) The Company classifies these embedded derivatives within liabilities given the underlying nature of the balances and the right-of-offset. The following table presents the Company's hierarchy for its assets and liabilities measured at fair value on a recurring basis as of December 31, 2021: Level 1 Level 2 Level 3 Total Assets: Fixed maturities, including securities pledged: U.S. Treasuries $ 745 $ 258 $ — $ 1,003 U.S. Government agencies and authorities — 81 — 81 State, municipalities and political subdivisions — 1,111 — 1,111 U.S. corporate public securities — 11,925 16 11,941 U.S. corporate private securities — 3,415 1,910 5,325 Foreign corporate public securities and foreign governments (1) — 3,723 — 3,723 Foreign corporate private securities (1) — 3,148 353 3,501 Residential mortgage-backed securities — 4,259 43 4,302 Commercial mortgage-backed securities — 4,183 — 4,183 Other asset-backed securities — 2,037 44 2,081 Total fixed maturities, including securities pledged 745 34,140 2,366 37,251 Equity securities 37 — 203 240 Derivatives: Interest rate contracts — 147 — 147 Foreign exchange contracts — 19 — 19 Equity contracts — 4 — 4 Credit contracts — 1 — 1 Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements 2,525 82 — 2,607 Assets held in separate accounts 94,943 5,174 316 100,433 Total assets $ 98,250 $ 39,567 $ 2,885 $ 140,702 Percentage of Level to total 70 % 28 % 2 % 100 % Liabilities: Derivatives: Guaranteed benefit derivatives (2) — — 48 48 Other derivatives: Interest rate contracts — 209 — 209 Foreign exchange contracts — 19 — 19 Equity contracts — 2 — 2 Credit contracts — 1 — 1 Embedded derivative on reinsurance — 109 87 196 Total liabilities $ — $ 340 $ 135 $ 475 (1) Primarily U.S. dollar denominated. (2) Includes GMWBL, GMWB, FIA, Stabilizer and MCGs.
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation	The following tables summarize the change in fair value of the Company's Level 3 assets and liabilities and transfers in and out of Level 3 for the periods indicated: Three Months Ended June 30, 2022 Fair Value as of April 1 Total Purchases Issuances Sales Settlements Transfers Transfers Fair Value as of June 30 Change In Unrealized Gains (Losses) Included in Earnings (3) Change In (3) Net OCI Fixed maturities, including securities pledged: U.S. corporate public securities $ 71 $ — $ (1) $ 1 $ — $ — $ — $ — $ (52) $ 19 $ — $ (1) U.S. corporate private securities 1,925 (1) (134) 89 — — (58) — (41) 1,780 (1) (133) Foreign corporate public securities and foreign governments (1) 11 — — 4 — — — — (11) 4 — — Foreign corporate private securities (1) 496 (3) (7) 51 — — (15) — (119) 403 (4) (7) Residential mortgage-backed securities 45 (6) — 2 — — (9) 1 (2) 31 (6) — Other asset-backed securities 49 — (2) 35 — — (5) — (14) 63 — (2) Total fixed maturities, including securities pledged 2,597 (10) (144) 182 — — (87) 1 (239) 2,300 (11) (143) Equity securities, at fair value 203 (17) — 26 — — — — (9) 203 (17) — Derivatives: Guaranteed benefit derivatives (2)(5) (42) 13 — — — — — — — (29) — — Embedded derivatives on reinsurance (86) — — — — — — — — (86) — — Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements 8 — — — — — (8) — — — — — Assets held in separate accounts (4) 334 (12) — 67 — (3) — — (37) 349 — — (1) Primarily U.S. dollar denominated. (2) All gains and losses on Level 3 liabilities are classified as realized gains (losses) for the purpose of this disclosure because it is impracticable to track realized and unrealized gains (losses) separately on a contract by contract basis. These amounts are included in Other net (losses) in the Condensed Consolidated Statements of Operations. (3) For financial instruments still held as of June 30 amounts are included in Net investment income and Total net gains (losses) in the Condensed Consolidated Statements of Operations or Unrealized gains (losses) on securities in the Condensed Consolidated Statements of Comprehensive Income. (4) The investment income and realized gains (losses) and change in unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on Net income (loss) for the Company. (5) Includes GMWBL, GMWB, FIA, Stabilizer and MCGs. Six Months Ended June 30, 2022 Fair Value as of January 1 Realized/Unrealized Purchases Issuances Sales Settlements Transfers Transfers Fair Value as of June 30 Change In (3) Change In Unrealized Gains (Losses) Included in OCI (3) Net OCI Fixed maturities, including securities pledged: U.S. corporate public securities $ 16 $ — $ (1) $ 5 $ — $ — $ — $ — $ (1) $ 19 $ — $ (1) U.S. corporate private securities 1,910 (2) (277) 158 — — (120) 121 (10) 1,780 (2) (276) Foreign corporate public securities and foreign governments (1) — — — 4 — — — — — 4 — — Foreign corporate private securities (1) 353 (22) (31) 97 — — (28) 148 (114) 403 (4) (31) Residential mortgage-backed securities 43 (15) — 4 — — — 1 (2) 31 (15) — Other asset-backed securities 44 — (4) 39 — (10) (6) — — 63 — (4) Total fixed maturities, including securities pledged 2,366 (39) (313) 307 — (10) (154) 270 (127) 2,300 (21) (312) Equity securities, at fair value 203 (26) — 26 — — — — — 203 (26) — Derivatives: Guaranteed benefit derivatives (2)(5) (48) 20 — — (1) — — — — (29) — — Embedded derivatives on reinsurance (87) 1 — — — — — — — (86) — — Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements — — — 8 — — (8) — — — — — Assets held in separate accounts (4) 316 (26) — 132 — (4) — 6 (75) 349 — — (1) Primarily U.S. dollar denominated. (2) All gains and losses on Level 3 liabilities are classified as realized gains (losses) for the purpose of this disclosure because it is impracticable to track realized and unrealized gains (losses) separately on a contract by contract basis. These amounts are included in Other net (losses) in the Condensed Consolidated Statements of Operations. (3) For financial instruments still held as of June 30 amounts are included in Net investment income and Total net gains (losses) in the Condensed Consolidated Statements of Operations or Unrealized gains (losses) on securities in the Condensed Consolidated Statements of Comprehensive Income. (4) The investment income and realized gains (losses) and change in unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on Net income (loss) for the Company. (5) Includes GMWBL, GMWB, FIA, Stabilizer and MCGs. Three Months Ended June 30, 2021 Fair Value as of April 1 Total Purchases Issuances Sales Settlements Transfers Transfers Fair Value as of June 30 Change In (3) Change In Unrealized Gains (Losses) Included in OCI (3) Net OCI Fixed maturities, including securities pledged: U.S. corporate public securities $ 60 $ — $ 1 $ — $ — $ — $ (1) $ — $ (37) $ 23 $ — $ 5 U.S. corporate private securities 1,584 1 40 23 — — (93) 504 (48) 2,011 — (2) Foreign corporate public securities and foreign governments (1) 7 — — 10 — — — — (7) 10 — — Foreign corporate private securities (1) 380 1 8 1 — (34) (4) — — 352 1 5 Residential mortgage-backed securities 47 (4) — 12 — — — 3 (12) 46 (4) — Commercial mortgage-backed securities — — — 2 — — — — — 2 — — Other asset-backed securities 69 — — 15 — — (7) 1 — 78 — — Total fixed maturities, including securities pledged 2,147 (2) 49 63 — (34) (105) 508 (104) 2,522 (3) 8 Fixed maturities, trading, at fair value — — — 45 — — — — — 45 — — Equity securities, at fair value 257 3 — — — (11) — — — 249 3 — Derivatives: Guaranteed benefit derivatives (2)(5) (26) (19) — — — — 1 — — (44) — — Embedded derivatives on reinsurance (88) 3 — — — — — — — (85) — — Assets held in separate accounts (4) 237 2 — 71 — — — — (17) 293 — — (1) Primarily U.S. dollar denominated. (2) All gains and losses on Level 3 liabilities are classified as realized gains (losses) for the purpose of this disclosure because it is impracticable to track realized and unrealized gains (losses) separately on a contract by contract basis. These amounts are included in Other net (losses) in the Condensed Consolidated Statements of Operations. (3) For financial instruments still held as of June 30, amounts are included in Net investment income and Total net gains (losses) in the Condensed Consolidated Statements of Operations or Unrealized gains (losses) on securities in the Condensed Consolidated Statements of Comprehensive Income. (4) The investment income and realized gains (losses) and change in unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on Net income (loss) for the Company. (5) Includes GMWBL, GMWB, FIA, Stabilizer and MCGs. Six Months Ended June 30, 2021 Fair Value as of January 1 Realized/Unrealized Purchases Issuances Sales Settlements Transfers Transfers Fair Value as of June 30 Change In (3) Change In Unrealized Gains (Losses) Included in OCI (3) Net OCI Fixed maturities, including securities pledged: U.S. corporate public securities $ 93 $ 1 $ — $ — $ — $ (25) $ (1) $ — $ (45) $ 23 $ — $ — U.S. corporate private securities 1,900 51 (96) 77 — (328) (137) 621 (77) 2,011 (1) (96) Foreign corporate public securities and foreign governments (1) — — — 10 — — — — — 10 — — Foreign corporate private securities (1) 457 9 (2) 1 — (81) (32) — — 352 2 (5) Residential mortgage-backed securities 43 (7) — 15 — (7) — 2 — 46 (7) — Commercial mortgage-backed securities — — — 1 — (1) (4) 6 — 2 — — Other asset-backed securities 61 — (2) 22 — (4) (22) 23 — 78 — (2) Total fixed maturities, including securities pledged 2,554 54 (100) 126 — (446) (196) 652 (122) 2,522 (6) (103) Fixed maturities, trading, at fair value — — — 45 — — — — — 45 — — Equity securities, at fair value 172 13 — 225 — (152) (9) — — 249 (2) — Derivatives: Guaranteed benefit derivatives (2)(5) (84) 38 — — — — 2 — — (44) — — Other derivatives, net 1 — — — — — (1) — — — (1) — Embedded derivatives on reinsurance — 4 — — (89) — — — — (85) — — Assets held in separate accounts (4) 222 3 — 104 — (1) — — (35) 293 — —
Fair Value, by Balance Sheet Grouping	The carrying values and estimated fair values of the Company's financial instruments as of the dates indicated: June 30, 2022 December 31, 2021 Carrying Fair Carrying Fair Assets: Fixed maturities, including securities pledged $ 32,666 $ 32,666 $ 37,251 $ 37,251 Equity securities 234 234 240 240 Mortgage loans on real estate 5,415 5,239 5,627 5,982 Policy loans 373 373 392 392 Cash, cash equivalents, short-term investments and short-term investments under securities loan agreements 2,113 2,113 2,607 2,607 Derivatives 277 277 171 171 Embedded derivative on reinsurance 21 21 — — Other investments 76 76 79 79 Assets held in separate accounts 80,017 80,017 100,433 100,433 Liabilities: Investment contract liabilities: Funding agreements without fixed maturities and deferred annuities (1) $ 36,125 $ 37,982 $ 35,334 $ 43,407 Funding agreements with fixed maturities 1,462 1,457 1,460 1,461 Supplementary contracts, immediate annuities and other 791 653 829 775 Derivatives: Guaranteed benefit derivatives (2) 29 29 48 48 Other derivatives 307 307 231 231 Embedded derivative on reinsurance 41 41 196 196 Short-term debt 1 1 1 1 Long-term debt 2,385 2,316 2,595 2,991 (1) Certain amounts included in Funding agreements without fixed maturities and deferred annuities are also reflected within the Guaranteed benefit derivatives section of the table above. (2) Includes GMWBL, GMWB, FIA, Stabilizer and MCGs. The following table summarizes the fair value hierarchy levels of consolidated investment entities as of June 30, 2022: Level 1 Level 2 Level 3 NAV Total Assets Cash and cash equivalents $ 85 $ — $ — $ — $ 85 Corporate loans, at fair value using the fair value option — 1,122 — — 1,122 Limited partnerships/corporations, at fair value — — — 2,943 2,943 Total assets, at fair value $ 85 $ 1,122 $ — $ 2,943 $ 4,150 Liabilities CLO notes, at fair value using the fair value option $ — $ 1,019 $ — $ — $ 1,019 Total liabilities, at fair value $ — $ 1,019 $ — $ — $ 1,019 The following table summarizes the fair value hierarchy levels of consolidated investment entities as of December 31, 2021: Level 1 Level 2 Level 3 NAV Total Assets Cash and cash equivalents $ 171 $ — $ — $ — $ 171 Corporate loans, at fair value using the fair value option — 1,111 — — 1,111 Limited partnerships/corporations, at fair value — — — 2,469 2,469 Total assets, at fair value $ 171 $ 1,111 $ — $ 2,469 $ 3,751 Liabilities CLO notes, at fair value using the fair value option $ — $ 880 $ — $ — $ 880 Total liabilities, at fair value $ — $ 880 $ — $ — $ 880
Financial Instruments Not Carried at Fair Value	The following table presents the classifications of financial instruments which are not carried at fair value on the Condensed Consolidated Balance Sheets: Financial Instrument Classification Mortgage loans on real estate Level 3 Policy loans Level 2 Other investments Level 2 Funding agreements without fixed maturities and deferred annuities Level 3 Funding agreements with fixed maturities Level 2 Supplementary contracts and immediate annuities Level 3 Short-term debt and Long-term debt Level 2

Deferred Policy Acquisition C_2

Deferred Policy Acquisition Costs and Value of Business Acquired (Tables)	6 Months Ended
	Jun. 30, 2022
Deferred Policy Acquisition Costs and Present Value of Future Insurance Profits, Net [Abstract]
Deferred Policy Acquisition Costs and Value of Business Acquired	The following tables present a rollforward of DAC and VOBA for the periods indicated: 2022 DAC VOBA Total Balance as of January 1, 2022 $ 1,217 $ 161 $ 1,378 Deferrals of commissions and expenses 56 3 59 Amortization: Amortization, excluding unlocking (116) (10) (126) Unlocking (1) (41) (45) (86) Interest accrued 49 16 (3) 65 Net amortization included in Condensed Consolidated Statements of Operations (108) (39) (147) Change due to unrealized capital gains/(losses) on available-for-sale securities 700 490 1,190 Balance as of June 30, 2022 $ 1,865 $ 615 $ 2,480 2021 DAC VOBA Total Balance as of January 1, 2021 $ 1,440 $ 70 $ 1,510 Deferrals of commissions and expenses 50 3 53 Amortization: Amortization, excluding unlocking (2) (479) (158) (637) Unlocking (1) (9) 7 (2) Interest accrued 56 18 (3) 74 Net amortization included in Condensed Consolidated Statements of Operations (432) (133) (565) Change due to unrealized capital gains/(losses) on available-for-sale securities 181 267 448 Balance as of June 30, 2021 $ 1,239 $ 207 $ 1,446 (1) Includes the impacts of annual review of assumptions which typically occurs in the third quarter; and retrospective and prospective unlocking. (2) There was no loss recognition during 2022. During 2021, the Company recorded loss recognition of $301 and $1 for DAC and VOBA, respectively. (3) Interest accrued at the following rates for VOBA: 3.5% to 7.2% during 2022 and 2021.

Share-based Incentive Compens_2

Share-based Incentive Compensation Plans (Tables)	6 Months Ended
	Jun. 30, 2022
Share-Based Payment Arrangement [Abstract]
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan	The following table summarizes share-based compensation expense, which includes expenses related to awards granted under the Omnibus Plans and Director Plan for the periods indicated: Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Restricted Stock Unit (RSU) awards $ 8 $ 8 $ 30 $ 26 Performance Stock Unit (PSU) awards 7 11 31 30 Stock options — 1 — 1 Total share-based compensation expense 15 20 61 57 Income tax benefit 3 4 18 15 After-tax share-based compensation expense $ 12 $ 16 $ 43 $ 42
Schedule of Share-based Compensation, Activity	The following table summarizes RSU and PSU awards activity under the Omnibus Plans and the Director Plan for the periods indicated: RSU Awards PSU Awards (awards in millions) Number of Awards Weighted Average Grant Date Fair Value Number of Awards Weighted Average Grant Date Fair Value Outstanding as of January 1, 2022 1.4 $ 57.53 2.0 $ 54.05 Adjustment for PSU performance factor — — 0.2 59.13 Granted 0.7 66.03 0.6 66.32 Vested (0.7) 56.62 (0.9) 51.34 Forfeited — * 60.87 — * 58.14 Outstanding as of June 30, 2022 1.4 $ 62.18 1.9 $ 58.85 *Less than 0.1
Schedule of Share-based Compensation, Stock Options, Activity	The following table summarizes the number of options under the Omnibus Plans for the periods indicated: Stock Options (awards in millions) Number of Awards Weighted Average Exercise Price Outstanding as of January 1, 2022 1.8 $ 42.91 Granted — — Exercised (0.1) 39.91 Forfeited — — Outstanding as of June 30, 2022 1.7 $ 43.15 Vested, exercisable, as of June 30, 2022 1.7 $ 43.15

Shareholders' Equity (Tables)

Shareholders' Equity (Tables)	6 Months Ended
	Jun. 30, 2022
Equity [Abstract]
Schedule of Common Stock Outstanding Roll Forward	The following table presents the rollforward of common shares used in calculating the weighted average shares utilized in the basic earnings per common share calculation for the periods indicated: Common Shares (shares in millions) Issued Held in Treasury Outstanding Balance, January 1, 2021 143.3 19.1 124.2 Common shares issued 0.1 — 0.1 Common shares acquired - share repurchase — 17.9 (17.9) Share-based compensation 2.4 1.0 1.4 Treasury Stock retirement (36.8) (36.8) — Balance, December 31, 2021 109.0 1.2 107.8 Common shares issued — — — Common shares acquired - share repurchase — 10.9 (10.9) Share-based compensation 1.6 0.6 1.0 Balance, June 30, 2022 110.6 12.7 97.9
Schedule of Dividends Declared	Dividends declared per share of Common Stock were as follows for the periods indicated: Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Dividends declared per share of Common Stock $ 0.20 $ 0.165 $ 0.40 $ 0.33 The declaration of dividends on preferred stock per share and in the aggregate were as follows for the periods indicated: Series A Series B Three Months Ended June 30, Per Share Aggregate Per Share Aggregate 2022 $ — $ — $ 13.375 $ 4 2021 — — 13.375 4 Six Months Ended June 30, 2022 $ 30.625 $ 10 $ 26.750 $ 8 2021 30.625 10 26.750 8
Schedule of Share Repurchase Agreements	The following table presents repurchases of the Company's common stock through share repurchase agreements with third-party financial institutions during the six months ended June 30, 2022. 2022 Execution Date Payment Initial Shares Delivered Closing Date Additional Shares Delivered Total Shares Repurchased June 21, 2022 $ 250 3,382,950 (1) (1) (1) March 17, 2022 $ 275 3,305,786 May 11, 2022 890,112 4,195,898 (1) This arrangement is scheduled to terminate no later than the end of the third quarter 2022, at which time the Company will settle any positive or negative share balances based on the daily volume-weighted average price of the Company's common stock.
Schedule of Preferred Stock Issued and Outstanding	As of June 30, 2022 and December 31, 2021, there were 100,000,000 shares of preferred stock authorized. Preferred stock issued and outstanding are as follows: June 30, 2022 December 31, 2021 Series Issued Outstanding Issued Outstanding 6.125% Non-cumulative Preferred Stock, Series A 325,000 325,000 325,000 325,000 5.35% Non-cumulative Preferred Stock, Series B 300,000 300,000 300,000 300,000 Total 625,000 625,000 625,000 625,000

Earnings per Common Share (Tabl

Earnings per Common Share (Tables)	6 Months Ended
	Jun. 30, 2022
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following table presents a reconciliation of Net income (loss) and shares used in calculating basic and diluted net income (loss) per common share for the periods indicated: Three Months Ended June 30, Six Months Ended June 30, (in millions, except for per share data) 2022 2021 2022 2021 Earnings Net income (loss) available to common shareholders: Income (loss) from continuing operations $ 143 $ 916 $ 227 $ 2,002 Less: Preferred stock dividends 4 4 18 18 Less: Net income (loss) attributable to noncontrolling interest 75 447 118 447 Income (loss) from continuing operations available to common shareholders 64 465 91 1,537 Income (loss) from discontinued operations, net of tax — (6) — 8 Net income (loss) available to common shareholders $ 64 $ 459 $ 91 $ 1,545 Weighted average common shares outstanding Basic 101.7 120.6 103.9 121.6 Dilutive Effects (1) : Warrants 7.1 7.3 7.7 6.3 RSU awards 0.8 0.9 0.9 1.0 PSU awards 0.6 0.7 0.8 0.9 Stock Options 0.6 0.7 0.6 0.7 Diluted 110.8 130.2 113.9 130.5 Basic (2) Income (loss) from continuing operations available to Voya Financial, Inc.'s common shareholders $ 0.62 $ 3.86 $ 0.88 $ 12.64 Income (loss) from discontinued operations, net of taxes available to Voya Financial, Inc.'s common shareholders $ — $ (0.05) $ — $ 0.06 Income (loss) available to Voya Financial, Inc.'s common shareholders $ 0.62 $ 3.81 $ 0.88 $ 12.71 Diluted (2) Income (loss) from continuing operations available to Voya Financial, Inc.'s common shareholders $ 0.57 $ 3.58 $ 0.80 $ 11.78 Income (loss) from discontinued operations, net of taxes available to Voya Financial, Inc.'s common shareholders $ — $ (0.04) $ — $ 0.06 Income (loss) available to Voya Financial, Inc.'s common shareholders $ 0.57 $ 3.53 $ 0.80 $ 11.84 (1) For the six months ended June 30, 2022 and June 30, 2021, weighted average shares used for calculating earnings per share excludes the impact of forward contracts related to the share repurchase agreement entered into on June 21, 2022 and June 30, 2021, respectively, as the inclusion of these instruments would be antidilutive to the earnings per share calculation. For more information on the share repurchase agreement, see the Shareholders' Equity Note to these Condensed Consolidated Financial Statements. (2) Basic and diluted earnings per share are calculated using unrounded, actual amounts. Therefore, the components of earnings per share may not sum to its corresponding total.

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Income (Loss) (Tables)	6 Months Ended
	Jun. 30, 2022
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Income	Shareholders' equity included the following components of AOCI as of the dates indicated: June 30, 2022 2021 Fixed maturities, net of impairment $ (1,926) $ 3,739 Derivatives (1) 129 63 DAC/VOBA adjustment on available-for-sale securities (2) 422 (877) (3) Premium deficiency reserve adjustment (2) — (15) Other intangibles adjustment on available-for-sale securities (2) (4) 5 Other — 2 Unrealized capital gains (losses), before tax (1,379) 2,917 Deferred income tax asset (liability) 413 (490) Net unrealized capital gains (losses) (966) 2,427 Pension and other postretirement benefits liability, net of tax 3 4 AOCI $ (963) $ 2,431 (1) Gains and losses reported in Accumulated Other Comprehensive Income (AOCI) from hedge transactions that resulted in the acquisition of an identified asset are reclassified into earnings in the same period or periods during which the asset acquired affects earnings. As of June 30, 2022, the portion of the AOCI that is expected to be reclassified into earnings within the next 12 months is $20. (2) Upon adoption of ASU 2018-12 on January 1, 2023, the DAC/VOBA adjustments on available-for-sale securities, Premium deficiency reserve adjustment and Other intangibles adjustment on available-for-sale securities will be reversed as of the January 1, 2021 transition date and in subsequent periods. (3) In connection with the closing of the Individual Life Transaction on January 4, 2021, the Company released stranded AOCI and reversed unrealized capital gains (losses) on available-for-sale securities associated with DAC for the disposed entities. In addition, the Company released the unrealized gains for the investments transferred associated with the reinsurance transactions entered into at closing.
Schedule of Amounts Recognized in Other Comprehensive Income (Loss)	Changes in AOCI, including the reclassification adjustments recognized in the Condensed Consolidated Statements of Operations were as follows for the periods indicated: Three Months Ended June 30, 2022 Before-Tax Amount Income Tax (Benefit) After-Tax Amount Available-for-sale securities: Fixed maturities $ (2,548) $ 535 $ (2,013) Adjustments for amounts recognized in Net gains (losses) in the Condensed Consolidated Statements of Operations 20 (4) 16 DAC/VOBA 593 (125) 468 Premium deficiency reserve adjustment 5 (1) 4 Other intangibles (5) 1 (4) Change in unrealized gains (losses) on available-for-sale securities (1,935) 406 (1,529) Derivatives: Derivatives 54 (1) (11) 43 Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Condensed Consolidated Statements of Operations (5) 1 (4) Change in unrealized gains (losses) on derivatives 49 (10) 39 Change in Accumulated other comprehensive income (loss) $ (1,886) $ 396 $ (1,490) (1) See the Derivative Financial Instruments Note to these Condensed Consolidated Financial Statements for additional information. Six Months Ended June 30, 2022 Before-Tax Amount Income Tax (Benefit) After-Tax Amount Available-for-sale securities: Fixed maturities $ (5,211) $ 1,094 $ (4,117) Adjustments for amounts recognized in Net gains (losses) in the Condensed Consolidated Statements of Operations 90 (19) 71 DAC/VOBA 1,190 (1) (250) 940 Premium deficiency reserve adjustment 14 (3) 11 Other intangibles (9) 2 (7) Change in unrealized gains (losses) on available-for-sale securities (3,926) 824 (3,102) Derivatives: Derivatives 59 (2) (12) 47 Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Condensed Consolidated Statements of Operations (10) 2 (8) Change in unrealized gains (losses) on derivatives 49 (10) 39 Change in Accumulated other comprehensive income (loss) $ (3,877) $ 814 $ (3,063) (1) See the Deferred Policy Acquisition Costs and Value of Business Acquired Note to these Condensed Consolidated Financial Statements for additional information. (2) See the Derivative Financial Instruments Note to these Condensed Consolidated Financial Statements for additional information Three Months Ended June 30, 2021 Before-Tax Amount Income Tax (Benefit) After-Tax Amount Available-for-sale securities: Fixed maturities $ 826 $ (173) $ 653 Other (2) — (2) Adjustments for amounts recognized in Net gains (losses) in the Condensed Consolidated Statements of Operations (15) 3 (12) DAC/VOBA (149) 31 (118) Premium deficiency reserve adjustment (1) 1 — Change in unrealized gains (losses) on available-for-sale securities 659 (138) 521 Derivatives: Derivatives 7 (1) (2) 5 Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Condensed Consolidated Statements of Operations (5) 1 (4) Change in unrealized gains (losses) on derivatives 2 (1) 1 Pension and other postretirement benefits liability: Amortization of prior service cost recognized in Operating expenses in the Condensed Consolidated Statements of Operations (1) — (1) Change in pension and other postretirement benefits liability (1) — (1) Change in Accumulated other comprehensive income (loss) $ 660 $ (139) $ 521 (1) See the Derivative Financial Instruments Note to these Condensed Consolidated Financial Statements for additional information . Six Months Ended June 30, 2021 Before-Tax Amount Income Tax (Benefit) After-Tax Amount Available-for-sale securities: Fixed maturities $ (3,099) $ 420 $ (2,679) Adjustments for amounts recognized in Net gains (losses) in the Condensed Consolidated Statements of Operations (1,775) 373 (1,402) DAC/VOBA 1,194 (1) (251) 943 Premium deficiency reserve adjustment 445 (93) 352 Other intangibles 419 (88) 331 Change in unrealized gains (losses) on available-for-sale securities (2,816) 361 (2,455) Derivatives: Derivatives (2) (2) — (2) Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Condensed Consolidated Statements of Operations (11) 2 (9) Change in unrealized gains (losses) on derivatives (13) 2 (11) Pension and other postretirement benefits liability: Amortization of prior service cost recognized in Operating expenses in the Condensed Consolidated Statements of Operations (1) — (1) Change in pension and other postretirement benefits liability (1) — (1) Change in Accumulated other comprehensive income (loss) $ (2,830) $ 363 $ (2,467) (1) See the Deferred Policy Acquisition Costs and Value of Business Acquired Note to these Condensed Consolidated Financial Statements for additional information. (2) See the Derivative Financial Instruments Note to these Condensed Consolidated Financial Statements for additional information.

Financing Agreements (Tables)

Financing Agreements (Tables)	6 Months Ended
	Jun. 30, 2022
Debt Disclosure [Abstract]
Schedule of Long-term Debt Instruments	The following table summarizes the carrying value of the Company’s debt securities issued and outstanding as of June 30, 2022 and December 31, 2021: Issuer Maturity June 30, 2022 December 31, 2021 3.65% Senior Notes, due 2026 (2)(3) Voya Financial, Inc. 06/15/2026 $ 445 $ 445 5.7% Senior Notes, due 2043 (2)(3) Voya Financial, Inc. 07/15/2043 395 395 4.8% Senior Notes, due 2046 (2)(3) Voya Financial, Inc. 06/15/2046 297 297 4.7% Fixed-to-Floating Rate Junior Subordinated Notes, due 2048 Voya Financial, Inc. 01/23/2048 345 345 5.65% Fixed-to-Floating Rate Junior Subordinated Notes, due 2053 (4) Voya Financial, Inc. 05/15/2053 530 740 7.25% Voya Holdings Inc. debentures, due 2023 (1) Voya Holdings, Inc. 08/15/2023 140 140 7.63% Voya Holdings Inc. debentures, due 2026 (1) Voya Holdings, Inc. 08/15/2026 139 139 6.97% Voya Holdings Inc. debentures, due 2036 (1) Voya Holdings, Inc. 08/15/2036 79 79 8.42% Equitable of Iowa Companies Capital Trust II Notes, due 2027 Equitable of Iowa Capital Trust II 04/01/2027 13 13 1.00% Windsor Property Loan Voya Retirement Insurance and Annuity Company 06/14/2027 3 3 Subtotal 2,386 2,596 Less: Current portion of long-term debt 1 1 Total $ 2,385 $ 2,595 (1) Guaranteed by ING Group. (2) Interest is paid semi-annually in arrears. (3) Guaranteed by Voya Holdings. (4) See the Junior Subordinated Notes section below.

Commitments and Contingencies (

Commitments and Contingencies (Tables)	6 Months Ended
	Jun. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Schedule of Restricted Assets	The components of the fair value of the restricted assets were as follows as of the dates indicated: June 30, 2022 December 31, 2021 Fixed maturity collateral pledged to FHLB (1) $ 1,990 $ 1,881 FHLB restricted stock (2) 75 78 Other fixed maturities-state deposits 43 46 Cash and cash equivalents 35 31 Securities pledged (3) 1,183 1,198 Total restricted assets $ 3,326 $ 3,234 (1) Included in Fixed maturities, available for sale, at fair value on the Condensed Consolidated Balance Sheets. (2) Included in Other investments on the Condensed Consolidated Balance Sheets. (3) Includes the fair value of loaned securities of $913 and $969 as of June 30, 2022 and December 31, 2021, respectively. In addition, as of June 30, 2022 and December 31, 2021, the Company delivered securities as collateral of $162 and $124 and repurchase agreements of $108 and $105, respectively. Loaned securities and securities delivered as collateral are included in Securities pledged on the Condensed Consolidated Balance Sheets.

Consolidated and Nonconsolida_2

Consolidated and Nonconsolidated Investment Entities (Tables)	6 Months Ended
	Jun. 30, 2022
Consolidated Investment Entities [Abstract]
Assets and Liabilities of the Consolidated Investment Entities	The following table summarizes the components of the consolidated investment entities as of the dates indicated: June 30, 2022 December 31, 2021 Assets of Consolidated Investment Entities VIEs Cash and cash equivalents $ 85 $ 171 Corporate loans, at fair value using the fair value option 1,122 1,111 Limited partnerships/corporations, at fair value 2,943 2,469 Other assets 15 28 Total VIE assets 4,165 3,779 Total assets of consolidated investment entities $ 4,165 $ 3,779 Liabilities and Shareholders' Equity of Consolidated Investment Entities VIEs CLO notes, at fair value using the fair value option $ 1,019 $ 880 Other liabilities 1,135 1,013 Total VIE liabilities 2,154 1,893 Total liabilities of consolidated investment entities 2,154 1,893 Noncontrolling interest 1,697 1,568 Total VIE shareholders' equity 1,697 1,568 Total liabilities and shareholders' equity of consolidated investment entities $ 3,851 $ 3,461
Fair Value, by Balance Sheet Grouping	The carrying values and estimated fair values of the Company's financial instruments as of the dates indicated: June 30, 2022 December 31, 2021 Carrying Fair Carrying Fair Assets: Fixed maturities, including securities pledged $ 32,666 $ 32,666 $ 37,251 $ 37,251 Equity securities 234 234 240 240 Mortgage loans on real estate 5,415 5,239 5,627 5,982 Policy loans 373 373 392 392 Cash, cash equivalents, short-term investments and short-term investments under securities loan agreements 2,113 2,113 2,607 2,607 Derivatives 277 277 171 171 Embedded derivative on reinsurance 21 21 — — Other investments 76 76 79 79 Assets held in separate accounts 80,017 80,017 100,433 100,433 Liabilities: Investment contract liabilities: Funding agreements without fixed maturities and deferred annuities (1) $ 36,125 $ 37,982 $ 35,334 $ 43,407 Funding agreements with fixed maturities 1,462 1,457 1,460 1,461 Supplementary contracts, immediate annuities and other 791 653 829 775 Derivatives: Guaranteed benefit derivatives (2) 29 29 48 48 Other derivatives 307 307 231 231 Embedded derivative on reinsurance 41 41 196 196 Short-term debt 1 1 1 1 Long-term debt 2,385 2,316 2,595 2,991 (1) Certain amounts included in Funding agreements without fixed maturities and deferred annuities are also reflected within the Guaranteed benefit derivatives section of the table above. (2) Includes GMWBL, GMWB, FIA, Stabilizer and MCGs. The following table summarizes the fair value hierarchy levels of consolidated investment entities as of June 30, 2022: Level 1 Level 2 Level 3 NAV Total Assets Cash and cash equivalents $ 85 $ — $ — $ — $ 85 Corporate loans, at fair value using the fair value option — 1,122 — — 1,122 Limited partnerships/corporations, at fair value — — — 2,943 2,943 Total assets, at fair value $ 85 $ 1,122 $ — $ 2,943 $ 4,150 Liabilities CLO notes, at fair value using the fair value option $ — $ 1,019 $ — $ — $ 1,019 Total liabilities, at fair value $ — $ 1,019 $ — $ — $ 1,019 The following table summarizes the fair value hierarchy levels of consolidated investment entities as of December 31, 2021: Level 1 Level 2 Level 3 NAV Total Assets Cash and cash equivalents $ 171 $ — $ — $ — $ 171 Corporate loans, at fair value using the fair value option — 1,111 — — 1,111 Limited partnerships/corporations, at fair value — — — 2,469 2,469 Total assets, at fair value $ 171 $ 1,111 $ — $ 2,469 $ 3,751 Liabilities CLO notes, at fair value using the fair value option $ — $ 880 $ — $ — $ 880 Total liabilities, at fair value $ — $ 880 $ — $ — $ 880

Restructuring (Tables)

Restructuring (Tables)	6 Months Ended
	Jun. 30, 2022
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Costs	The summary below presents Organizational Restructuring expenses, pre-tax, by type of costs incurred, for the periods indicated: Three Months Ended June 30, Six Months Ended June 30, Cumulative Amounts Incurred to Date (1) 2022 2021 2022 2021 Severance benefits $ 2 $ 9 $ 2 $ 13 $ 86 Organizational transition costs 6 32 17 39 409 Total restructuring expenses $ 8 $ 41 $ 19 $ 52 $ 495 Continuing operations $ 8 $ 41 $ 19 $ 52 $ 430 Discontinued operations $ — $ — $ — $ — $ 65 (1) Includes expenses incurred during 2017-2022.
Schedule of Restructuring Reserve by Type of Cost	The following table presents the accrued liability associated with Organizational Restructuring expenses as of June 30, 2022: Severance Benefits Organizational Transition Costs Total Accrued liability as of January 1, 2022 $ 30 $ 22 $ 52 Provision 2 17 19 Payments (6) (30) (36) Accrued liability as of June 30, 2022 $ 26 $ 9 $ 35
Organizational restructuring
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Costs	The summary below presents Organizational Restructuring expenses, pre-tax, by type of costs incurred, for the periods indicated: Three Months Ended June 30, Six Months Ended June 30, Cumulative Amounts Incurred to Date (1) 2022 2021 2022 2021 Severance benefits $ 2 $ 9 $ 2 $ 13 $ 86 Organizational transition costs 6 32 17 39 409 Total restructuring expenses $ 8 $ 41 $ 19 $ 52 $ 495 Continuing operations $ 8 $ 41 $ 19 $ 52 $ 430 Discontinued operations $ — $ — $ — $ — $ 65 (1) Includes expenses incurred during 2017-2022.
Schedule of Restructuring Reserve by Type of Cost	The following table presents the accrued liability associated with Organizational Restructuring expenses as of June 30, 2022: Severance Benefits Organizational Transition Costs Total Accrued liability as of January 1, 2022 $ 30 $ 22 $ 52 Provision 2 17 19 Payments (6) (30) (36) Accrued liability as of June 30, 2022 $ 26 $ 9 $ 35

Segments (Tables)

Segments (Tables)	6 Months Ended
	Jun. 30, 2022
Segment Reporting [Abstract]
Reconciliation of Operating Earnings Before Income Taxes from Segments to Consolidated	The summary below reconciles Adjusted operating earnings before income taxes for the segments to Income (loss) from continuing operations before income taxes for the periods indicated: Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Income (loss) from continuing operations before income taxes $ 153 $ 1,028 $ 244 $ 2,066 Less Adjustments: Net investment gains (losses) and related charges and adjustments (52) 29 (139) 67 Net guaranteed benefit gains (losses) and related charges and adjustments 3 (5) (19) 5 Income (loss) related to businesses exited or to be exited through reinsurance or divestment (50) 247 (97) 971 Income (loss) attributable to noncontrolling interest 75 447 118 447 Income (loss) related to early extinguishment of debt 1 — (4) (10) Immediate recognition of net actuarial gains (losses) related to pension and other post-employment benefit obligations and gains (losses) from plan amendments and curtailments — — 4 — Dividend payments made to preferred shareholders 4 4 18 18 Other adjustments (51) (46) (68) (57) Total adjustments to income (loss) from continuing operations (70) 675 (188) 1,441 Adjusted operating earnings before income taxes by segment: Wealth Solutions $ 186 $ 295 $ 391 $ 550 Health Solutions 47 63 68 100 Investment Management 40 66 79 118 Corporate (49) (71) (107) (142) Total $ 223 $ 353 $ 431 $ 626
Reconciliation of Revenue from Segments to Total Revenues	The summary below reconciles Adjusted operating revenues for the segments to Total revenues for the periods indicated: Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Total revenues $ 1,519 $ 2,503 $ 3,033 $ 546 Adjustments: Net investment gains (losses) and related charges and adjustments (60) (71) (157) (39) Gains (losses) on change in fair value of derivatives related to guaranteed benefits 3 (5) (19) 5 Revenues related to businesses exited or to be exited through reinsurance or divestment (58) 296 (104) (3,413) Revenues attributable to noncontrolling interest 93 464 142 470 Other adjustments 8 205 36 315 Total adjustments to revenues $ (14) $ 889 $ (102) $ (2,663) Adjusted operating revenues by segment: Wealth Solutions $ 706 $ 807 $ 1,460 $ 1,589 Health Solutions 640 591 1,287 1,190 Investment Management 171 193 349 382 Corporate 17 24 39 48 Total $ 1,534 $ 1,614 $ 3,135 $ 3,209
Schedule of Intersegment Revenues Included in Investment Management Segment	The Investment Management segment revenues include the following intersegment revenues, primarily consisting of asset-based management and administration fees for the periods indicated: Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Investment Management intersegment revenues $ 23 $ 22 $ 45 $ 45
Summary of Financial Information for Segments	The summary below presents Total assets for the Company’s segments as of the dates indicated: June 30, 2022 December 31, 2021 Wealth Solutions $ 115,202 $ 137,544 Health Solutions 2,901 3,002 Investment Management 970 1,226 Corporate 24,595 26,025 Total assets, before consolidation (1) 143,668 167,797 Consolidation of investment entities 3,852 3,465 Total assets $ 147,520 $ 171,262 (1) Total assets, before consolidation includes the Company's direct investments in CIEs prior to consolidation, which are accounted for using the equity method or fair value option.

Business, Basis of Presentati_4

Business, Basis of Presentation and Significant Accounting Policies - Narrative (Details) $ in Millions		6 Months Ended
	Jun. 09, 2021 USD ($) professional	Jun. 30, 2022 USD ($) segments
Number of operating segments | segments		3
Impairment loss | $		$ 32
Discontinued Operations, Disposed of by Sale | Independent Financial Planning Channel | Cetera Financial Group, Inc
Number of independent financial professionals serving retail customers transferred | professional	800
Disposal Group, Including Discontinued Operation, Assets | $	$ 38,000
Number of field and phone-based financial professionals who support Retirement business retained | professional	500

Business, Basis of Presentati_5

Business, Basis of Presentation and Significant Accounting Policies - Revision of Prior Period (Details) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net cash provided by (used in) operating activities	$ 715	$ (325)
Net decrease in cash and cash equivalents, including cash in CIEs	(534)	(293)
Total cash and cash equivalents, including cash in CIEs	$ 1,039	1,850	$ 1,573	$ 2,143
Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net cash provided by (used in) operating activities		(189)
Net decrease in cash and cash equivalents, including cash in CIEs		(157)
Total cash and cash equivalents, including cash in CIEs		1,765		1,922
Revision of Prior Period, Adjustment
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net cash provided by (used in) operating activities		(136)
Net decrease in cash and cash equivalents, including cash in CIEs		(136)
Total cash and cash equivalents, including cash in CIEs		$ 85		$ 221

Business, Basis of Presentati_6

Business, Basis of Presentation and Significant Accounting Policies - Adoption of New Pronouncements (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest			$ 6,213,000,000	$ 7,704,000,000	$ 9,821,000,000	$ 9,775,000,000	$ 8,999,000,000	$ 11,178,000,000
Forecast
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Accounting Standards Update [Extensible List]	Accounting Standards Update 2018-12 [Member]
Cumulative Effect, Period of Adoption, Adjustment, Other Adjustment Balances | Forecast | Minimum
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		$ 100,000,000
Cumulative Effect, Period of Adoption, Adjustment, Other Adjustment Balances | Forecast | Maximum
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		300,000,000
AOCI Including Portion Attributable to Noncontrolling Interest, Period Increase (Decrease)		(1,200,000,000)
Cumulative Effect, Period of Adoption, Adjusted Balance | Forecast | Minimum
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
AOCI Including Portion Attributable to Noncontrolling Interest, Period Increase (Decrease)		(1,000,000,000)
Accumulated Other Comprehensive Income (Loss)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest			$ (963,000,000)	$ 527,000,000	$ 2,100,000,000	$ 2,431,000,000	$ 1,910,000,000	$ 4,898,000,000
Accumulated Other Comprehensive Income (Loss) | Cumulative Effect, Period of Adoption, Adjustment, Other Adjustment Balances | Forecast
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		1,300,000,000
Retained Earnings (Accumulated Deficit)		$ (100,000,000)

Discontinued Operations - Narra

Discontinued Operations - Narrative (Details) - SLD, SLDI, RRII, MUL, and VAE - Discontinued Operations, Held-for-sale - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax		$ 8
Total loss recognition	$ 523
Deferred Policy Acquisition Costs and Present Value of Future Insurance Profits, Impairment Loss	302
Premium Deficiency Testing Expense, Long-Duration Contract, Amount	$ 221

Investments (excluding Consol_3

Investments (excluding Consolidated Investment Entities) - Fixed Maturities (Details) - USD ($) $ in Millions	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	$ 31,205	$ 30,656
Securities pledged, amortized costs	1,265	1,091
U.S. Treasuries
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	800	764
Gross Unrealized Capital Gains	93	239
Gross Unrealized Capital Losses	9	0
Embedded Derivatives	0	0
Fixed maturities, available-for-sale, at fair value	884	1,003
OTTI	0	0
U.S. Government agencies and authorities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	58	69
Gross Unrealized Capital Gains	6	12
Gross Unrealized Capital Losses	1	0
Embedded Derivatives	0	0
Fixed maturities, available-for-sale, at fair value	63	81
OTTI	0	0
State, municipalities and political subdivisions
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	993	1,000
Gross Unrealized Capital Gains	4	112
Gross Unrealized Capital Losses	69	1
Embedded Derivatives	0	0
Fixed maturities, available-for-sale, at fair value	928	1,111
OTTI	0	0
U.S. corporate public securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	10,211	10,402
Gross Unrealized Capital Gains	265	1,580
Gross Unrealized Capital Losses	933	41
Embedded Derivatives	0	0
Fixed maturities, available-for-sale, at fair value	9,541	11,941
OTTI	2	0
U.S. corporate private securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	4,993	4,889
Gross Unrealized Capital Gains	38	459
Gross Unrealized Capital Losses	289	23
Embedded Derivatives	0	0
Fixed maturities, available-for-sale, at fair value	4,742	5,325
OTTI	0	0
Foreign corporate public securities and foreign governments
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	3,356	3,373
Gross Unrealized Capital Gains	42	368
Gross Unrealized Capital Losses	317	18
Embedded Derivatives	0	0
Fixed maturities, available-for-sale, at fair value	3,057	3,723
OTTI	24	0
Foreign corporate private securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	3,391	3,320
Gross Unrealized Capital Gains	15	238
Gross Unrealized Capital Losses	166	1
Embedded Derivatives	0	0
Fixed maturities, available-for-sale, at fair value	3,222	3,501
OTTI	18	56
Residential mortgage-backed
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	4,330	4,183
Gross Unrealized Capital Gains	53	139
Gross Unrealized Capital Losses	205	31
Embedded Derivatives	6	12
Fixed maturities, available-for-sale, at fair value	4,183	4,302
OTTI	1	1
Commercial mortgage-backed securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	4,351	4,032
Gross Unrealized Capital Gains	9	173
Gross Unrealized Capital Losses	317	22
Embedded Derivatives	0	0
Fixed maturities, available-for-sale, at fair value	4,042	4,183
OTTI	1	0
Other asset-backed securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	2,146	2,069
Gross Unrealized Capital Gains	3	25
Gross Unrealized Capital Losses	144	12
Embedded Derivatives	0	0
Fixed maturities, available-for-sale, at fair value	2,004	2,081
OTTI	1	1
Fixed maturities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	34,629	34,101
Gross Unrealized Capital Gains	528	3,345
Gross Unrealized Capital Losses	2,450	149
Embedded Derivatives	6	12
Fixed maturities, available-for-sale, at fair value	32,666	37,251
OTTI	47	58
Total fixed maturities, less securities pledged, Amortized Cost	33,364	33,010
Total fixed maturities, less securities pledged, Gross Unrealized Capital Gains	506	3,238
Total fixed maturities, less securities pledged, Gross Unrealized Capital Losses	2,346	149
Total fixed maturities, less securities pledged, Fair Value	31,483	36,053
Collateral Pledged
Available-for-sale Securities, Including Securities Pledged [Line Items]
Securities pledged	1,183	1,198
Collateral Pledged | Fixed maturities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Embedded Derivatives	0	0
OTTI	0	0
Securities pledged, amortized costs	1,265	1,091
Securities pledged, Gross Unrealized Capital Gains	22	107
Securities pledged, Gross Unrealized Capital Losses	104	0
Securities pledged	$ 1,183	$ 1,198

Investments (excluding Consol_4

Investments (excluding Consolidated Investment Entities) - Debt Maturities (Details) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Amortized Cost
Fixed maturities, including securities pledged	$ 31,205	$ 30,656
Fair Value
Single issuer in excess of total equity	no
Communications
Amortized Cost
Fixed maturities, including securities pledged	$ 1,313	1,261
Fair Value
Fixed maturities, available-for-sale, at fair value	1,269	1,496
Financial
Amortized Cost
Fixed maturities, including securities pledged	4,056	3,752
Fair Value
Fixed maturities, available-for-sale, at fair value	3,752	4,133
Industrial and other companies
Amortized Cost
Fixed maturities, including securities pledged	9,187	9,600
Fair Value
Fixed maturities, available-for-sale, at fair value	8,547	10,626
Energy
Amortized Cost
Fixed maturities, including securities pledged	1,879	1,907
Fair Value
Fixed maturities, available-for-sale, at fair value	1,832	2,203
Utilities
Amortized Cost
Fixed maturities, including securities pledged	3,757	3,782
Fair Value
Fixed maturities, available-for-sale, at fair value	3,585	4,270
Transportation
Amortized Cost
Fixed maturities, including securities pledged	1,150	1,130
Fair Value
Fixed maturities, available-for-sale, at fair value	1,063	1,222
Total
Amortized Cost
Fixed maturities, including securities pledged	21,342	21,432
Fair Value
Fixed maturities, available-for-sale, at fair value	20,048	23,950
Fixed maturities
Amortized Cost
One year or less	766
After one year through five years	4,212
After five years through ten years	5,129
After ten years	13,695
Fixed maturities, including securities pledged	34,629	34,101
Fair Value
One year or less	742
After one year through five years	4,102
After five years through ten years	4,886
After ten years	12,707
Fixed maturities, available-for-sale, at fair value	32,666	37,251
Mortgage-backed securities
Amortized Cost
Without single maturity date	8,681
Fair Value
Without single maturity date	8,225
Other asset-backed securities
Amortized Cost
Without single maturity date	2,146
Fixed maturities, including securities pledged	2,146	2,069
Fair Value
Without single maturity date	2,004
Fixed maturities, available-for-sale, at fair value	$ 2,004	$ 2,081

Investments (excluding Consol_5

Investments (excluding Consolidated Investment Entities) - Composition of US and Foreign Corporate Securities (Details) - USD ($) $ in Millions	Jun. 30, 2022	Dec. 31, 2021
Schedule of Available for Sale, including Securities Pledged [Line Items]
Fixed maturities, amortized cost	$ 31,205	$ 30,656
Fixed maturities
Schedule of Available for Sale, including Securities Pledged [Line Items]
Fixed maturities, amortized cost	34,629	34,101
Gross Unrealized Capital Gains	528	3,345
Gross Unrealized Capital Losses	2,450	149
Fixed maturities, available-for-sale, at fair value	32,666	37,251
Communications
Schedule of Available for Sale, including Securities Pledged [Line Items]
Fixed maturities, amortized cost	1,313	1,261
Gross Unrealized Capital Gains	46	238
Gross Unrealized Capital Losses	90	3
Fixed maturities, available-for-sale, at fair value	1,269	1,496
Financial
Schedule of Available for Sale, including Securities Pledged [Line Items]
Fixed maturities, amortized cost	4,056	3,752
Gross Unrealized Capital Gains	60	394
Gross Unrealized Capital Losses	364	13
Fixed maturities, available-for-sale, at fair value	3,752	4,133
Industrial and other companies
Schedule of Available for Sale, including Securities Pledged [Line Items]
Fixed maturities, amortized cost	9,187	9,600
Gross Unrealized Capital Gains	114	1,058
Gross Unrealized Capital Losses	754	32
Fixed maturities, available-for-sale, at fair value	8,547	10,626
Energy
Schedule of Available for Sale, including Securities Pledged [Line Items]
Fixed maturities, amortized cost	1,879	1,907
Gross Unrealized Capital Gains	66	314
Gross Unrealized Capital Losses	113	18
Fixed maturities, available-for-sale, at fair value	1,832	2,203
Utilities
Schedule of Available for Sale, including Securities Pledged [Line Items]
Fixed maturities, amortized cost	3,757	3,782
Gross Unrealized Capital Gains	63	499
Gross Unrealized Capital Losses	235	11
Fixed maturities, available-for-sale, at fair value	3,585	4,270
Transportation
Schedule of Available for Sale, including Securities Pledged [Line Items]
Fixed maturities, amortized cost	1,150	1,130
Gross Unrealized Capital Gains	7	93
Gross Unrealized Capital Losses	94	1
Fixed maturities, available-for-sale, at fair value	1,063	1,222
Total
Schedule of Available for Sale, including Securities Pledged [Line Items]
Fixed maturities, amortized cost	21,342	21,432
Gross Unrealized Capital Gains	356	2,596
Gross Unrealized Capital Losses	1,650	78
Fixed maturities, available-for-sale, at fair value	$ 20,048	$ 23,950

Investments (excluding Consol_6

Investments (excluding Consolidated Investment Entities) - CMO's, Repurchase Agreements and Securities Pledged (Details) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Available-for-sale Securities, Including Securities Pledged [Line Items]
Initial collateral required, percent of market value of loaned securities	102%
Securities received as collateral	$ 132	$ 117
Payables under securities loan and repurchase agreements, including collateral held	1,220	1,183
Collateral Pledged
Available-for-sale Securities, Including Securities Pledged [Line Items]
Securities Sold under Agreements to Repurchase, Asset	0
Securities pledged as collateral
Available-for-sale Securities, Including Securities Pledged [Line Items]
Securities Pledged under repurchase agreements, carrying value	108	105
Fair value of loaned securities	913	969
Short-term Investments
Available-for-sale Securities, Including Securities Pledged [Line Items]
Securities received as collateral	819	884
Cash collateral, included in Payables
Available-for-sale Securities, Including Securities Pledged [Line Items]
Payables under securities loan and repurchase agreements, including collateral held	$ 819	$ 884
Mortgage-backed securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Percent collateralized mortgage backed securities including interest-only strip or principal-only strip	38.90%	40.60%
U.S. Treasuries
Available-for-sale Securities, Including Securities Pledged [Line Items]
Payables under securities loan and repurchase agreements, including collateral held	$ 41	$ 42
U.S. Government agencies and authorities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Payables under securities loan and repurchase agreements, including collateral held	3	3
U.S. corporate public securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Payables under securities loan and repurchase agreements, including collateral held	605	599
Foreign corporate public securities and foreign governments
Available-for-sale Securities, Including Securities Pledged [Line Items]
Payables under securities loan and repurchase agreements, including collateral held	302	357
Payables under securities loan agreements
Available-for-sale Securities, Including Securities Pledged [Line Items]
Payables under securities loan and repurchase agreements, including collateral held	$ 951	$ 1,001

Investments (excluding Consol_7

Investments (excluding Consolidated Investment Entities) - Allowance for Credit Losses (Details) - USD ($) $ in Millions	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	$ 58	$ 26
Credit losses on securities for which credit losses were not previously recorded	29	41
Initial allowance for credit losses recognized on financial assets accounted for as PCD	0	0
Reductions for securities sold during the period	(41)	(1)
Reductions for intent to sell or more likely than not will be required to sell securities prior to recovery of amortized cost	0	0
Change in allowance due to transfer of loans from Voya Reinsurance portfolios to Resolution	0	0
Increase (decrease) on securities with allowance recorded in previous period	1	(8)
Write-offs	0	0
Recoveries of amounts previously written-off	0	0
Ending Balance	47	58
Residential mortgage-backed
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	1	2
Credit losses on securities for which credit losses were not previously recorded	1	1
Initial allowance for credit losses recognized on financial assets accounted for as PCD	0	0
Reductions for securities sold during the period	0	0
Reductions for intent to sell or more likely than not will be required to sell securities prior to recovery of amortized cost	0	0
Change in allowance due to transfer of loans from Voya Reinsurance portfolios to Resolution	0	0
Increase (decrease) on securities with allowance recorded in previous period	(1)	(2)
Write-offs	0	0
Recoveries of amounts previously written-off	0	0
Ending Balance	1	1
Commercial mortgage-backed securities
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	0	1
Credit losses on securities for which credit losses were not previously recorded	1	0
Initial allowance for credit losses recognized on financial assets accounted for as PCD	0	0
Reductions for securities sold during the period	0	(1)
Reductions for intent to sell or more likely than not will be required to sell securities prior to recovery of amortized cost	0	0
Change in allowance due to transfer of loans from Voya Reinsurance portfolios to Resolution	0	0
Increase (decrease) on securities with allowance recorded in previous period	0	0
Write-offs	0	0
Recoveries of amounts previously written-off	0	0
Ending Balance	1	0
Foreign corporate public securities and foreign governments
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	0
Credit losses on securities for which credit losses were not previously recorded	24
Initial allowance for credit losses recognized on financial assets accounted for as PCD	0
Reductions for securities sold during the period	0
Reductions for intent to sell or more likely than not will be required to sell securities prior to recovery of amortized cost	0
Change in allowance due to transfer of loans from Voya Reinsurance portfolios to Resolution	0
Increase (decrease) on securities with allowance recorded in previous period	0
Write-offs	0
Recoveries of amounts previously written-off	0
Ending Balance	24	0
Foreign corporate private securities
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	56	15
Credit losses on securities for which credit losses were not previously recorded	0	40
Initial allowance for credit losses recognized on financial assets accounted for as PCD	0	0
Reductions for securities sold during the period	(41)	0
Reductions for intent to sell or more likely than not will be required to sell securities prior to recovery of amortized cost	0	0
Change in allowance due to transfer of loans from Voya Reinsurance portfolios to Resolution	0	0
Increase (decrease) on securities with allowance recorded in previous period	3	1
Write-offs	0	0
Recoveries of amounts previously written-off	0	0
Ending Balance	18	56
Other asset-backed securities
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	1	8
Credit losses on securities for which credit losses were not previously recorded	1	0
Initial allowance for credit losses recognized on financial assets accounted for as PCD	0	0
Reductions for securities sold during the period	0	0
Reductions for intent to sell or more likely than not will be required to sell securities prior to recovery of amortized cost	0	0
Change in allowance due to transfer of loans from Voya Reinsurance portfolios to Resolution	0	0
Increase (decrease) on securities with allowance recorded in previous period	(1)	(7)
Write-offs	0	0
Recoveries of amounts previously written-off	0	0
Ending Balance	1	1
U.S. corporate private securities
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	0
Credit losses on securities for which credit losses were not previously recorded	2
Initial allowance for credit losses recognized on financial assets accounted for as PCD	0
Reductions for securities sold during the period	0
Reductions for intent to sell or more likely than not will be required to sell securities prior to recovery of amortized cost	0
Change in allowance due to transfer of loans from Voya Reinsurance portfolios to Resolution	0
Increase (decrease) on securities with allowance recorded in previous period	0
Write-offs	0
Recoveries of amounts previously written-off	0
Ending Balance	$ 2	$ 0

Investments (excluding Consol_8

Investments (excluding Consolidated Investment Entities) - Unrealized Capital Losses (Details) $ in Millions	Jun. 30, 2022 USD ($) security	Dec. 31, 2021 USD ($) security
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	$ 21,421	$ 5,313
Twelve months or less below amortized cost, Unrealized Capital Loss	$ 2,150	$ 96
Twelve months or less below amortized cost, total number of securities in an unrealized loss position | security	3,846	1,116
More than twelve months below amortized cost, Fair Value	$ 1,549	$ 908
More than twelve months below amortized cost, Unrealized Capital Loss	$ 300	$ 53
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	522	349
Total, Fair Value	$ 22,970	$ 6,221
Total Unrealized Capital Losses	$ 2,450	$ 149
Total, Number of securities | security	4,368	1,465
Percent of loss position	20%
U.S. Treasuries
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	$ 59	$ 16
Twelve months or less below amortized cost, Unrealized Capital Loss	$ 8	$ 0
Twelve months or less below amortized cost, total number of securities in an unrealized loss position | security	19	8
More than twelve months below amortized cost, Fair Value	$ 14	$ 12
More than twelve months below amortized cost, Unrealized Capital Loss	$ 1	$ 0
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	4	2
Total, Fair Value	$ 73	$ 28
Total Unrealized Capital Losses	$ 9	$ 0
Total, Number of securities | security	23	10
State, municipalities and political subdivisions
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	$ 739	$ 58
Twelve months or less below amortized cost, Unrealized Capital Loss	$ 69	$ 1
Twelve months or less below amortized cost, total number of securities in an unrealized loss position | security	255	22
More than twelve months below amortized cost, Fair Value	$ 1	$ 0
More than twelve months below amortized cost, Unrealized Capital Loss	$ 0	$ 0
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	1	0
Total, Fair Value	$ 740	$ 58
Total Unrealized Capital Losses	$ 69	$ 1
Total, Number of securities | security	256	22
U.S. corporate public securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	$ 5,725	$ 1,425
Twelve months or less below amortized cost, Unrealized Capital Loss	$ 812	$ 35
Twelve months or less below amortized cost, total number of securities in an unrealized loss position | security	1,111	292
More than twelve months below amortized cost, Fair Value	$ 358	$ 115
More than twelve months below amortized cost, Unrealized Capital Loss	$ 121	$ 6
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	175	119
Total, Fair Value	$ 6,083	$ 1,540
Total Unrealized Capital Losses	$ 933	$ 41
Total, Number of securities | security	1,286	411
U.S. corporate private securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	$ 3,337	$ 447
Twelve months or less below amortized cost, Unrealized Capital Loss	$ 253	$ 5
Twelve months or less below amortized cost, total number of securities in an unrealized loss position | security	356	34
More than twelve months below amortized cost, Fair Value	$ 230	$ 122
More than twelve months below amortized cost, Unrealized Capital Loss	$ 36	$ 18
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	9	9
Total, Fair Value	$ 3,567	$ 569
Total Unrealized Capital Losses	$ 289	$ 23
Total, Number of securities | security	365	43
Foreign corporate public securities and foreign governments
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	$ 2,071	$ 534
Twelve months or less below amortized cost, Unrealized Capital Loss	$ 261	$ 16
Twelve months or less below amortized cost, total number of securities in an unrealized loss position | security	392	97
More than twelve months below amortized cost, Fair Value	$ 175	$ 28
More than twelve months below amortized cost, Unrealized Capital Loss	$ 56	$ 2
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	46	14
Total, Fair Value	$ 2,246	$ 562
Total Unrealized Capital Losses	$ 317	$ 18
Total, Number of securities | security	438	111
Foreign corporate private securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	$ 2,455	$ 70
Twelve months or less below amortized cost, Unrealized Capital Loss	$ 165	$ 1
Twelve months or less below amortized cost, total number of securities in an unrealized loss position | security	199	7
More than twelve months below amortized cost, Fair Value	$ 13	$ 11
More than twelve months below amortized cost, Unrealized Capital Loss	$ 1	$ 0
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	3	1
Total, Fair Value	$ 2,468	$ 81
Total Unrealized Capital Losses	$ 166	$ 1
Total, Number of securities | security	202	8
Residential mortgage-backed
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	$ 1,808	$ 704
Twelve months or less below amortized cost, Unrealized Capital Loss	$ 172	$ 18
Twelve months or less below amortized cost, total number of securities in an unrealized loss position | security	530	244
More than twelve months below amortized cost, Fair Value	$ 353	$ 294
More than twelve months below amortized cost, Unrealized Capital Loss	$ 33	$ 13
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	163	116
Total, Fair Value	$ 2,161	$ 998
Total Unrealized Capital Losses	$ 205	$ 31
Total, Number of securities | security	693	360
Commercial mortgage-backed securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	$ 3,468	$ 1,137
Twelve months or less below amortized cost, Unrealized Capital Loss	$ 282	$ 12
Twelve months or less below amortized cost, total number of securities in an unrealized loss position | security	561	191
More than twelve months below amortized cost, Fair Value	$ 261	$ 228
More than twelve months below amortized cost, Unrealized Capital Loss	$ 35	$ 10
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	47	32
Total, Fair Value	$ 3,729	$ 1,365
Total Unrealized Capital Losses	$ 317	$ 22
Total, Number of securities | security	608	223
Other asset-backed securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	$ 1,751	$ 922
Twelve months or less below amortized cost, Unrealized Capital Loss	$ 127	$ 8
Twelve months or less below amortized cost, total number of securities in an unrealized loss position | security	422	221
More than twelve months below amortized cost, Fair Value	$ 144	$ 98
More than twelve months below amortized cost, Unrealized Capital Loss	$ 17	$ 4
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	74	56
Total, Fair Value	$ 1,895	$ 1,020
Total Unrealized Capital Losses	$ 144	$ 12
Total, Number of securities | security	496	277
U.S. Government agencies and authorities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	$ 8
Twelve months or less below amortized cost, Unrealized Capital Loss	$ 1
Twelve months or less below amortized cost, total number of securities in an unrealized loss position | security	1
More than twelve months below amortized cost, Fair Value	$ 0
More than twelve months below amortized cost, Unrealized Capital Loss	$ 0
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	0
Total, Fair Value	$ 8
Total Unrealized Capital Losses	$ 1
Total, Number of securities | security	1

Investments (excluding Consol_9

Investments (excluding Consolidated Investment Entities) - Unrealized Capital Losses 1 (Details) $ in Millions	6 Months Ended
	Jun. 30, 2022 USD ($) security	Dec. 31, 2021 USD ($) security
Available-for-sale Securities, Including Securities Pledged [Line Items]
Available-for-sale Securities, change in loss position	$ 2,301
Total Unrealized Capital Losses	2,450	$ 149
More than twelve months below amortized cost, Unrealized Capital Loss	$ 300	$ 53
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	522	349
Commercial mortgage-backed securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Total Unrealized Capital Losses	$ 317	$ 22
More than twelve months below amortized cost, Unrealized Capital Loss	$ 35	$ 10
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	47	32
Fair value decline below amortized cost greater than 20%
Available-for-sale Securities, Including Securities Pledged [Line Items]
More than twelve months below amortized cost, Unrealized Capital Loss	$ 5
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	5

Investments (excluding Conso_10

Investments (excluding Consolidated Investment Entities) - OTTI (Details) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2022 USD ($) security	Jun. 30, 2021 USD ($) security	Jun. 30, 2022 USD ($) security	Jun. 30, 2021 USD ($) security
Available-for-sale Securities, Including Securities Pledged [Line Items]
Impairment | $	$ 2	$ 0	$ 9	$ 0
No. of Securities | security	18	4	28	11
Residential mortgage-backed
Available-for-sale Securities, Including Securities Pledged [Line Items]
Impairment | $	$ 2	$ 0	$ 9	$ 0
No. of Securities | security	17	4	27	10
Commercial mortgage-backed securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Impairment | $	$ 0	$ 0	$ 0	$ 0
No. of Securities | security	1	0	1	1

Investments (excluding Conso_11

Investments (excluding Consolidated Investment Entities) - Troubled Debt Restructuring (Details) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2022 USD ($) loan	Jun. 30, 2021 loan	Jun. 30, 2022 USD ($) loan	Jun. 30, 2021 loan
Commercial mortgage loans
Financing Receivable, Troubled Debt Restructuring [Line Items]
Troubled debt restructuring, number of contracts | loan	0	0		1,000,000
Financing Receivable, Troubled Debt Restructuring, Subsequent Default			$ 0
Private Placement
Financing Receivable, Troubled Debt Restructuring [Line Items]
Troubled debt restructuring, number of contracts | loan	3		6	0
Pre-modification carrying value	$ 74		$ 102
Post-modification carrying value	$ 65		75
Commercial mortgage-backed securities
Financing Receivable, Troubled Debt Restructuring [Line Items]
Post-modification carrying value			$ 5

Investments (excluding Conso_12

Investments (excluding Consolidated Investment Entities) - Loans by Loan to Value (Details) - USD ($) $ in Millions	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Schedule of Loans by Loan to Value Ratio [Line Items]
Targeted maximum amount of mortgage loans lended, percent of estimated fair value of underlying real estate	75%
Benchmark loan to value ratio, greater than indicates unpaid loan amount exceeds underlying collateral	100%
Benchmark ratio	100%
Commercial mortgage loans	$ 5,415	$ 5,627
0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Loan to value ratio, minimum	0%	0%
Loan to value ratio, maximum	50%	50%
Commercial mortgage loans	$ 3,530	$ 3,655
50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Loan to value ratio, minimum	50%	50%
Loan to value ratio, maximum	60%	60%
Commercial mortgage loans	$ 1,471	$ 1,595
60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Loan to value ratio, minimum	60%	60%
Loan to value ratio, maximum	70%	70%
Commercial mortgage loans	$ 394	$ 377
70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Loan to value ratio, minimum	70%	70%
Loan to value ratio, maximum	80%	80%
Commercial mortgage loans	$ 20	$ 0
80% and above
Schedule of Loans by Loan to Value Ratio [Line Items]
Loan to value ratio, minimum	80%	80%
Commercial mortgage loans	$ 0	$ 0
Year of Origination 2022
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	311
Year of Origination 2022 | 0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	151
Year of Origination 2022 | 50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	101
Year of Origination 2022 | 60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	59
Year of Origination 2022 | 70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0
Year of Origination 2022 | 80% and above
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0
Year of Origination 2021
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	777	785
Year of Origination 2021 | 0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	247	269
Year of Origination 2021 | 50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	314	315
Year of Origination 2021 | 60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	206	201
Year of Origination 2021 | 70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	10	0
Year of Origination 2021 | 80% and above
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2020
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	403	457
Year of Origination 2020 | 0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	115	140
Year of Origination 2020 | 50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	244	240
Year of Origination 2020 | 60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	34	77
Year of Origination 2020 | 70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	10	0
Year of Origination 2020 | 80% and above
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2019
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	432	462
Year of Origination 2019 | 0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	194	201
Year of Origination 2019 | 50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	173	192
Year of Origination 2019 | 60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	65	69
Year of Origination 2019 | 70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2019 | 80% and above
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2018
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	210	221
Year of Origination 2018 | 0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	161	169
Year of Origination 2018 | 50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	46	50
Year of Origination 2018 | 60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	3	2
Year of Origination 2018 | 70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2018 | 80% and above
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2017
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	855	874
Year of Origination 2017 | 0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	648	656
Year of Origination 2017 | 50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	203	214
Year of Origination 2017 | 60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	4	4
Year of Origination 2017 | 70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2017 | 80% and above
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2016
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	2,427	2,828
Year of Origination 2016 | 0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	2,014	2,220
Year of Origination 2016 | 50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	390	584
Year of Origination 2016 | 60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	23	24
Year of Origination 2016 | 70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2016 | 80% and above
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	$ 0	$ 0

Investments (excluding Conso_13

Investments (excluding Consolidated Investment Entities) - Loans by Debt Service Coverage Ratio (Details) - USD ($) $ in Millions	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	$ 5,415	$ 5,627
>1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Debt Service Coverage Ratio, minimum	150%	150%
>1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Debt Service Coverage Ratio, minimum	125%	125%
Debt Service Coverage Ratio, maximum	150%	150%
>1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Debt Service Coverage Ratio, minimum	100%	100%
Debt Service Coverage Ratio, maximum	125%	125%
Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Debt Service Coverage Ratio, maximum	100%	100%
Year of Origination 2022
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	$ 311
Year of Origination 2022 | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	311
Year of Origination 2022 | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	0
Year of Origination 2022 | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	0
Year of Origination 2022 | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	0
Year of Origination 2022 | Commercial mortgage loans secured by land or construction loans
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	0
Year of Origination 2022 | Total
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	311
Year of Origination 2021
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	777	$ 785
Year of Origination 2021 | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	650	652
Year of Origination 2021 | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	26	27
Year of Origination 2021 | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	36	38
Year of Origination 2021 | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	65	68
Year of Origination 2021 | Commercial mortgage loans secured by land or construction loans
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2021 | Total
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	777	785
Year of Origination 2020
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	403	457
Year of Origination 2020 | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	310	396
Year of Origination 2020 | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	36	21
Year of Origination 2020 | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	33	34
Year of Origination 2020 | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	24	6
Year of Origination 2020 | Commercial mortgage loans secured by land or construction loans
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2020 | Total
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	403	457
Year of Origination 2019
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	432	462
Year of Origination 2019 | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	254	278
Year of Origination 2019 | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	13	49
Year of Origination 2019 | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	106	108
Year of Origination 2019 | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	59	27
Year of Origination 2019 | Commercial mortgage loans secured by land or construction loans
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2019 | Total
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	432	462
Year of Origination 2018
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	210	221
Year of Origination 2018 | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	127	131
Year of Origination 2018 | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	7	5
Year of Origination 2018 | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	53	54
Year of Origination 2018 | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	23	31
Year of Origination 2018 | Commercial mortgage loans secured by land or construction loans
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2018 | Total
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	210	221
Year of Origination 2017
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	855	874
Year of Origination 2017 | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	495	414
Year of Origination 2017 | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	61	156
Year of Origination 2017 | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	114	111
Year of Origination 2017 | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	185	193
Year of Origination 2017 | Commercial mortgage loans secured by land or construction loans
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2017 | Total
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	855	874
Year of Origination 2016
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	2,427	2,828
Year of Origination 2016 | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	1,829	2,237
Year of Origination 2016 | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	311	242
Year of Origination 2016 | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	193	242
Year of Origination 2016 | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	94	107
Year of Origination 2016 | Commercial mortgage loans secured by land or construction loans
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2016 | Total
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	2,427	2,828
Total | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	3,976	4,108
Total | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	454	500
Total | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	535	587
Total | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	450	432
Total | Commercial mortgage loans secured by land or construction loans
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	0	0
Total | Total
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	$ 5,415	$ 5,627

Investments (excluding Conso_14

Investments (excluding Consolidated Investment Entities) - Loans by U.S. Region (Details) - USD ($) $ in Millions	Jun. 30, 2022	Dec. 31, 2021
Open Option Contracts Written [Line Items]
Commercial mortgage loans	$ 5,415	$ 5,627
Year of Origination 2022
Open Option Contracts Written [Line Items]
Commercial mortgage loans	311
Year of Origination 2022 | Pacific
Open Option Contracts Written [Line Items]
Commercial mortgage loans	38
Year of Origination 2022 | South Atlantic
Open Option Contracts Written [Line Items]
Commercial mortgage loans	49
Year of Origination 2022 | Middle Atlantic
Open Option Contracts Written [Line Items]
Commercial mortgage loans	18
Year of Origination 2022 | West South Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	60
Year of Origination 2022 | Mountain
Open Option Contracts Written [Line Items]
Commercial mortgage loans	85
Year of Origination 2022 | East North Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	38
Year of Origination 2022 | New England
Open Option Contracts Written [Line Items]
Commercial mortgage loans	4
Year of Origination 2022 | West North Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	1
Year of Origination 2022 | East South Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	18
Year of Origination 2022 | Total
Open Option Contracts Written [Line Items]
Commercial mortgage loans	311
Year of Origination 2021
Open Option Contracts Written [Line Items]
Commercial mortgage loans	777	785
Year of Origination 2021 | Pacific
Open Option Contracts Written [Line Items]
Commercial mortgage loans	98	98
Year of Origination 2021 | South Atlantic
Open Option Contracts Written [Line Items]
Commercial mortgage loans	72	79
Year of Origination 2021 | Middle Atlantic
Open Option Contracts Written [Line Items]
Commercial mortgage loans	138	143
Year of Origination 2021 | West South Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	139	137
Year of Origination 2021 | Mountain
Open Option Contracts Written [Line Items]
Commercial mortgage loans	110	110
Year of Origination 2021 | East North Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	142	140
Year of Origination 2021 | New England
Open Option Contracts Written [Line Items]
Commercial mortgage loans	9	9
Year of Origination 2021 | West North Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	47	47
Year of Origination 2021 | East South Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	22	22
Year of Origination 2021 | Total
Open Option Contracts Written [Line Items]
Commercial mortgage loans	777	785
Year of Origination 2020
Open Option Contracts Written [Line Items]
Commercial mortgage loans	403	457
Year of Origination 2020 | Pacific
Open Option Contracts Written [Line Items]
Commercial mortgage loans	74	84
Year of Origination 2020 | South Atlantic
Open Option Contracts Written [Line Items]
Commercial mortgage loans	176	187
Year of Origination 2020 | Middle Atlantic
Open Option Contracts Written [Line Items]
Commercial mortgage loans	22	31
Year of Origination 2020 | West South Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	24	35
Year of Origination 2020 | Mountain
Open Option Contracts Written [Line Items]
Commercial mortgage loans	32	39
Year of Origination 2020 | East North Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	40	39
Year of Origination 2020 | New England
Open Option Contracts Written [Line Items]
Commercial mortgage loans	2	3
Year of Origination 2020 | West North Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	8	14
Year of Origination 2020 | East South Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	25	25
Year of Origination 2020 | Total
Open Option Contracts Written [Line Items]
Commercial mortgage loans	403	457
Year of Origination 2019
Open Option Contracts Written [Line Items]
Commercial mortgage loans	432	462
Year of Origination 2019 | Pacific
Open Option Contracts Written [Line Items]
Commercial mortgage loans	59	59
Year of Origination 2019 | South Atlantic
Open Option Contracts Written [Line Items]
Commercial mortgage loans	143	145
Year of Origination 2019 | Middle Atlantic
Open Option Contracts Written [Line Items]
Commercial mortgage loans	14	14
Year of Origination 2019 | West South Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	109	130
Year of Origination 2019 | Mountain
Open Option Contracts Written [Line Items]
Commercial mortgage loans	47	47
Year of Origination 2019 | East North Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	10	17
Year of Origination 2019 | New England
Open Option Contracts Written [Line Items]
Commercial mortgage loans	15	15
Year of Origination 2019 | West North Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	13	13
Year of Origination 2019 | East South Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	22	22
Year of Origination 2019 | Total
Open Option Contracts Written [Line Items]
Commercial mortgage loans	432	462
Year of Origination 2018
Open Option Contracts Written [Line Items]
Commercial mortgage loans	210	221
Year of Origination 2018 | Pacific
Open Option Contracts Written [Line Items]
Commercial mortgage loans	50	54
Year of Origination 2018 | South Atlantic
Open Option Contracts Written [Line Items]
Commercial mortgage loans	63	68
Year of Origination 2018 | Middle Atlantic
Open Option Contracts Written [Line Items]
Commercial mortgage loans	57	59
Year of Origination 2018 | West South Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	10	10
Year of Origination 2018 | Mountain
Open Option Contracts Written [Line Items]
Commercial mortgage loans	14	14
Year of Origination 2018 | East North Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	10	10
Year of Origination 2018 | New England
Open Option Contracts Written [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2018 | West North Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	6	6
Year of Origination 2018 | East South Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2018 | Total
Open Option Contracts Written [Line Items]
Commercial mortgage loans	210	221
Year of Origination 2017
Open Option Contracts Written [Line Items]
Commercial mortgage loans	855	874
Year of Origination 2017 | Pacific
Open Option Contracts Written [Line Items]
Commercial mortgage loans	126	128
Year of Origination 2017 | South Atlantic
Open Option Contracts Written [Line Items]
Commercial mortgage loans	92	94
Year of Origination 2017 | Middle Atlantic
Open Option Contracts Written [Line Items]
Commercial mortgage loans	349	360
Year of Origination 2017 | West South Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	137	139
Year of Origination 2017 | Mountain
Open Option Contracts Written [Line Items]
Commercial mortgage loans	54	56
Year of Origination 2017 | East North Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	55	56
Year of Origination 2017 | New England
Open Option Contracts Written [Line Items]
Commercial mortgage loans	5	5
Year of Origination 2017 | West North Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	37	36
Year of Origination 2017 | East South Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2017 | Total
Open Option Contracts Written [Line Items]
Commercial mortgage loans	855	874
Year of Origination 2016
Open Option Contracts Written [Line Items]
Commercial mortgage loans	2,427	2,828
Year of Origination 2016 | Pacific
Open Option Contracts Written [Line Items]
Commercial mortgage loans	683	718
Year of Origination 2016 | South Atlantic
Open Option Contracts Written [Line Items]
Commercial mortgage loans	550	617
Year of Origination 2016 | Middle Atlantic
Open Option Contracts Written [Line Items]
Commercial mortgage loans	477	590
Year of Origination 2016 | West South Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	118	159
Year of Origination 2016 | Mountain
Open Option Contracts Written [Line Items]
Commercial mortgage loans	183	256
Year of Origination 2016 | East North Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	207	239
Year of Origination 2016 | New England
Open Option Contracts Written [Line Items]
Commercial mortgage loans	51	71
Year of Origination 2016 | West North Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	123	142
Year of Origination 2016 | East South Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	35	36
Year of Origination 2016 | Total
Open Option Contracts Written [Line Items]
Commercial mortgage loans	2,427	2,828
Total | Pacific
Open Option Contracts Written [Line Items]
Commercial mortgage loans	1,128	1,141
Total | South Atlantic
Open Option Contracts Written [Line Items]
Commercial mortgage loans	1,145	1,190
Total | Middle Atlantic
Open Option Contracts Written [Line Items]
Commercial mortgage loans	1,075	1,197
Total | West South Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	597	610
Total | Mountain
Open Option Contracts Written [Line Items]
Commercial mortgage loans	525	522
Total | East North Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	502	501
Total | New England
Open Option Contracts Written [Line Items]
Commercial mortgage loans	86	103
Total | West North Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	235	258
Total | East South Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	122	105
Total | Total
Open Option Contracts Written [Line Items]
Commercial mortgage loans	$ 5,415	$ 5,627

Investments (excluding Conso_15

Investments (excluding Consolidated Investment Entities) - Loans by Property Type (Details) - USD ($) $ in Millions	Jun. 30, 2022	Dec. 31, 2021
Investment Holdings [Line Items]
Commercial mortgage loans	$ 5,415	$ 5,627
Year of Origination 2022
Investment Holdings [Line Items]
Commercial mortgage loans	311
Year of Origination 2022 | Retail
Investment Holdings [Line Items]
Commercial mortgage loans	24
Year of Origination 2022 | Industrial
Investment Holdings [Line Items]
Commercial mortgage loans	118
Year of Origination 2022 | Apartments
Investment Holdings [Line Items]
Commercial mortgage loans	155
Year of Origination 2022 | Office
Investment Holdings [Line Items]
Commercial mortgage loans	14
Year of Origination 2022 | Hotel/Motel
Investment Holdings [Line Items]
Commercial mortgage loans	0
Year of Origination 2022 | Other
Investment Holdings [Line Items]
Commercial mortgage loans	0
Year of Origination 2022 | Mixed Use
Investment Holdings [Line Items]
Commercial mortgage loans	0
Year of Origination 2022 | Total
Investment Holdings [Line Items]
Commercial mortgage loans	311
Year of Origination 2021
Investment Holdings [Line Items]
Commercial mortgage loans	777	785
Year of Origination 2021 | Retail
Investment Holdings [Line Items]
Commercial mortgage loans	38	39
Year of Origination 2021 | Industrial
Investment Holdings [Line Items]
Commercial mortgage loans	172	185
Year of Origination 2021 | Apartments
Investment Holdings [Line Items]
Commercial mortgage loans	412	405
Year of Origination 2021 | Office
Investment Holdings [Line Items]
Commercial mortgage loans	128	129
Year of Origination 2021 | Hotel/Motel
Investment Holdings [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2021 | Other
Investment Holdings [Line Items]
Commercial mortgage loans	18	18
Year of Origination 2021 | Mixed Use
Investment Holdings [Line Items]
Commercial mortgage loans	9	9
Year of Origination 2021 | Total
Investment Holdings [Line Items]
Commercial mortgage loans	777	785
Year of Origination 2020
Investment Holdings [Line Items]
Commercial mortgage loans	403	457
Year of Origination 2020 | Retail
Investment Holdings [Line Items]
Commercial mortgage loans	58	58
Year of Origination 2020 | Industrial
Investment Holdings [Line Items]
Commercial mortgage loans	74	90
Year of Origination 2020 | Apartments
Investment Holdings [Line Items]
Commercial mortgage loans	111	140
Year of Origination 2020 | Office
Investment Holdings [Line Items]
Commercial mortgage loans	160	169
Year of Origination 2020 | Hotel/Motel
Investment Holdings [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2020 | Other
Investment Holdings [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2020 | Mixed Use
Investment Holdings [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2020 | Total
Investment Holdings [Line Items]
Commercial mortgage loans	403	457
Year of Origination 2019
Investment Holdings [Line Items]
Commercial mortgage loans	432	462
Year of Origination 2019 | Retail
Investment Holdings [Line Items]
Commercial mortgage loans	46	46
Year of Origination 2019 | Industrial
Investment Holdings [Line Items]
Commercial mortgage loans	94	96
Year of Origination 2019 | Apartments
Investment Holdings [Line Items]
Commercial mortgage loans	200	211
Year of Origination 2019 | Office
Investment Holdings [Line Items]
Commercial mortgage loans	66	82
Year of Origination 2019 | Hotel/Motel
Investment Holdings [Line Items]
Commercial mortgage loans	26	27
Year of Origination 2019 | Other
Investment Holdings [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2019 | Mixed Use
Investment Holdings [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2019 | Total
Investment Holdings [Line Items]
Commercial mortgage loans	432	462
Year of Origination 2018
Investment Holdings [Line Items]
Commercial mortgage loans	210	221
Year of Origination 2018 | Retail
Investment Holdings [Line Items]
Commercial mortgage loans	37	38
Year of Origination 2018 | Industrial
Investment Holdings [Line Items]
Commercial mortgage loans	86	88
Year of Origination 2018 | Apartments
Investment Holdings [Line Items]
Commercial mortgage loans	56	57
Year of Origination 2018 | Office
Investment Holdings [Line Items]
Commercial mortgage loans	13	16
Year of Origination 2018 | Hotel/Motel
Investment Holdings [Line Items]
Commercial mortgage loans	0	4
Year of Origination 2018 | Other
Investment Holdings [Line Items]
Commercial mortgage loans	18	18
Year of Origination 2018 | Mixed Use
Investment Holdings [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2018 | Total
Investment Holdings [Line Items]
Commercial mortgage loans	210	221
Year of Origination 2017
Investment Holdings [Line Items]
Commercial mortgage loans	855	874
Year of Origination 2017 | Retail
Investment Holdings [Line Items]
Commercial mortgage loans	108	110
Year of Origination 2017 | Industrial
Investment Holdings [Line Items]
Commercial mortgage loans	403	417
Year of Origination 2017 | Apartments
Investment Holdings [Line Items]
Commercial mortgage loans	193	195
Year of Origination 2017 | Office
Investment Holdings [Line Items]
Commercial mortgage loans	147	149
Year of Origination 2017 | Hotel/Motel
Investment Holdings [Line Items]
Commercial mortgage loans	4	3
Year of Origination 2017 | Other
Investment Holdings [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2017 | Mixed Use
Investment Holdings [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2017 | Total
Investment Holdings [Line Items]
Commercial mortgage loans	855	874
Year of Origination 2016
Investment Holdings [Line Items]
Commercial mortgage loans	2,427	2,828
Year of Origination 2016 | Retail
Investment Holdings [Line Items]
Commercial mortgage loans	819	936
Year of Origination 2016 | Industrial
Investment Holdings [Line Items]
Commercial mortgage loans	401	566
Year of Origination 2016 | Apartments
Investment Holdings [Line Items]
Commercial mortgage loans	529	576
Year of Origination 2016 | Office
Investment Holdings [Line Items]
Commercial mortgage loans	390	398
Year of Origination 2016 | Hotel/Motel
Investment Holdings [Line Items]
Commercial mortgage loans	76	93
Year of Origination 2016 | Other
Investment Holdings [Line Items]
Commercial mortgage loans	159	205
Year of Origination 2016 | Mixed Use
Investment Holdings [Line Items]
Commercial mortgage loans	53	54
Year of Origination 2016 | Total
Investment Holdings [Line Items]
Commercial mortgage loans	2,427	2,828
Total | Retail
Investment Holdings [Line Items]
Commercial mortgage loans	1,130	1,227
Total | Industrial
Investment Holdings [Line Items]
Commercial mortgage loans	1,348	1,442
Total | Apartments
Investment Holdings [Line Items]
Commercial mortgage loans	1,656	1,584
Total | Office
Investment Holdings [Line Items]
Commercial mortgage loans	918	943
Total | Hotel/Motel
Investment Holdings [Line Items]
Commercial mortgage loans	106	127
Total | Other
Investment Holdings [Line Items]
Commercial mortgage loans	195	241
Total | Mixed Use
Investment Holdings [Line Items]
Commercial mortgage loans	62	63
Total | Total
Investment Holdings [Line Items]
Commercial mortgage loans	$ 5,415	$ 5,627

Investments (excluding Conso_16

Investments (excluding Consolidated Investment Entities) - Allowance for Losses for Commercial Mortgage Loans (Details) - USD ($) $ in Millions	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	$ 58	$ 26
Credit losses on securities for which credit losses were not previously recorded	29	41
Increase (decrease) on securities with allowance recorded in previous period	1	(8)
Financing Receivable, Allowance for Credit Loss, Writeoff	0	0
Recoveries of amounts previously written-off	0	0
Ending Balance	47	58
Commercial Portfolio Segment
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	15
Credit losses on securities for which credit losses were not previously recorded	0	1
Accounts Receivable, Sale	0	(14)
Increase (decrease) on securities with allowance recorded in previous period	(3)	(61)
Premium Receivable, Credit Loss Expense (Reversal)	12	15
Financing Receivable, Allowance for Credit Loss, Writeoff	0	0
Recoveries of amounts previously written-off	0	0
Ending Balance	$ 12	15
Commercial Portfolio Segment | Cumulative Effect, Period of Adoption, Adjusted Balance
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance		$ 89

Investments (excluding Conso_17

Investments (excluding Consolidated Investment Entities) - Past due commercial mortgage loans (Details) - USD ($)	6 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Financing Receivable, Past Due [Line Items]
Financing Receivable, 90 Days or More Past Due, Still Accruing		$ 0
Financing Receivable, Nonaccrual, Interest Income	$ 0
Current
Financing Receivable, Past Due [Line Items]
Past due commercial mortgage loans	5,415,000,000	5,627,000,000
30-59 days past due
Financing Receivable, Past Due [Line Items]
Past due commercial mortgage loans	0	0
60-89 days past due
Financing Receivable, Past Due [Line Items]
Past due commercial mortgage loans	0	0
Greater than 90 days past due
Financing Receivable, Past Due [Line Items]
Past due commercial mortgage loans	0	0
Total
Financing Receivable, Past Due [Line Items]
Past due commercial mortgage loans	$ 5,415,000,000	$ 5,627,000,000

Investments (excluding Conso_18

Investments (excluding Consolidated Investment Entities) - Net Investment Income (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Schedule of Investment Income, Reported Amounts, by Category [Line Items]
Gross investment income	$ 596	$ 673	$ 1,241	$ 1,404
Less: Investment expenses	15	17	30	34
Net investment income	581	656	1,211	$ 1,370
Discontinued Operation, Equity Method Investment Retained after Disposal, Ownership Interest after Disposal				999%
Fixed maturities
Schedule of Investment Income, Reported Amounts, by Category [Line Items]
Gross investment income	495	497	974	$ 1,012
Investments in fixed maturities that did not produce net investment income	32		32		$ 0
Equity securities
Schedule of Investment Income, Reported Amounts, by Category [Line Items]
Gross investment income	5	6	9	11
Mortgage loans on real estate
Schedule of Investment Income, Reported Amounts, by Category [Line Items]
Gross investment income	60	64	119	125
Policy loans
Schedule of Investment Income, Reported Amounts, by Category [Line Items]
Gross investment income	5	5	11	11
Short-term investments and cash equivalents
Schedule of Investment Income, Reported Amounts, by Category [Line Items]
Gross investment income	2	4	3	5
Limited partnerships and other
Schedule of Investment Income, Reported Amounts, by Category [Line Items]
Gross investment income	$ 29	$ 97	$ 125	$ 240

Investments (excluding Conso_19

Investments (excluding Consolidated Investment Entities) - Net Realized Capital Gains (Losses) (Details) - USD ($) $ in Millions		3 Months Ended		6 Months Ended
	Jun. 01, 2021	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Gain (Loss) on Securities [Line Items]
Net realized capital gains (losses)		$ (227)	$ (37)	$ (512)	$ 1,705
Proceeds on sales		971	608	2,220	10,213
Gross gains		15	14	30	1,711
Gross losses		12	0	44	2
Fixed maturities
Gain (Loss) on Securities [Line Items]
Net realized capital gains (losses)		(2)	0	(6)	(5)
Product Guarantees [Member]
Gain (Loss) on Securities [Line Items]
Net realized capital gains (losses)		12	(9)	18	48
Other derivatives
Gain (Loss) on Securities [Line Items]
Net realized capital gains (losses)		32	(39)	126	(16)
Mortgage loans on real estate
Gain (Loss) on Securities [Line Items]
Net realized capital gains (losses)		1	25	5	163
Other investments
Gain (Loss) on Securities [Line Items]
Net realized capital gains (losses)		5	95	6	98
Fixed maturities, available-for-sale, including securities pledged
Gain (Loss) on Securities [Line Items]
Net realized capital gains (losses)		(6)	15	(79)	1,783
Fixed maturities, at fair value option
Gain (Loss) on Securities [Line Items]
Net realized capital gains (losses)		(245)	(129)	(550)	(377)
Equity securities, at fair value
Gain (Loss) on Securities [Line Items]
Net realized capital gains (losses)		$ (24)	$ 5	$ (32)	$ 11
Discontinued Operations
Gain (Loss) on Securities [Line Items]
Net realized capital gains (losses)	$ 95

Derivative Financial Instrume_3

Derivative Financial Instruments - Notional and Fair Values (Details) - USD ($) $ in Millions	Jun. 30, 2022	Dec. 31, 2021
Derivatives, Fair Value [Line Items]
Asset Fair Value	$ 304	$ 183
Liability Fair Value	377	475
Credit contracts
Derivatives, Fair Value [Line Items]
Notional Amount	179	135
Not Designated as Hedging Instrument | Credit contracts
Derivatives, Fair Value [Line Items]
Notional Amount	179	135
Not Designated as Hedging Instrument | Derivatives | Credit contracts
Derivatives, Fair Value [Line Items]
Asset Fair Value	0	1
Liability Fair Value	3	1
Foreign exchange contracts
Derivatives, Fair Value [Line Items]
Notional Amount	970	923
Foreign exchange contracts | Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Notional Amount	183	146
Foreign exchange contracts | Not Designated as Hedging Instrument | Derivatives
Derivatives, Fair Value [Line Items]
Asset Fair Value	4	1
Liability Fair Value	3	3
Foreign exchange contracts | Fair Value Hedging | Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Notional Amount	88	94
Foreign exchange contracts | Fair Value Hedging | Designated as Hedging Instrument | Derivatives
Derivatives, Fair Value [Line Items]
Asset Fair Value	3	2
Liability Fair Value	0	0
Foreign exchange contracts | Cash Flow Hedging | Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Notional Amount	699	683
Foreign exchange contracts | Cash Flow Hedging | Designated as Hedging Instrument | Derivatives
Derivatives, Fair Value [Line Items]
Asset Fair Value	62	16
Liability Fair Value	0	16
Interest rate contracts
Derivatives, Fair Value [Line Items]
Notional Amount	10,838	12,003
Interest rate contracts | Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Notional Amount	17,585	13,382
Interest rate contracts | Not Designated as Hedging Instrument | Derivatives
Derivatives, Fair Value [Line Items]
Asset Fair Value	207	147
Liability Fair Value	301	209
Interest rate contracts | Cash Flow Hedging | Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Notional Amount	22	22
Interest rate contracts | Cash Flow Hedging | Designated as Hedging Instrument | Derivatives
Derivatives, Fair Value [Line Items]
Asset Fair Value	0	0
Liability Fair Value	0	0
Equity contracts
Derivatives, Fair Value [Line Items]
Notional Amount	201	239
Equity contracts | Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Notional Amount	248	299
Equity contracts | Not Designated as Hedging Instrument | Derivatives
Derivatives, Fair Value [Line Items]
Asset Fair Value	1	4
Liability Fair Value	0	2
Fixed maturities | Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Asset Fair Value	6	12
Liability Fair Value	0	0
Within products(3) | Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Asset Fair Value	0	0
Liability Fair Value	25	47
Within reinsurance agreements(4) | Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Asset Fair Value	21	0
Liability Fair Value	41	196
Managed custody guarantees(3) | Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Asset Fair Value	0	0
Liability Fair Value	$ 4	$ 1

Derivative Financial Instrume_4

Derivative Financial Instruments - Offsetting Assets and Liabilities (Details) - USD ($) $ in Millions	Jun. 30, 2022	Dec. 31, 2021
Offsetting Assets and Liabilities [Line Items]
Asset Fair Value	$ 277	$ 171
Liability Fair Value	294	231
Counterparty netting, Assets	(208)	(156)
Counterparty netting, Liabilities	(208)	(156)
Cash collateral netting, Assets	(59)	(12)
Cash collateral netting, Liabilities	(81)	(70)
Securities collateral netting, Assets	(6)	(2)
Securities collateral netting, Liabilities	(1)	(2)
Net receivables/payables, Assets	4	1
Net receivables/payables, Liabilities	4	3
Equity contracts
Offsetting Assets and Liabilities [Line Items]
Notional Amount	201	239
Asset Fair Value	1	4
Liability Fair Value	0	2
Foreign exchange contracts
Offsetting Assets and Liabilities [Line Items]
Notional Amount	970	923
Asset Fair Value	69	19
Liability Fair Value	3	19
Interest rate contracts
Offsetting Assets and Liabilities [Line Items]
Notional Amount	10,838	12,003
Asset Fair Value	207	147
Liability Fair Value	288	209
Credit contracts
Offsetting Assets and Liabilities [Line Items]
Notional Amount	179	135
Asset Fair Value	0	1
Liability Fair Value	$ 3	$ 1

Derivative Financial Instrume_5

Derivative Financial Instruments - Collateral and Credit Default Swaps (Details) - USD ($) $ in Millions	Jun. 30, 2022	Dec. 31, 2021
Securities pledged as collateral
Derivatives, Fair Value [Line Items]
Securities held as collateral	$ 6	$ 2
Collateral Securities Repledged, Delivered, or Used	162	124
Over the counter | Cash collateral, included in Payables
Derivatives, Fair Value [Line Items]
Securities held as collateral	59	17
Cleared derivative contract | Cash collateral, included in Payables
Derivatives, Fair Value [Line Items]
Securities held as collateral	$ 82	$ 71

Derivative Financial Instrume_6

Derivative Financial Instruments - Net Realized Gains (Losses) (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Derivatives, Fair Value [Line Items]
Net investment income	$ 581	$ 656	$ 1,211	$ 1,370
Other net gains (losses)	(225)	(37)	(503)	1,705
Amount of Gain or (Loss) Recognized in Other Comprehensive Income	122	(73)	308	41
Interest rate contracts | Other Comprehensive Income (Loss) | Designated as Hedging Instrument | Cash Flow Hedging
Derivatives, Fair Value [Line Items]
Amount of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income	(1)	0	(2)	(1)
Interest rate contracts | Net investment income | Designated as Hedging Instrument | Cash Flow Hedging
Derivatives, Fair Value [Line Items]
Amount of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income	0	0	0	0
Foreign exchange contracts | Other Comprehensive Income (Loss) | Designated as Hedging Instrument | Cash Flow Hedging
Derivatives, Fair Value [Line Items]
Amount of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income	55	6	62	12
Foreign exchange contracts | Net investment income | Fair Value Hedging
Derivatives, Fair Value [Line Items]
Amount of Gain or (Loss) Recognized in Other Comprehensive Income	0	0	0	0
Foreign exchange contracts | Net investment income | Designated as Hedging Instrument | Cash Flow Hedging
Derivatives, Fair Value [Line Items]
Amount of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income	2	2	5	(1)
Amount of Gain or (Loss) Recognized in Other Comprehensive Income	2	2	5	4
Foreign exchange contracts | Net investment income | Designated as Hedging Instrument | Fair Value Hedging
Derivatives, Fair Value [Line Items]
Amount of Gain or (Loss) Recognized in Other Comprehensive Income	0	0	0	0
Foreign exchange contracts | Other net gains/(losses) | Fair Value Hedging
Derivatives, Fair Value [Line Items]
Amount of Gain or (Loss) Recognized in Other Comprehensive Income	(5)	(1)	(7)	(1)
Foreign exchange contracts | Other net gains/(losses) | Designated as Hedging Instrument | Cash Flow Hedging
Derivatives, Fair Value [Line Items]
Amount of Gain or (Loss) Recognized in Other Comprehensive Income	0	0	0	(5)
Foreign exchange contracts | Other net gains/(losses) | Designated as Hedging Instrument | Fair Value Hedging
Derivatives, Fair Value [Line Items]
Amount of Gain or (Loss) Recognized in Other Comprehensive Income	$ 6	$ 1	$ 8	$ 1

Derivative Financial Instrume_7

Derivative Financial Instruments - Effect of derivative qualified as hedge accounting (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	$ 122	$ (73)	$ 308	$ 41
Interest rate contracts | Other net gains/(losses) | Not Designated as Hedging Instrument
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	52	(48)	152	(23)
Foreign exchange contracts | Other net gains/(losses) | Not Designated as Hedging Instrument
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	(1)	(2)	(2)	(2)
Equity contracts | Other net gains/(losses) | Not Designated as Hedging Instrument
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	(20)	9	(28)	12
Fixed maturities | Other net gains/(losses)
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	(2)	0	(6)	(5)
Within products(3) | Other net gains/(losses)
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	12	(4)	22	31
Embedded derivative on reinsurance | Level 3 | Measured at fair value on a recurring basis
Derivative Instruments, Gain (Loss) [Line Items]
Total Realized/Unrealized Gains (Losses) Included in Net income	0	3	1	4
Fair Value, Assets and Liabilities Measured on Recurring Basis, Gain (Loss) Included in Earnings			1	0
Embedded derivative on reinsurance | Policyholder Benefits
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	84	(29)	176	23
Managed custody guarantees(3) | Other net gains/(losses)
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	1	0	(2)	4
Credit contracts | Other net gains/(losses) | Not Designated as Hedging Instrument
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	$ (4)	$ 1	$ (4)	$ 1

Fair Value Measurements (excl_3

Fair Value Measurements (excluding Consolidated Investment Entities) - Fair Value Measurement (Details) - USD ($) $ in Millions	Jun. 30, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets held in separate accounts	$ 80,017	$ 100,433
Total assets	147,520	171,262
Derivatives	307	231
Total liabilities	141,307	161,441
U.S. Treasuries
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	884	1,003
U.S. Government agencies and authorities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	63	81
State, municipalities and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	928	1,111
U.S. corporate public securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	9,541	11,941
U.S. corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	4,742	5,325
Foreign corporate public securities and foreign governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	3,057	3,723
Foreign corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	3,222	3,501
Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	4,183	4,302
Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	4,042	4,183
Other asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	2,004	2,081
Measured at fair value on a recurring basis
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	32,666	37,251
Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements	2,113	2,607
Assets held in separate accounts	80,017	100,433
Total assets	$ 115,328	$ 140,702
Percentage of Level to total	100%	100%
Total liabilities	$ 377	$ 475
Measured at fair value on a recurring basis | Guaranteed benefit derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	29	48
Measured at fair value on a recurring basis | Interest rate contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	207	147
Derivatives	301	209
Measured at fair value on a recurring basis | Foreign exchange contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	69	19
Derivatives	3	19
Measured at fair value on a recurring basis | Equity contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	1	4
Derivatives		2
Measured at fair value on a recurring basis | Embedded derivative on reinsurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	21
Derivatives	41	196
Measured at fair value on a recurring basis | Credit contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives		1
Derivatives	3	1
Measured at fair value on a recurring basis | U.S. Treasuries
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	884	1,003
Measured at fair value on a recurring basis | U.S. Government agencies and authorities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	63	81
Measured at fair value on a recurring basis | State, municipalities and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	928	1,111
Measured at fair value on a recurring basis | U.S. corporate public securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	9,541	11,941
Measured at fair value on a recurring basis | U.S. corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	4,742	5,325
Measured at fair value on a recurring basis | Foreign corporate public securities and foreign governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	3,057	3,723
Measured at fair value on a recurring basis | Foreign corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	3,222	3,501
Measured at fair value on a recurring basis | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	4,183	4,302
Measured at fair value on a recurring basis | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	4,042	4,183
Measured at fair value on a recurring basis | Other asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	2,004	2,081
Measured at fair value on a recurring basis | Equity securities, at fair value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity securities	234	240
Measured at fair value on a recurring basis | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	653	745
Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements	2,106	2,525
Assets held in separate accounts	74,144	94,943
Total assets	$ 76,926	$ 98,250
Percentage of Level to total	67%	70%
Total liabilities	$ 13	$ 0
Measured at fair value on a recurring basis | Level 1 | Guaranteed benefit derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	0	0
Measured at fair value on a recurring basis | Level 1 | Interest rate contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Derivatives	13	0
Measured at fair value on a recurring basis | Level 1 | Foreign exchange contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Derivatives	0	0
Measured at fair value on a recurring basis | Level 1 | Equity contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Derivatives		0
Measured at fair value on a recurring basis | Level 1 | Embedded derivative on reinsurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0
Derivatives	0	0
Measured at fair value on a recurring basis | Level 1 | Credit contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives		0
Derivatives	0	0
Measured at fair value on a recurring basis | Level 1 | U.S. Treasuries
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	653	745
Measured at fair value on a recurring basis | Level 1 | U.S. Government agencies and authorities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 1 | State, municipalities and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 1 | U.S. corporate public securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 1 | U.S. corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 1 | Foreign corporate public securities and foreign governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 1 | Foreign corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 1 | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 1 | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 1 | Other asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 1 | Equity securities, at fair value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity securities	23	37
Measured at fair value on a recurring basis | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	29,713	34,140
Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements	7	82
Assets held in separate accounts	5,524	5,174
Total assets	$ 35,550	$ 39,567
Percentage of Level to total	31%	28%
Total liabilities	$ 249	$ 340
Measured at fair value on a recurring basis | Level 2 | Guaranteed benefit derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	0	0
Measured at fair value on a recurring basis | Level 2 | Interest rate contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	207	147
Derivatives	288	209
Measured at fair value on a recurring basis | Level 2 | Foreign exchange contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	69	19
Derivatives	3	19
Measured at fair value on a recurring basis | Level 2 | Equity contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	1	4
Derivatives		2
Measured at fair value on a recurring basis | Level 2 | Embedded derivative on reinsurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	21
Derivatives	(45)	109
Measured at fair value on a recurring basis | Level 2 | Credit contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives		1
Derivatives	3	1
Measured at fair value on a recurring basis | Level 2 | U.S. Treasuries
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	231	258
Measured at fair value on a recurring basis | Level 2 | U.S. Government agencies and authorities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	63	81
Measured at fair value on a recurring basis | Level 2 | State, municipalities and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	928	1,111
Measured at fair value on a recurring basis | Level 2 | U.S. corporate public securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	9,522	11,925
Measured at fair value on a recurring basis | Level 2 | U.S. corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	2,962	3,415
Measured at fair value on a recurring basis | Level 2 | Foreign corporate public securities and foreign governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	3,053	3,723
Measured at fair value on a recurring basis | Level 2 | Foreign corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	2,819	3,148
Measured at fair value on a recurring basis | Level 2 | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	4,152	4,259
Measured at fair value on a recurring basis | Level 2 | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	4,042	4,183
Measured at fair value on a recurring basis | Level 2 | Other asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	1,941	2,037
Measured at fair value on a recurring basis | Level 2 | Equity securities, at fair value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity securities	8	0
Measured at fair value on a recurring basis | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	2,300	2,366
Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements	0	0
Assets held in separate accounts	349	316
Total assets	$ 2,852	$ 2,885
Percentage of Level to total	2%	2%
Total liabilities	$ 115	$ 135
Measured at fair value on a recurring basis | Level 3 | Guaranteed benefit derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	29	48
Measured at fair value on a recurring basis | Level 3 | Interest rate contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Derivatives	0	0
Measured at fair value on a recurring basis | Level 3 | Foreign exchange contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Derivatives	0	0
Measured at fair value on a recurring basis | Level 3 | Equity contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Derivatives		0
Measured at fair value on a recurring basis | Level 3 | Embedded derivative on reinsurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0
Derivatives	86	87
Measured at fair value on a recurring basis | Level 3 | Credit contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives		0
Derivatives	0	0
Measured at fair value on a recurring basis | Level 3 | U.S. Treasuries
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 3 | U.S. Government agencies and authorities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 3 | State, municipalities and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 3 | U.S. corporate public securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	19	16
Measured at fair value on a recurring basis | Level 3 | U.S. corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	1,780	1,910
Measured at fair value on a recurring basis | Level 3 | Foreign corporate public securities and foreign governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	4	0
Measured at fair value on a recurring basis | Level 3 | Foreign corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	403	353
Measured at fair value on a recurring basis | Level 3 | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	31	43
Measured at fair value on a recurring basis | Level 3 | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 3 | Other asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	63	44
Measured at fair value on a recurring basis | Level 3 | Equity securities, at fair value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity securities	$ 203	$ 203

Fair Value Measurements (excl_4

Fair Value Measurements (excluding Consolidated Investment Entities) - Level 3 Financial Instruments (Details) - Measured at fair value on a recurring basis - Level 3 - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Assets held in separate accounts
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance	$ 334	$ 237	$ 316	$ 222
Total Realized/Unrealized Gains (Losses) Included in Net income	(12)	2	(26)	3
Total Realized/Unrealized Gains (Losses) Included in OCI	0	0	0	0
Purchases	67	71	132	104
Issuances	0	0	0	0
Sales	(3)	0	(4)	(1)
Settlements	0	0	0	0
Transfers in to Level 3	0	0	6	0
Transfers out of Level 3	(37)	(17)	(75)	(35)
Fair Value, Assets, ending balance	349	293	349	293
Change In Unrealized Gains (Losses) Included in Earnings	0	0	0	0
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI			0
Change In Unrealized Gains (Losses) Included in OCI	0	0		0
Other derivatives
Derivatives Rollforward:
Fair Value, Derivatives, beginning balance				1
Total Realized/Unrealized Gains (Losses) Included in Net income				0
Total Realized/Unrealized Gains (Losses) Included in OCI				0
Purchases				0
Issuances				0
Sales				0
Settlements				(1)
Transfers in to Level 3				0
Transfers out of Level 3				0
Fair Value, Derivatives, ending balance		0		0
Change In Unrealized Gains (Losses) Included in Earnings				(1)
Change In Unrealized Gains (Losses) Included in OCI				0
Embedded derivative on reinsurance
Derivatives Rollforward:
Fair Value, Derivatives, beginning balance	(86)	(88)	(87)	0
Total Realized/Unrealized Gains (Losses) Included in Net income	0	3	1	4
Total Realized/Unrealized Gains (Losses) Included in OCI	0	0	0	0
Purchases	0	0	0	0
Issuances	0	0	0	(89)
Sales	0	0	0	0
Settlements	0	0	0	0
Transfers in to Level 3	0	0	0	0
Transfers out of Level 3	0	0	0	0
Fair Value, Derivatives, ending balance	(86)	(85)	(86)	(85)
Change In Unrealized Gains (Losses) Included in Earnings	0	0	0	0
Change In Unrealized Gains (Losses) Included in OCI	0	0	0	0
Cash and cash equivalents
Derivatives Rollforward:
Fair Value, Derivatives, beginning balance	8		0
Total Realized/Unrealized Gains (Losses) Included in Net income	0		0
Total Realized/Unrealized Gains (Losses) Included in OCI	0		0
Purchases	0		8
Issuances	0		0
Sales	0		0
Settlements	8		8
Transfers in to Level 3	0		0
Transfers out of Level 3	0		0
Fair Value, Derivatives, ending balance	0		0
Change In Unrealized Gains (Losses) Included in Earnings	0		0
Change In Unrealized Gains (Losses) Included in OCI	0		0
Guaranteed benefit derivatives
Derivatives Rollforward:
Fair Value, Derivatives, beginning balance	(42)	(26)	(48)	(84)
Total Realized/Unrealized Gains (Losses) Included in Net income	13	(19)	20	38
Total Realized/Unrealized Gains (Losses) Included in OCI	0	0	0	0
Purchases	0	0	0	0
Issuances	0	0	(1)	0
Sales	0	0	0	0
Settlements	0	1	0	2
Transfers in to Level 3	0	0	0	0
Transfers out of Level 3	0	0	0	0
Fair Value, Derivatives, ending balance	(29)	(44)	(29)	(44)
Change In Unrealized Gains (Losses) Included in Earnings	0	0	0	0
Change In Unrealized Gains (Losses) Included in OCI		0	0	0
U.S. corporate public securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance		60		93
Total Realized/Unrealized Gains (Losses) Included in Net income		0		1
Total Realized/Unrealized Gains (Losses) Included in OCI		1		0
Purchases		0		0
Issuances		0		0
Sales		0		(25)
Settlements		(1)		(1)
Transfers in to Level 3		0		0
Transfers out of Level 3		(37)		(45)
Fair Value, Assets, ending balance		23		23
Change In Unrealized Gains (Losses) Included in Earnings		0		0
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI		5		0
U.S. corporate public securities | Available-for-sale Securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance	71		16
Total Realized/Unrealized Gains (Losses) Included in Net income	0		0
Total Realized/Unrealized Gains (Losses) Included in OCI	(1)		(1)
Purchases	1		5
Issuances	0		0
Sales	0		0
Settlements	0		0
Transfers in to Level 3	0		0
Transfers out of Level 3	(52)		(1)
Fair Value, Assets, ending balance	19		19
Change In Unrealized Gains (Losses) Included in Earnings	0		0
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	(1)		(1)
U.S. corporate private securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance		1,584		1,900
Total Realized/Unrealized Gains (Losses) Included in Net income		1		51
Total Realized/Unrealized Gains (Losses) Included in OCI		40		(96)
Purchases		23		77
Issuances		0		0
Sales		0		(328)
Settlements		(93)		(137)
Transfers in to Level 3		504		621
Transfers out of Level 3		(48)		(77)
Fair Value, Assets, ending balance		2,011		2,011
Change In Unrealized Gains (Losses) Included in Earnings		0		(1)
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI		(2)		(96)
U.S. corporate private securities | Available-for-sale Securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance	1,925		1,910
Total Realized/Unrealized Gains (Losses) Included in Net income	(1)		(2)
Total Realized/Unrealized Gains (Losses) Included in OCI	(134)		(277)
Purchases	89		158
Issuances	0		0
Sales	0		0
Settlements	(58)		(120)
Transfers in to Level 3	0		121
Transfers out of Level 3	(41)		(10)
Fair Value, Assets, ending balance	1,780		1,780
Change In Unrealized Gains (Losses) Included in Earnings	(1)		(2)
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	(133)		(276)
Foreign corporate public securities and foreign governments
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance		7		0
Total Realized/Unrealized Gains (Losses) Included in Net income		0		0
Total Realized/Unrealized Gains (Losses) Included in OCI		0		0
Purchases		10		10
Issuances		0		0
Sales		0		0
Settlements		0		0
Transfers in to Level 3		0		0
Transfers out of Level 3		(7)		0
Fair Value, Assets, ending balance		10		10
Change In Unrealized Gains (Losses) Included in Earnings		0		0
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI		0		0
Foreign corporate public securities and foreign governments | Available-for-sale Securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance	11		0
Total Realized/Unrealized Gains (Losses) Included in Net income	0		0
Total Realized/Unrealized Gains (Losses) Included in OCI	0		0
Purchases	4		4
Issuances	0		0
Sales	0		0
Settlements	0		0
Transfers in to Level 3	0		0
Transfers out of Level 3	(11)		0
Fair Value, Assets, ending balance	4		4
Change In Unrealized Gains (Losses) Included in Earnings	0		0
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	0		0
Foreign corporate private securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance		380		457
Total Realized/Unrealized Gains (Losses) Included in Net income		1		9
Total Realized/Unrealized Gains (Losses) Included in OCI		8		(2)
Purchases		1		1
Issuances		0		0
Sales		(34)		(81)
Settlements		(4)		(32)
Transfers in to Level 3		0		0
Transfers out of Level 3		0		0
Fair Value, Assets, ending balance		352		352
Change In Unrealized Gains (Losses) Included in Earnings		1		2
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI		5		(5)
Foreign corporate private securities | Available-for-sale Securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance	496		353
Total Realized/Unrealized Gains (Losses) Included in Net income	(3)		(22)
Total Realized/Unrealized Gains (Losses) Included in OCI	(7)		(31)
Purchases	51		97
Issuances	0		0
Sales	0		0
Settlements	(15)		(28)
Transfers in to Level 3	0		148
Transfers out of Level 3	(119)		(114)
Fair Value, Assets, ending balance	403		403
Change In Unrealized Gains (Losses) Included in Earnings	(4)		(4)
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	(7)		(31)
Residential mortgage-backed securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance		47		43
Total Realized/Unrealized Gains (Losses) Included in Net income		(4)		(7)
Total Realized/Unrealized Gains (Losses) Included in OCI		0		0
Purchases		12		15
Issuances		0		0
Sales		0		(7)
Settlements		0		0
Transfers in to Level 3		3		2
Transfers out of Level 3		(12)		0
Fair Value, Assets, ending balance		46		46
Change In Unrealized Gains (Losses) Included in Earnings		(4)		(7)
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI		0		0
Residential mortgage-backed securities | Available-for-sale Securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance	45		43
Total Realized/Unrealized Gains (Losses) Included in Net income	(6)		(15)
Total Realized/Unrealized Gains (Losses) Included in OCI	0		0
Purchases	2		4
Issuances	0		0
Sales	0		0
Settlements	(9)		0
Transfers in to Level 3	1		1
Transfers out of Level 3	(2)		(2)
Fair Value, Assets, ending balance	31		31
Change In Unrealized Gains (Losses) Included in Earnings	(6)		(15)
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	0		0
Commercial mortgage-backed securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance		0		0
Total Realized/Unrealized Gains (Losses) Included in Net income		0		0
Total Realized/Unrealized Gains (Losses) Included in OCI		0		0
Purchases		2		1
Issuances		0		0
Sales		0		(1)
Settlements		0		(4)
Transfers in to Level 3		0		6
Transfers out of Level 3		0		0
Fair Value, Assets, ending balance		2		2
Change In Unrealized Gains (Losses) Included in Earnings		0		0
Commercial mortgage-backed securities | Available-for-sale Securities
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI		0
Asset-backed Securities [Member]
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance		69		61
Total Realized/Unrealized Gains (Losses) Included in Net income		0		0
Total Realized/Unrealized Gains (Losses) Included in OCI		0		(2)
Purchases		15		22
Issuances		0		0
Sales		0		(4)
Settlements		(7)		(22)
Transfers in to Level 3		1		23
Transfers out of Level 3		0		0
Fair Value, Assets, ending balance		78		78
Change In Unrealized Gains (Losses) Included in Earnings		0		0
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI		0		(2)
Asset-backed Securities [Member] | Available-for-sale Securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance	49		44
Total Realized/Unrealized Gains (Losses) Included in Net income	0		0
Total Realized/Unrealized Gains (Losses) Included in OCI	(2)		(4)
Purchases	35		39
Issuances	0		0
Sales	0		(10)
Settlements	(5)		(6)
Transfers in to Level 3	0		0
Transfers out of Level 3	(14)		0
Fair Value, Assets, ending balance	63		63
Change In Unrealized Gains (Losses) Included in Earnings	0		0
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	(2)		(4)
Fixed maturities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance		2,147		2,554
Total Realized/Unrealized Gains (Losses) Included in Net income		(2)		54
Total Realized/Unrealized Gains (Losses) Included in OCI		49		(100)
Purchases		63		126
Issuances		0		0
Sales		(34)		(446)
Settlements		(105)		(196)
Transfers in to Level 3		508		652
Transfers out of Level 3		(104)		(122)
Fair Value, Assets, ending balance		2,522		2,522
Change In Unrealized Gains (Losses) Included in Earnings		(3)		(6)
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI		8		(103)
Fixed maturities | Available-for-sale Securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance	2,597		2,366
Total Realized/Unrealized Gains (Losses) Included in Net income	(10)		(39)
Total Realized/Unrealized Gains (Losses) Included in OCI	(144)		(313)
Purchases	182		307
Issuances	0		0
Sales	0		(10)
Settlements	(87)		(154)
Transfers in to Level 3	1		270
Transfers out of Level 3	(239)		(127)
Fair Value, Assets, ending balance	2,300		2,300
Change In Unrealized Gains (Losses) Included in Earnings	(11)		(21)
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	(143)		(312)
Equity securities, at fair value
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance	203	257	203	172
Total Realized/Unrealized Gains (Losses) Included in Net income	(17)	3	(26)	13
Total Realized/Unrealized Gains (Losses) Included in OCI	0	0	0	0
Purchases	26	0	26	225
Issuances	0	0	0	0
Sales	0	(11)	0	(152)
Settlements	0	0	0	(9)
Transfers in to Level 3	0	0	0	0
Transfers out of Level 3	(9)	0	0	0
Fair Value, Assets, ending balance	203	249	203	249
Change In Unrealized Gains (Losses) Included in Earnings	(17)	3	(26)	(2)
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	$ 0	0	$ 0	0
Fixed Maturities, Trading
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance		0		0
Total Realized/Unrealized Gains (Losses) Included in Net income		0		0
Total Realized/Unrealized Gains (Losses) Included in OCI		0		0
Purchases		45		45
Issuances		0		0
Sales		0		0
Settlements		0		0
Transfers in to Level 3		0		0
Transfers out of Level 3		0		0
Fair Value, Assets, ending balance		45		45
Change In Unrealized Gains (Losses) Included in Earnings		0		0
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI		$ 0		$ 0

Fair Value Measurements (excl_5

Fair Value Measurements (excluding Consolidated Investment Entities) - Other Financial Instruments (Details) - USD ($) $ in Millions	Jun. 30, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets held in separate accounts	$ 80,017	$ 100,433
Derivatives	307	231
Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	32,666	37,251
Equity securities	234	240
Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements	2,113	2,607
Derivatives	277	171
Other investments	76	79
Assets held in separate accounts	80,017	100,433
Short-term debt	1	1
Long-term debt	2,385	2,595
Carrying Value | Other derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	307	231
Carrying Value | Embedded derivative on reinsurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Embedded Derivatives	21	0
Embedded Derivative, Fair Value of Embedded Derivative Liability	41	196
Carrying Value | Funding agreements without fixed maturities and deferred annuities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	36,125	35,334
Carrying Value | Funding agreements with fixed maturities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	1,462	1,460
Carrying Value | Supplementary contracts, immediate annuities and other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	791	829
Carrying Value | Guaranteed benefit derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	29	48
Carrying Value | Mortgage loans on real estate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans Receivable, Fair Value Disclosure	5,415	5,627
Carrying Value | Policy loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans Receivable, Fair Value Disclosure	373	392
Estimate of Fair Value Measurement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	32,666	37,251
Equity securities	234	240
Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements	2,113	2,607
Derivatives	277	171
Other investments	76	79
Assets held in separate accounts	80,017	100,433
Short-term debt	1	1
Long-term debt	2,316	2,991
Estimate of Fair Value Measurement | Other derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	307	231
Estimate of Fair Value Measurement | Embedded derivative on reinsurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Embedded Derivatives	21	0
Embedded Derivative, Fair Value of Embedded Derivative Liability	41	196
Estimate of Fair Value Measurement | Funding agreements without fixed maturities and deferred annuities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	37,982	43,407
Estimate of Fair Value Measurement | Funding agreements with fixed maturities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	1,457	1,461
Estimate of Fair Value Measurement | Supplementary contracts, immediate annuities and other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	653	775
Estimate of Fair Value Measurement | Guaranteed benefit derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	29	48
Estimate of Fair Value Measurement | Mortgage loans on real estate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans Receivable, Fair Value Disclosure	5,239	5,982
Estimate of Fair Value Measurement | Policy loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans Receivable, Fair Value Disclosure	$ 373	$ 392

Deferred Policy Acquisition C_3

Deferred Policy Acquisition Costs and Value of Business Acquired - DAC and VOBA Activity (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Beginning balance			$ 1,217	$ 1,440
Deferrals of commissions and expenses			56	50
Amortization:
Amortization, excluding unlocking			(116)	(479)
Unlocking			(41)	(9)
Interest accrued			49	56
Net amortization included in the Consolidated Statements of Operations			(108)	(432)
Change due to unrealized capital gains/losses on available-for-sale securities			700	181
Ending balance	$ 1,865	$ 1,239	1,865	1,239
Movement Analysis Of Value of Business Acquired VOBA [Roll Forward]
Beginning balance			161	70
Deferrals of commissions and expenses			3	3
Amortization:
Amortization, excluding unlocking			(10)	(158)
Unlocking			(45)	7
Interest accrued			16	18
Net amortization included in Condensed Consolidated Statements of Operations			(39)	(133)
Change due to unrealized capital gains/(losses) on available-for-sale securities			490	267
Ending balance	615	207	615	207
Movement Analysis of Deferred Policy Acquisition Costs and Value of Business Acquired (VOBA) [Roll Forward]
Beginning balance			1,378	1,510
Deferrals of commissions and expenses			59	53
Amortization:
Amortization, excluding unlocking			(126)	(637)
Unlocking			(86)	(2)
Interest accrued			65	74
Net amortization included in Condensed Consolidated Statements of Operations	(67)	(26)	(147)	(565)
Change due to unrealized capital gains/(losses) on available-for-sale securities			1,190	448
Ending balance	$ 2,480	$ 1,446	2,480	$ 1,446
Deferred Policy Acquisition Costs, Impairment Loss			301
Present Value of Future Insurance Profits, Impairment Loss			$ 1
Minimum
Amortization:
Value of Business Acquired (VOBA), Interest accrued percentage			3.50%
Maximum
Amortization:
Value of Business Acquired (VOBA), Interest accrued percentage			7.20%

Share-based Incentive Compens_3

Share-based Incentive Compensation Plans - Narrative (Details)	Jun. 30, 2022 shares
2013 Omnibus Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for grant (in shares)	347,663
2014 Omnibus Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for grant (in shares)	3,027,864
2019 Omnibus Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for grant (in shares)	8,028,432

Share-based Incentive Compens_4

Share-based Incentive Compensation Plans - Compensation Cost (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost	$ 15	$ 20	$ 61	$ 57
Income tax benefit	3	4	18	15
After-tax share-based compensation expense	12	16	43	42
Restricted Stock Unit (RSU) awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost	8	8	30	26
Performance Stock Unit (PSU) awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost	7	11	31	30
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost	$ 0	$ 1	$ 0	$ 1

Share-based Incentive Compens_5

Share-based Incentive Compensation Plans - Awards Outstanding (Details)	6 Months Ended
	Jun. 30, 2022 $ / shares shares
RSU awards
Number of Awards
Outstanding, beginning balance (in shares) | shares	1,400,000
Adjustment for PSU performance factor (in shares) | shares	0
Granted (in shares) | shares	700,000
Vested (in shares) | shares	(700,000)
Forfeited (in shares) | shares	0
Outstanding, ending balance (in shares) | shares	1,400,000
Weighted Average Grant Date Fair Value
Outstanding, beginning balance (usd per share) | $ / shares	$ 57.53
Adjustment for PSU performance factor (usd per share) | $ / shares	0
Granted (usd per share) | $ / shares	66.03
Vested (usd per share) | $ / shares	56.62
Forfeited (usd per share) | $ / shares	60.87
Outstanding, ending balance (usd per share) | $ / shares	$ 62.18
PSU awards
Number of Awards
Outstanding, beginning balance (in shares) | shares	2,000,000
Adjustment for PSU performance factor (in shares) | shares	200,000
Granted (in shares) | shares	600,000
Vested (in shares) | shares	(900,000)
Forfeited (in shares) | shares	0
Outstanding, ending balance (in shares) | shares	1,900,000
Weighted Average Grant Date Fair Value
Outstanding, beginning balance (usd per share) | $ / shares	$ 54.05
Adjustment for PSU performance factor (usd per share) | $ / shares	59.13
Granted (usd per share) | $ / shares	66.32
Vested (usd per share) | $ / shares	51.34
Forfeited (usd per share) | $ / shares	58.14
Outstanding, ending balance (usd per share) | $ / shares	$ 58.85
Stock options
Number of Awards
Outstanding, beginning balance (in shares) | shares	1,800,000
Granted (in shares) | shares	0
Exercised (in shares) | shares	(100,000)
Forfeited (in shares) | shares	0
Outstanding, ending balance (in shares) | shares	1,700,000
Vested, exercisable (in shares) | shares	1,700,000
Weighted Average Exercise Price
Outstanding, beginning balance (usd per share) | $ / shares	$ 42.91
Granted (usd per share) | $ / shares	0
Exercised (usd per share) | $ / shares	39.91
Forfeited (usd per share) | $ / shares	0
Outstanding, ending balance (usd per share) | $ / shares	43.15
Vested, exercisable, weighted average exercise price (usd per share) | $ / shares	$ 43.15

Shareholders' Equity - Common S

Shareholders' Equity - Common Stock Rollforward (Details) - shares				6 Months Ended	9 Months Ended
	May 11, 2022	Mar. 31, 2022	Jun. 30, 2021	Jun. 30, 2022	Sep. 30, 2021
Increase (Decrease) in Stockholders' Equity
Common stock, shares issued, beginning balance (in shares)				108,987,650
Common shares, beginning balance (in shares)				107,758,376
Common stock acquired - share repurchase (in shares)	890,112	3,305,786	3,382,950	10,900,000	17,900,000
Share-based compensation programs (in shares)				1,000,000	1,400,000
Treasury Stock retirement (in shares)					0
Common stock, shares issued, ending balance (in shares)				110,634,763
Common shares, ending balance (in shares)				97,912,907
Common Stock
Increase (Decrease) in Stockholders' Equity
Common stock, shares issued, beginning balance (in shares)				109,000,000	143,300,000
Common shares, beginning balance (in shares)				107,800,000	124,200,000
Common shares issued (in shares)				0	100,000
Common stock acquired - share repurchase (in shares)				0	0
Share-based compensation programs (in shares)				1,600,000	2,400,000
Treasury Stock retirement (in shares)					(36,800,000)
Common stock, shares issued, ending balance (in shares)				110,600,000
Treasury Stock
Increase (Decrease) in Stockholders' Equity
Common shares, held in treasury, beginning balance (in shares)				(1,200,000)	(19,100,000)
Common shares issued (in shares)				0	0
Common stock acquired - share repurchase (in shares)				10,900,000	17,900,000
Share-based compensation programs (in shares)				600,000	1,000,000
Treasury Stock retirement (in shares)					(36,800,000)
Common shares, held in treasury, ending balance (in shares)				12,700,000

Shareholders' Equity - Common_2

Shareholders' Equity - Common stock Dividends Declared (Details) - $ / shares	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Equity [Abstract]
Dividends declared per share of Common Stock (usd per share)	$ 0.20	$ 0.165	$ 0.40	$ 0.33

Shareholders' Equity - Summary

Shareholders' Equity - Summary of Share Repurchases (Details) - USD ($) $ in Millions				3 Months Ended		6 Months Ended		9 Months Ended
	May 11, 2022	Mar. 31, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Sep. 30, 2021
Equity [Abstract]
Payment for share repurchases		$ 275	$ 250	$ 250	$ 548	$ 750	$ 803
Common stock acquired - share repurchase (in shares)	890,112	3,305,786	3,382,950			10,900,000		17,900,000
Number of shares authorized to be repurchased (in shares)	4,195,898

Shareholders' Equity - Narrativ

Shareholders' Equity - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions			6 Months Ended
	Mar. 29, 2021	May 07, 2013	Jun. 30, 2022	Dec. 31, 2021
Equity [Abstract]
Number of warrants issued and outstanding (in shares)		26,050,846
Warrants issued allowing purchase of shares, percentage of common stock issued and outstanding		9.99%
Exercise price of warrants (usd per share)	$ 47.21	$ 48.75
Cash dividends, per share (usd per share)	$ 0.20	$ 0.01
Warrants net share settled, fair value		$ 94
Number of shares of common stock for which each warrant is exercisable (in shares)	1.032523411
Number of warrants exercised (in shares)			0
Preferred Stock, shares authorized (in shares)			100,000,000	100,000,000
Preferred Stock, amount of preferred dividends in arrears			$ 0
Amount authorized for repurchase			$ 500

Shareholders' Equity - Preferre

Shareholders' Equity - Preferred Stock (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Class of Stock [Line Items]
Aggregate (in shares)	$ 4	$ 4	$ 18	$ 18
Preferred Stock
Class of Stock [Line Items]
Preferred Stock, shares issued (in shares)	625,000		625,000		625,000
Preferred Stock, shares outstanding (in shares)	625,000		625,000		625,000
Aggregate (in shares)	$ 0	$ 0	$ 0	$ 0
Series A Preferred Stock
Class of Stock [Line Items]
Dividend rate, percentage			0.06125%
Preferred Stock, shares issued (in shares)	325,000		325,000		325,000
Preferred Stock, shares outstanding (in shares)	325,000		325,000		325,000
Per Share (usd per share)	$ 0	$ 0	$ 30.625	$ 30.625
Aggregate (in shares)	$ 0	$ 0	$ 10	$ 10
Series B Preferred Stock
Class of Stock [Line Items]
Dividend rate, percentage			0.0535%
Preferred Stock, shares issued (in shares)	300,000		300,000		300,000
Preferred Stock, shares outstanding (in shares)	300,000		300,000		300,000
Per Share (usd per share)	$ 13.375	$ 13.375	$ 26.750	$ 26.750
Aggregate (in shares)	$ 4	$ 4	$ 8	$ 8

Earnings per Common Share (Deta

Earnings per Common Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Net income (loss) available to common shareholders:
Income (loss) from continuing operations	$ 143	$ 916	$ 227	$ 2,002
Less: Preferred stock dividends	4	4	18	18
Less: Net income (loss) attributable to noncontrolling interest	75	447	118	447
Income (loss) from continuing operations available to common shareholders	64	465	91	1,537
Income (loss) from discontinued operations, net of tax	0	(6)	0	8
Net income (loss) available to common shareholders	$ 64	$ 459	$ 91	$ 1,545
Weighted average common shares outstanding
Basic (in shares)	101.7	120.6	103.9	121.6
Dilutive Effects:
Diluted (in shares)	110.8	130.2	113.9	130.5
Basic
Income (loss) from continuing operations available to Voya Financial, Inc.'s common shareholders (usd per share)	$ 0.62	$ 3.86	$ 0.88	$ 12.64
Income (loss) from discontinued operations, net of taxes available to Voya Financial, Inc.'s common shareholders (usd per share)	0	(0.05)	0	0.06
Income (loss) available to Voya Financial, Inc.'s common shareholders (usd per share)	0.62	3.81	0.88	12.71
Diluted
Income (loss) from continuing operations available to Voya Financial, Inc.'s common shareholders (usd per share)	0.57	3.58	0.80	11.78
Income (loss) from discontinued operations, net of taxes available to Voya Financial, Inc.'s common shareholders (usd per share)	0	(0.04)	0	0.06
Income (loss) available to Voya Financial, Inc.'s common shareholders (usd per share)	$ 0.57	$ 3.53	$ 0.80	$ 11.84
Warrant
Dilutive Effects:
Dilutive Effects (in shares)	7.1	7.3	7.7	6.3
RSU awards
Dilutive Effects:
Dilutive Effects (in shares)	0.8	0.9	0.9	1
PSU awards
Dilutive Effects:
Dilutive Effects (in shares)	0.6	0.7	0.8	0.9
Stock options
Dilutive Effects:
Dilutive Effects (in shares)	0.6	0.7	0.6	0.7

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Income (Loss) - Components of AOCI (Details) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]
Fixed maturities, net of impairment	$ (1,926)	$ 3,739
Derivatives	129	63
DAC/VOBA adjustment on available-for-sale securities(2)	422	(877)
Premium deficiency reserve adjustment(2)	0	(15)
Other intangibles adjustment on available-for-sale securities(2)	(4)	5
Other		2
Unrealized capital gains (losses), before tax	(1,379)	2,917
Deferred income tax asset (liability)	413	(490)
Net unrealized capital gains (losses)	(966)	2,427
Pension and other postretirement benefits liability, net of tax	3	4
AOCI	(963)	$ 2,431	$ 2,100
Other Contract
Accumulated Other Comprehensive Income (Loss) [Line Items]
Portion of AOCI expected to be reclassified into earnings within next 12 months	$ 20

Accumulated Other Comprehensi_4

Accumulated Other Comprehensive Income (Loss) - Changes in AOCI, including Reclassification Adjustments (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Available-for-sale securities, Before-Tax Amount:
Fixed maturities	$ (2,548)	$ 826	$ (5,211)	$ (3,099)
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, before Tax	20	(2)	90	(1,775)
Other Comprehensive Income (Loss), Deferred Acquisition Costs and Value Of Business Acquired (VOBA), Available-for-Sale Securities Adjustment, before Tax	593	(15)	1,190	1,194
Premium deficiency reserve	5	(149)	14	445
Sales inducements and other intangibles	(5)	(1)	(9)	419
Change in unrealized gains/losses on available-for-sale securities	(1,935)	659	(3,926)	(2,816)
Available-for-sale securities, Income Tax:
Fixed maturities	535	(173)	1,094	420
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Tax	(4)	0	(19)	373
DAC/VOBA	(125)	3	(250)	(251)
Premium deficiency reserve	(1)	31	(3)	(93)
Sales inducements and other intangibles	1	1	2	(88)
Change in unrealized gains/losses on available-for-sale securities	406	(138)	824	361
Available-for-sale securities, After-Tax Amount:
Fixed maturities	(2,013)	653	(4,117)	(2,679)
Adjustments for amounts recognized in Net realized capital gains (losses) in the Condensed Consolidated Statements of Operations	16	(2)	71	(1,402)
DAC/VOBA	468	(12)	940	943
Premium deficiency reserve	4	(118)	11	352
Sales inducements and other intangibles	(4)	0	(7)	331
Change in unrealized gains/losses on available-for-sale securities	(1,529)	521	(3,102)	(2,455)
Derivatives, Before-Tax Amount:
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax	54	7	59	(2)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax	(5)	(5)	(10)	(11)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax, Total	49	2	49	(13)
Derivatives, Income Tax:
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax	(11)	(2)	(12)	0
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax	1	1	2	2
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax	(10)	(1)	(10)	2
Derivatives, After-Tax Amount:
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax	43	5	47	(2)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax	(4)	(4)	(8)	(9)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Total	39	1	39	(11)
Pension and other postretirement benefits liability, Before-tax Amount:
Amortization of prior service cost recognized in Operating expenses in the Condensed Consolidated Statements of Operations		(1)		(1)
Pension and other postretirement benefits liability	0	(1)	0	(1)
Pension and other post-employment benefit liability, Income Tax:
Amortization of prior service cost recognized in Operating expenses in the Condensed Consolidated Statements of Operations		0		0
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax		0		0
Pension and other postretirement benefits liability, After-tax Amount:
Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax		(1)		(1)
Change in pension and other postretirement benefits liability		(1)		(1)
Other comprehensive income (loss), before tax	(1,886)	660	(3,877)	(2,830)
Other comprehensive income (loss), tax	396	(139)	814	363
Other comprehensive income (loss), after tax	(1,490)	521	(3,063)	(2,467)
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Fixed maturities	(2,548)	826	(5,211)	(3,099)
Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, Tax	(535)	173	(1,094)	(420)
Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, after Tax	(2,013)	653	(4,117)	(2,679)
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, before Tax	(20)	2	(90)	1,775
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Tax	(4)	0	(19)	373
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax	(16)	2	(71)	1,402
Other Comprehensive Income (Loss), Deferred Acquisition Costs and Value Of Business Acquired (VOBA), Available-for-Sale Securities Adjustment, before Tax	593	(15)	1,190	1,194
Other Comprehensive Income (Loss), Deferred Acquisition Costs and Value Of Business Acquired (VOBA), Available-for-Sale Securities Adjustment, Tax	125	(3)	250	251
Other Comprehensive Income (Loss), Deferred Acquisition Costs and Value Of Business Acquired (VOBA), Available-for-Sale Securities Adjustment, Net of Tax	468	(12)	940	943
Premium deficiency reserve	5	(149)	14	445
Other Comprehensive Income (Loss), Premium Deficiency Reserve, Available-for-sale Securities Adjustment, Tax	1	(31)	3	93
Other Comprehensive Income (Loss), Premium Deficiency Reserve, Available-for-sale Securities Adjustment, Net of Tax	4	(118)	11	352
Sales inducements and other intangibles	(5)	(1)	(9)	419
Other Comprehensive Income (Loss), Sales Inducements, Available-for-sale Securities Adjustment, Tax	(1)	(1)	(2)	88
Other Comprehensive Income (Loss), Sales Inducements, Available-for-sale Securities Adjustment, Net of Tax	(4)	0	(7)	331
Change in unrealized gains/losses on available-for-sale securities	(1,935)	659	(3,926)	(2,816)
Other Comprehensive Income (Loss), Securities, Available-for-sale, Tax	(406)	138	(824)	(361)
Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, after Tax	(1,529)	521	(3,102)	(2,455)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax	54	7	59	(2)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax	11	2	12	0
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax	43	5	47	(2)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax	5	5	10	11
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax	1	1	2	2
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax	4	4	8	9
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax	49	2	49	(13)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax	10	1	10	(2)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	39	1	39	(11)
Other comprehensive income (loss), before tax	(1,886)	660	(3,877)	(2,830)
Income tax expense (benefit) related to items of other comprehensive income (loss)	(396)	139	(814)	(363)
Other comprehensive income (loss), after tax	(1,490)	521	(3,063)	(2,467)
Amortization of prior service cost recognized in Operating expenses in the Condensed Consolidated Statements of Operations		(1)		(1)
Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, Tax		0		0
Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax		(1)		(1)
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax	$ 0	1	$ 0	1
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax		0		0
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax		$ 1		$ 1

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Income Tax Disclosure [Abstract]
Effective tax rate	6.50%	10.90%	7%	3.10%
Effective Income Tax Rate Reconciliation, Tax Exempt Income, Percent		21%
Income tax expense (benefit) related to items of other comprehensive income (loss)	$ (396)	$ 139	$ (814)	$ (363)

Reinsurance - Assets and Liabil

Reinsurance - Assets and Liabilities (Details) - USD ($) $ in Millions	Jun. 30, 2022	Dec. 31, 2021
Assets
Premiums receivable, direct	$ 195	$ 169
Premiums Receivable, assumed	10	8
Premiums receivable, ceded	(205)	(213)
Premiums Receivable, net	0	(36)
Reinsurance recoverable, net of allowance for credit losses, ceded	13,079	13,671
Premium receivable and reinsurance recoverable	13,079	13,671
Total assets, direct	195	169
Total assets, assumed	10	8
Total assets, ceded	12,874	13,458
Premium receivable and reinsurance recoverable, net	13,079	13,635
Liabilities
Future policy benefits and contract owner account balances, direct	52,076	51,648
Future policy benefits and contract owner account balances, assumed	1,075	1,110
Future policy benefits and contract owner account balances, net	53,151	52,758
Liability for funds withheld under reinsurance agreements, direct	71	203
Liability for funds withheld under reinsurance agreements, net	71	203
Total liabilities, direct	52,147	51,851
Total liabilities, assumed	1,075	1,110
Total liabilities, net	53,222	$ 52,961
Deposits Assets	$ 1,600

Reinsurance - Effect of Reinusa

Reinsurance - Effect of Reinusance (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Premiums:
Direct Premiums Earned	$ 814	$ 760	$ 1,628	$ 1,532
Assumed Premiums Earned	4	5	13	14
Ceded Premiums Earned	223	249	433	6,017
Premiums	595	516	1,208	(4,471)
Fee income:
Revenue from Contract with Customer, Including Assessed Tax	510	537	1,043	1,097
Ceded Insurance Commissions And Fees	103	105	208	212
Fee income	411	436	844	894
Interest credited and other benefits to contract owners / policyholders:
Policyholder Benefits and Claims Incurred, Direct	1,076	1,037	1,954	3,004
Policyholder Benefits and Claims Incurred, Assumed	14	20	22	41
Policyholder Benefits and Claims Incurred, Ceded	447	371	668	6,549
Policyholder Interest and Other Benefits, Net	643	686	1,308	(3,504)
Universal Life
Interest credited and other benefits to contract owners / policyholders:
Policyholder Benefits and Claims Incurred, Ceded	72	56	150	5,845
assumed
Fee income:
Assumed Insurance Commissions and Fees	$ 4	$ 4	$ 9	$ 9

Financing Agreements - Schedule

Financing Agreements - Schedule of Long-term Debt (Details) - USD ($) $ in Millions	Jun. 30, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Long-term debt	$ 2,386	$ 2,596
Less: Current portion of long-term debt	1	1
Total long-term debt, excluding current portion	2,385	2,595
Senior Notes | 3.65% Senior Notes, due 2026
Debt Instrument [Line Items]
Long-term debt	$ 445	445
Annual interest rate on debt	3.65%
Senior Notes | 5.7% Senior Notes, due 2043
Debt Instrument [Line Items]
Long-term debt	$ 395	395
Annual interest rate on debt	5.70%
Senior Notes | 4.8% Senior Notes, due 2046
Debt Instrument [Line Items]
Long-term debt	$ 297	297
Annual interest rate on debt	4.80%
Junior Subordinated Notes | 4.7% Fixed-to-Floating Rate Junior Subordinated Notes, due 2048
Debt Instrument [Line Items]
Long-term debt	$ 345	345
Annual interest rate on debt	4.70%
Junior Subordinated Notes | 5.65% Fixed-to-Floating Rate Junior Subordinated Notes, due 2053
Debt Instrument [Line Items]
Long-term debt	$ 530	740
Annual interest rate on debt	5.65%
Debentures | 7.25% Voya Holdings Inc. debentures, due 2023
Debt Instrument [Line Items]
Long-term debt	$ 140	140
Annual interest rate on debt	7.25%
Debentures | 7.63% Voya Holdings Inc. debentures, due 2026
Debt Instrument [Line Items]
Long-term debt	$ 139	139
Annual interest rate on debt	7.63%
Debentures | 6.97% Voya Holdings Inc. debentures, due 2036
Debt Instrument [Line Items]
Long-term debt	$ 79	79
Annual interest rate on debt	6.97%
Debentures | Voya Holdings Debentures
Debt Instrument [Line Items]
Long-term debt	$ 358
Notes payable, other | 8.42% Equitable of Iowa Companies Capital Trust II Notes, due 2027
Debt Instrument [Line Items]
Long-term debt	$ 13	13
Annual interest rate on debt	8.42%
Loans payable | 1.00% Windsor Property Loan
Debt Instrument [Line Items]
Long-term debt	$ 3	$ 3
Annual interest rate on debt	1%

Financing Agreements - Narrativ

Financing Agreements - Narrative (Details) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2022	Dec. 31, 2021	Feb. 24, 2021	Nov. 01, 2019
Debt Instrument [Line Items]
Outstanding par amount of guaranteed debentures	$ 2,386	$ 2,596
Aetna Notes
Debt Instrument [Line Items]
Amount of letters of credit outstanding	163
Revolving Credit agreement
Debt Instrument [Line Items]
Maximum borrowing capacity	500
Minimum net worth required for compliance				$ 6,150
Voya Holdings Debentures | Aetna Notes
Debt Instrument [Line Items]
Amount of collateral for credit facility	363
Amount of collateral deposited to a control account	200
Debentures | Voya Holdings Debentures
Debt Instrument [Line Items]
Outstanding par amount of guaranteed debentures	358
Revolving Credit agreement
Debt Instrument [Line Items]
Amount of letters of credit outstanding	0
Outstanding borrowings	$ 0
Senior Notes | 3.125% Senior Notes, due 2024
Debt Instrument [Line Items]
Outstanding par amount of guaranteed debentures			$ 214
Annual interest rate on debt	5.65%
Debt Securities | Interest Expense
Debt Instrument [Line Items]
Income (loss) related to early extinguishment of debt	$ (4)

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) - USD ($) $ in Millions	3 Months Ended	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Loss Contingencies [Line Items]
Impairment of right-of-use asset	$ 0	$ 3	$ 13
Pledged Collateral	1,990	1,990		$ 1,881
Possible losses in excess of amounts accrued	25	25
Potential future loss	136	136
Henkel of America v. ReliaStar Life Insurance Company
Loss Contingencies [Line Items]
Potential future loss	47	47
Federal Home Loan Bank | Line of Credit
Loss Contingencies [Line Items]
Non-putable funding agreements issued to FHLB	$ 1,462	1,462		$ 1,461
Acquisition of mortgage loans
Loss Contingencies [Line Items]
Amount of purchase commitments		200
Purchase of limited partnership and private placement investments
Loss Contingencies [Line Items]
Amount of purchase commitments		1,094
Purchase of limited partnership and private placement investments | VOEs
Loss Contingencies [Line Items]
Amount of purchase commitments		$ 393

Commitments and Contingencies_2

Commitments and Contingencies - Restricted Assets (Details) - USD ($) $ in Millions	Jun. 30, 2022	Dec. 31, 2021
Loss Contingencies [Line Items]
Pledged Collateral	$ 1,990	$ 1,881
FHLB restricted stock	75	78
Trading securities	43	46
Cash and cash equivalents	35	31
Total restricted assets	3,326	3,234
Collateral Pledged
Loss Contingencies [Line Items]
Securities pledged	1,183	1,198
Securities pledged as collateral
Loss Contingencies [Line Items]
Fair value of loaned securities	913	969
Securities Pledged under repurchase agreements, carrying value	108	105
Securities Loaned
Loss Contingencies [Line Items]
Securities Owned and Pledged as Collateral	$ 162	$ 124

Consolidated and Nonconsolida_3

Consolidated and Nonconsolidated Investment Entities - General and Consolidated VIEs and VOEs and Nonconsolidated VIEs (Details) $ in Millions	6 Months Ended
	Jun. 30, 2022 USD ($) CLO fund	Dec. 31, 2021 USD ($) CLO
Variable Interest Entity [Line Items]
Consolidated collateral loan obligations | CLO	8	7
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Net	$ 0
Consolidated funds | fund	11
Noncontrolling interest	$ 1,697	$ 1,568
Consolidated Investment Entities
Variable Interest Entity [Line Items]
Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount	314	317
Noncontrolling interest	$ 1,697	$ 1,568

Consolidated and Nonconsolida_4

Consolidated and Nonconsolidated Investment Entities - Components of the Consolidated Investment Entities (Details) - USD ($) $ in Millions	Jun. 30, 2022	Dec. 31, 2021
Assets of Consolidated Investment Entities
Assets	$ 147,520	$ 171,262
Liabilities and Shareholders' Equity of Consolidated Investment Entities
Liabilities	141,307	161,441
Noncontrolling interest	1,697	1,568
Total liabilities and shareholders' equity	147,520	171,262
Consolidated Investment Entities
Liabilities and Shareholders' Equity of Consolidated Investment Entities
Noncontrolling interest	1,697	1,568
Total liabilities and shareholders' equity	3,851	3,461
VIEs
Assets of Consolidated Investment Entities
Assets	4,165	3,779
VIEs | Cash and cash equivalents
Assets of Consolidated Investment Entities
Assets	85	171
VIEs | Corporate loans, at fair value using the fair value option
Assets of Consolidated Investment Entities
Assets	1,122	1,111
VIEs | Limited partnerships/corporations, at fair value
Assets of Consolidated Investment Entities
Assets	2,943	2,469
VIEs | Other assets
Assets of Consolidated Investment Entities
Assets	15	28
VIEs | Other Liabilities
Liabilities and Shareholders' Equity of Consolidated Investment Entities
Liabilities	2,154	1,893
VOEs
Liabilities and Shareholders' Equity of Consolidated Investment Entities
Liabilities	2,154	1,893
VOEs | CLO notes, at fair value using the fair value option
Liabilities and Shareholders' Equity of Consolidated Investment Entities
Liabilities	1,019	880
VOEs | Other Liabilities
Liabilities and Shareholders' Equity of Consolidated Investment Entities
Liabilities	$ 1,135	$ 1,013

Consolidated and Nonconsolida_5

Consolidated and Nonconsolidated Investment Entities - Fair Value Measurement (Details) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
VOEs | Private Equity Funds
Variable Interest Entity [Line Items]
Revolving lines of credit capacity	$ 1,204	$ 1,214
Renewal period for term loan	3 years
Outstanding borrowings	$ 1,048	697
VOEs | Minimum | Private Equity Funds
Variable Interest Entity [Line Items]
Basis spread on notes	1.50%
Term of debt	5 years
VOEs | Maximum | Private Equity Funds
Variable Interest Entity [Line Items]
Basis spread on notes	2.15%
Term of debt	3 years
VOEs | LIBOR | Private Equity Funds
Variable Interest Entity [Line Items]
Description of variable rate basis	LIBOR
VOEs | EURIBOR | Private Equity Funds
Variable Interest Entity [Line Items]
Description of variable rate basis	EURIBOR
Senior secured corporate loans | VIEs
Variable Interest Entity [Line Items]
Unpaid principal exceeds fair value, amount	$ 55	$ 8
Default of collateral assets, percentage	1%
Weighted average maturity	12 years
Senior secured corporate loans | VIEs | Maximum
Variable Interest Entity [Line Items]
Basis spread on loans	10%
Senior secured corporate loans | VIEs | LIBOR
Variable Interest Entity [Line Items]
Description of variable rate basis	LIBOR
Senior secured corporate loans | VIEs | LIBOR | Minimum
Variable Interest Entity [Line Items]
Basis spread on notes	1%
Senior secured corporate loans | VIEs | LIBOR | Maximum
Variable Interest Entity [Line Items]
Basis spread on notes	8.80%
Senior secured corporate loans | VIEs | EURIBOR
Variable Interest Entity [Line Items]
Description of variable rate basis	EURIBOR
Senior secured corporate loans | VIEs | PRIME
Variable Interest Entity [Line Items]
Description of variable rate basis	PRIME
Senior secured corporate loans | VIEs | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Variable Interest Entity [Line Items]
Description of variable rate basis	SOFR

Consolidated and Nonconsolida_6

Consolidated and Nonconsolidated Investment Entities - Fair Value Hierarchy (Details) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	$ 0
Measured at fair value on a recurring basis
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets, Net Asset Value (NAV)	2,943	$ 2,469
Assets, Including NAV	4,150	3,751
Liabilities	1,019	880
Measured at fair value on a recurring basis | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets, Net Asset Value (NAV)	0	0
Measured at fair value on a recurring basis | Cash and cash equivalents | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	85	171
Assets, Net Asset Value (NAV)	0	0
Measured at fair value on a recurring basis | Corporate loans, at fair value using the fair value option | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	1,122	1,111
Assets, Net Asset Value (NAV)	0	0
Measured at fair value on a recurring basis | Limited partnerships/corporations, at fair value | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets, Net Asset Value (NAV)	2,943	2,469
Assets, Including NAV	2,943	2,469
Measured at fair value on a recurring basis | CLO notes, at fair value using the fair value option | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets, Net Asset Value (NAV)	0	0
Liabilities	1,019	880
Measured at fair value on a recurring basis | Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	85	171
Liabilities	0	0
Measured at fair value on a recurring basis | Level 1 | Cash and cash equivalents | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	85	171
Measured at fair value on a recurring basis | Level 1 | Corporate loans, at fair value using the fair value option | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Measured at fair value on a recurring basis | Level 1 | Limited partnerships/corporations, at fair value | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Measured at fair value on a recurring basis | Level 1 | CLO notes, at fair value using the fair value option | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	0	0
Measured at fair value on a recurring basis | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	1,122	1,111
Liabilities	1,019	880
Measured at fair value on a recurring basis | Level 2 | Cash and cash equivalents | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Measured at fair value on a recurring basis | Level 2 | Corporate loans, at fair value using the fair value option | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	1,122	1,111
Measured at fair value on a recurring basis | Level 2 | Limited partnerships/corporations, at fair value | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Measured at fair value on a recurring basis | Level 2 | CLO notes, at fair value using the fair value option | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	1,019	880
Measured at fair value on a recurring basis | Level 3
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Liabilities	0	0
Measured at fair value on a recurring basis | Level 3 | Cash and cash equivalents | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Measured at fair value on a recurring basis | Level 3 | Corporate loans, at fair value using the fair value option | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Measured at fair value on a recurring basis | Level 3 | Limited partnerships/corporations, at fair value | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Measured at fair value on a recurring basis | Level 3 | CLO notes, at fair value using the fair value option | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	$ 0	$ 0

Consolidated and Nonconsolida_7

Consolidated and Nonconsolidated Investment Entities - Deconsolidation and Nonconsolidated VIEs (Details) $ in Millions	6 Months Ended
	Jun. 30, 2022 USD ($) loan	Dec. 31, 2021 USD ($)
Variable Interest Entity [Line Items]
Number of deconsolidated investment entities | loan	0
Total assets	$ 147,520	$ 171,262
VIEs, Not Primary Beneficiary
Variable Interest Entity [Line Items]
Amount of ownership interest in unconsolidated CLOs	358	415
VIEs, Not Primary Beneficiary | Limited Partnerships
Variable Interest Entity [Line Items]
Total assets	$ 1,848	$ 1,739

Restructuring - Narrative (Deta

Restructuring - Narrative (Details) - Organizational restructuring - Discontinued Operations $ in Millions	3 Months Ended	6 Months Ended
	Mar. 31, 2022 USD ($)	Jun. 30, 2022 USD ($) subsidiary
Restructuring Cost and Reserve [Line Items]
Number of subsidiaries sold | subsidiary		5
Restructuring Charges, expenses related to Individual Life Transaction	$ 91	$ 19
Minimum
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost Remaining		20
Maximum
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost Remaining		$ 40

Restructuring - Restructuring E

Restructuring - Restructuring Expense by Type (Details) - Organizational restructuring - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Restructuring Cost and Reserve [Line Items]
Total restructuring expenses	$ 8	$ 41	$ 19	$ 52
Cumulative Amounts Incurred to Date	495		495
Continuing Operations
Restructuring Cost and Reserve [Line Items]
Total restructuring expenses	8	41	19	52
Cumulative Amounts Incurred to Date	430		430
Discontinued Operations
Restructuring Cost and Reserve [Line Items]
Total restructuring expenses	0	0	0	0
Cumulative Amounts Incurred to Date	65		65
Severance benefits
Restructuring Cost and Reserve [Line Items]
Total restructuring expenses	2	9	2	13
Cumulative Amounts Incurred to Date	86		86
Transition Costs
Restructuring Cost and Reserve [Line Items]
Total restructuring expenses	6	$ 32	17	$ 39
Cumulative Amounts Incurred to Date	$ 409		$ 409

Restructuring - Accrued Liabili

Restructuring - Accrued Liability for Restructuring Expense (Details) - Organizational restructuring $ in Millions	6 Months Ended
	Jun. 30, 2022 USD ($)
Restructuring Reserve [Roll Forward]
Accrued liability, beginning balance	$ 52
Provision	19
Payments	(36)
Accrued liability, ending balance	35
Severance Benefits
Restructuring Reserve [Roll Forward]
Accrued liability, beginning balance	30
Provision	2
Payments	(6)
Accrued liability, ending balance	26
Transition Costs
Restructuring Reserve [Roll Forward]
Accrued liability, beginning balance	22
Provision	17
Payments	(30)
Accrued liability, ending balance	$ 9

Segments - Narrative (Details)

Segments - Narrative (Details)	6 Months Ended
	Jun. 30, 2022 segments
Segment Reporting [Abstract]
Number of operating segments	3

Segments - Operating Earnings B

Segments - Operating Earnings Before Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Segment Reporting Information [Line Items]
Total adjustments to income (loss) from continuing operations	$ 153	$ 1,028	$ 244	$ 2,066
Income (loss) attributable to noncontrolling interest	75	447	118	447
Less: Preferred stock dividends	4	4	18	18
Adjustments
Segment Reporting Information [Line Items]
Total adjustments to income (loss) from continuing operations	(70)	675	(188)	1,441
Net investment gains (losses) and related charges and adjustments	(52)	29	(139)	67
Net guaranteed benefit gains (losses) and related charges and adjustments	3	(5)	(19)	5
Income (loss) related to businesses exited or to be exited through reinsurance or divestment	(50)	247	(97)	971
Income (loss) attributable to noncontrolling interest	75	447	118	447
Income (loss) related to early extinguishment of debt	1	0	(4)	(10)
Immediate recognition of net actuarial gains (losses) related to pension and other post-employment benefit obligations and gains (losses) from plan amendments and curtailments	0	0	4	0
Other adjustments	(51)	(46)	(68)	(57)
Operating Segments
Segment Reporting Information [Line Items]
Adjusted operating earnings before income taxes	223	353	431	626
Operating Segments | Wealth Solutions
Segment Reporting Information [Line Items]
Adjusted operating earnings before income taxes	186	295	391	550
Operating Segments | Investment Management
Segment Reporting Information [Line Items]
Adjusted operating earnings before income taxes	40	66	79	118
Operating Segments | Health Solutions
Segment Reporting Information [Line Items]
Adjusted operating earnings before income taxes	47	63	68	100
Operating Segments | Corporate
Segment Reporting Information [Line Items]
Adjusted operating earnings before income taxes	$ (49)	$ (71)	$ (107)	$ (142)

Segments - Operating Revenues (

Segments - Operating Revenues (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Segment Reporting Information [Line Items]
Total revenues	$ 1,519	$ 2,503	$ 3,033	$ 546
Adjustments
Segment Reporting Information [Line Items]
Total revenues	(14)	889	(102)	(2,663)
Net investment gains (losses) and related charges and adjustments	(60)	(71)	(157)	(39)
Gains (losses) on change in fair value of derivatives related to guaranteed benefits	3	(5)	(19)	5
Revenues related to businesses exited or to be exited through reinsurance or divestment	(58)	296	(104)	(3,413)
Revenues attributable to noncontrolling interest	93	464	142	470
Other adjustments	8	205	36	315
Operating Segments
Segment Reporting Information [Line Items]
Total revenues	1,534	1,614	3,135	3,209
Operating Segments | Wealth Solutions
Segment Reporting Information [Line Items]
Total revenues	706	807	1,460	1,589
Operating Segments | Investment Management
Segment Reporting Information [Line Items]
Total revenues	171	193	349	382
Operating Segments | Health Solutions
Segment Reporting Information [Line Items]
Total revenues	640	591	1,287	1,190
Operating Segments | Corporate
Segment Reporting Information [Line Items]
Total revenues	17	24	39	48
Intersegment | Investment Management
Segment Reporting Information [Line Items]
Total revenues	$ 23	$ 22	$ 45	$ 45

Segments - Total Assets (Detail

Segments - Total Assets (Details) - USD ($) $ in Millions	Jun. 30, 2022	Dec. 31, 2021
Segment Reporting Information [Line Items]
Total assets	$ 147,520	$ 171,262
Noncontrolling Interest
Segment Reporting Information [Line Items]
Total assets	3,852	3,465
Total | Parent
Segment Reporting Information [Line Items]
Total assets	143,668	167,797
Operating Segments | Wealth Solutions
Segment Reporting Information [Line Items]
Total assets	115,202	137,544
Operating Segments | Investment Management
Segment Reporting Information [Line Items]
Total assets	970	1,226
Operating Segments | Health Solutions
Segment Reporting Information [Line Items]
Total assets	2,901	3,002
Corporate | Parent
Segment Reporting Information [Line Items]
Total assets	$ 24,595	$ 26,025